10-Q 1 d279365d10q.htm AB PRIVATE CREDIT INVESTORS CORPORATION AB Private Credit Investors Corporation
Table of Contents

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 10-Q

 

 

(Mark One)

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2022

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

COMMISSION FILE NUMBER: 814-01196

 

 

AB Private Credit Investors Corporation

(Exact name of registrant as specified in its charter)

 

 

 

Maryland   81-2491356
(State of incorporation)  

(I.R.S. Employer

Identification No.)

1345 Avenue of the Americas

New York, NY 10105

(Address of principal executive offices)

(212) 969-1000

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading Symbol(s)

 

Name of each exchange on which  registered

   

Securities registered pursuant to Section 12(g) of the Act:

Common Stock, par value $0.01 per share

(Title of Class)

 

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ☒    No  ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  ☒    No  ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer      Accelerated filer  
Non-accelerated filer      Smaller reporting company  
Emerging Growth Company       

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act).  ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).     Yes  ☐    No  ☒

The issuer had 38,544,494 shares of common stock, $0.01 par value per share, outstanding as of March 31, 2022.

 

 

 


Table of Contents

AB PRIVATE CREDIT INVESTORS CORPORATION

FORM 10-Q FOR THE QUARTER ENDED March 31, 2022

Table of Contents

 

    

INDEX

   PAGE
NO.
 

PART I.

   FINANCIAL INFORMATION      3  

Item 1.

  

Consolidated Financial Statements

     3  

Item 2.

  

Management’s Discussion and Analysis of Financial Condition and Results of Operations

     53  

Item 3.

  

Quantitative and Qualitative Disclosures About Market Risk

     66  

Item 4.

  

Controls and Procedures

     67  

PART II.

   OTHER INFORMATION      67  

Item 1.

  

Legal Proceedings

     67  

Item 1A.

  

Risk Factors

     67  

Item 2.

  

Unregistered Sales of Equity Securities and Use of Proceeds

     68  

Item 3.

  

Defaults Upon Senior Securities

     68  

Item 4.

  

Mine Safety Disclosures

     68  

Item 5.

  

Other Information

     68  

Item 6.

  

Exhibits

     69  

SIGNATURES

     

 

2


Table of Contents
Item 1.

Financial Statements

AB Private Credit Investors Corporation

Consolidated Statements of Assets and Liabilities

 

     As of
March 31, 2022
(Unaudited)
     As of
December 31,
2021
 

Assets

 

Investments, at fair value (amortized cost of $946,391,430 and $885,880,524, respectively)

   $ 950,185,904      $ 892,580,993  

Cash and cash equivalents

     61,344,800        54,489,043  

Interest receivable

     4,030,832        3,221,620  

Deferred financing costs

     2,852,031        3,438,175  

Receivable for fund shares

     2,143,951        22,528,538  

Receivable for investments sold

     196,407        938,678  

Prepaid expenses

     103,294        256,534  

Prepaid directors’ fee

     —          63,025  
  

 

 

    

 

 

 

Total assets

   $ 1,020,857,219      $ 977,516,606  
  

 

 

    

 

 

 

Liabilities

 

Credit facility payable

   $ 408,600,000      $ 380,600,000  

Notes payable (net of unamortized discount of $20,661 and $21,813, respectively, and debt issuance costs of $399,273 and $673,583, respectively)

     212,730,066        212,454,604  

Secured borrowings

     5,360,494        10,228,115  

Distribution payable

     4,608,141        2,340,900  

Payable for Fund shares repurchased

     4,081,370        4,736,139  

Interest and borrowing expenses payable

     3,225,523        2,866,844  

Management fees payable

     3,119,226        2,653,052  

Incentive fee payable

     2,668,251        2,660,332  

Professional fees payable

     705,809        597,318  

Payable to Adviser

     695,220        1,680,410  

Administrator and custodian fees payable

     572,944        506,871  

Miscellaneous payable

     507,227        200,000  

Payable for investments purchased

     132,447        9,692,322  

Accrued expenses and other liabilities

     33,955        —    

Transfer agent fees payable

     25,676        23,019  
  

 

 

    

 

 

 

Total liabilities

   $ 647,066,349      $ 631,239,926  
  

 

 

    

 

 

 

Commitments and Contingencies (Note 6)

 

Net Assets

 

Common stock, par value $0.01 per share (200,000,000 shares authorized, 38,544,494 and 35,343,949 shares issued and outstanding at March 31, 2022 and December 31, 2021, respectively)

     385,445        353,440  

Paid-in capital in excess of par value

     370,964,346        339,292,017  

Distributable earnings (accumulated loss)

     2,416,317        6,614,462  
  

 

 

    

 

 

 

Total net assets of AB Private Credit Investors Corporation

   $ 373,766,108      $ 346,259,919  
  

 

 

    

 

 

 

Non-Controlling Interest in ABPCIC Equity Holdings, LLC

   $ 24,762      $ 16,761  
  

 

 

    

 

 

 

Total net assets

   $ 373,790,870      $ 346,276,680  
  

 

 

    

 

 

 

Total liabilities and net assets

   $ 1,020,857,219      $ 977,516,606  
  

 

 

    

 

 

 

Net asset value per share of AB Private Credit Investors Corporation

   $ 9.70      $ 9.80  
  

 

 

    

 

 

 

See Notes to Unaudited Consolidated Financial Statements

 

3


Table of Contents

AB Private Credit Investors Corporation

Unaudited Consolidated Statements of Operations

 

     For the Three Months Ended
March 31,
 
     2022     2021  

Investment Income:

Interest income, net of amortization/accretion

   $ 19,084,451     $ 10,484,277  

Payment-in-kind interest

     594,399       375,483  

Dividend income

     8,587       —    
  

 

 

   

 

 

 

Total investment income

     19,687,437       10,859,760  
  

 

 

   

 

 

 

Expenses:

Interest and borrowing expenses

     5,140,785       2,605,053  

Management fees

     3,402,792       2,069,181  

Income-based incentive fee

     1,931,939       641,062  

Professional fees

     476,980       549,052  

Collateral management fees

     456,498       454,343  

Administration and custodian fees

     223,237       163,051  

Insurance expenses

     153,239       146,334  

Directors’ fees

     50,000       50,000  

Transfer agent fees

     25,676       16,386  

Capital gains incentive fee

     (546,733     —    

Other expenses

     299,625       163,622  
  

 

 

   

 

 

 

Total expenses

     11,614,038       6,858,084  

Reimbursement payments to Adviser (See Note 3: Expense Support and Conditional Reimbursement Agreement)

     259,263       280,779  

Waived collateral management fees

     (456,498     (454,343

Waived management fees

     (283,566     (183,001
  

 

 

   

 

 

 

Net expenses

     11,133,237       6,501,519  
  

 

 

   

 

 

 

Net investment income before taxes

     8,554,200       4,358,241  
  

 

 

   

 

 

 

Income tax expense, including excise tax

     308,827       —    
  

 

 

   

 

 

 

Net investment income after tax

     8,245,373       4,358,241  
  

 

 

   

 

 

 

Net realized and change in unrealized gains (losses) on investment transactions:

 

Net realized gain (loss) from investments

     172,332       59,470  

Net change in unrealized appreciation (depreciation) on investments

     (2,905,995     1,753,609  
  

 

 

   

 

 

 

Net realized and change in unrealized gains (losses) on investment transactions

     (2,733,663     1,813,079  
  

 

 

   

 

 

 

Net increase in net assets resulting from operations

   $ 5,511,710     $ 6,171,320  
  

 

 

   

 

 

 

Less: Net increase (decrease) in net assets resulting from operations related to Non-Controlling Interest in ABPCIC Equity Holdings, LLC

   $ 10     $ (193
  

 

 

   

 

 

 

Net increase (decrease) in net assets resulting from operations related to AB Private Credit Investors Corporation

   $ 5,511,700     $ 6,171,513  
  

 

 

   

 

 

 

Net investment income per share (basic and diluted):

Net investment income per share (basic and diluted):

   $ 0.23     $ 0.16  

Earnings per share (basic and diluted):

   $ 0.15     $ 0.23  

Weighted average shares outstanding:

     36,411,259       26,432,156  

See Notes to Unaudited Consolidated Financial Statements

 

4


Table of Contents

AB Private Credit Investors Corporation

Unaudited Consolidated Statements of Changes in Net Assets

 

     Common Stock                          
     Shares     Par
Amount
    Paid in
Capital in
Excess of Par
    Distributable
Earnings
    Non-Controlling
Interest -
ABPCIC
Equity
Holdings, LLC
    Total
Net Assets
 

Net assets at December 31, 2021

     35,343,949     $ 353,440     $ 339,292,017     $ 6,614,462     $ 16,761     $ 346,276,680  

Increase (decrease) in net assets resulting from operations:

 

Net investment income

     —         —         —         8,245,567       (194     8,245,373  

Net realized gain (loss) on investments

     —         —         —         172,332       —         172,332  

Net change in unrealized appreciation (depreciation) on investments

     —         —         —         (2,906,199     204       (2,905,995

Capital transactions:

 

Issuance of common stock

     3,095,246       30,952       30,653,048       —         —         30,684,000  

Contribution of non-controlling interest into ABPCIC Equity Holdings, LLC

     —         —         —         —         7,991       7,991  

Issuance of common shares pursuant to distribution reinvestment plan

     526,163       5,262       5,096,442       —         —         5,101,704  

Repurchase of common stock

     (420,864     (4,209     (4,077,161     —         —         (4,081,370

Distributions to stockholders

     —         —         —         (9,709,845     —         (9,709,845
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) for the three months ended March 31, 2022

     3,200,545       32,005       31,672,329       (4,198,145     8,001       27,514,190  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net assets at March 31, 2022

     38,544,494     $ 385,445     $ 370,964,346     $ 2,416,317     $ 24,762     $ 373,790,870  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Distributions declared per share

     —       $ —       $ —       $ 0.25     $ —       $ 0.25  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

See Notes to Unaudited Consolidated Financial Statements

 

5


Table of Contents

AB Private Credit Investors Corporation

Unaudited Consolidated Statements of Changes in Net Assets

 

     Common Stock                          
     Shares     Par
Amount
    Paid in
Capital in
Excess of Par
    Distributable
Earnings
    Non-Controlling
Interest -
ABPCIC
Equity
Holdings, LLC
    Total
Net Assets
 

Net assets at December 31, 2020

     23,775,222     $ 237,752     $ 227,482,784     $ (5,360,904   $ 641     $ 222,360,273  

Increase (decrease) in net assets resulting from operations:

 

Net investment income

     —         —         —         4,358,498       (257     4,358,241  

Net realized gain (loss) on investments

     —         —         —         59,470       —         59,470  

Net change in unrealized appreciation (depreciation) on investments

     —         —         —         1,753,545       64       1,753,609  

Capital transactions:

 

Issuance of common stock

     4,001,981       40,020       37,668,979       —         —         37,708,999  

Contribution of non-controlling interest into ABPCIC Equity Holdings, LLC

     —         —         —         —         2,625       2,625  

Issuance of common shares pursuant to distribution reinvestment plan

     229,904       2,299       2,165,269       —         —         2,167,568  

Repurchase of common stock

     (1,173,288     (11,733     (11,050,148     —         —         (11,061,881

Distributions to stockholders

     —         —         —         (4,358,022     —         (4,358,022
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) for the three months ended March 31, 2021

     3,058,597       30,586       28,784,100       1,813,491       2,432       30,630,609  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net assets at March 31, 2021

     26,833,819     $ 268,338     $ 256,266,884     $ (3,547,413   $ 3,073     $ 252,990,882  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Distributions declared per share

     —       $ —       $ —       $ 0.16     $ —       $ 0.16  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

See Notes to Unaudited Consolidated Financial Statements

 

6


Table of Contents

AB Private Credit Investors Corporation

Unaudited Consolidated Statements of Cash Flows

 

     Three Months
Ended
March 31, 2022
    Three Months
Ended
March 31, 2021
 

Cash flows from operating activities

 

Net increase (decrease) in net assets resulting from operations

   $ 5,511,710     $ 6,171,320  

Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used for) operating activities:

 

Purchases of investments

     (88,226,756     (70,237,468

Payment-in-kind investments

     (594,399     (375,483

Proceeds from sales of investments and principal repayments

     29,873,338       23,559,275  

Net realized (gain) loss on investments

     (172,332     (59,470

Net change in unrealized (appreciation) depreciation on investments

     2,905,995       (1,753,609

Amortization of premium and accretion of discount, net

     (1,390,757     (788,271

Amortization of discount, debt issuance and deferred financing costs

     1,164,762       492,785  

Increase (decrease) in operating assets and liabilities:

 

(Increase) decrease in receivable for investments sold

     742,271       55,058  

(Increase) decrease in interest receivable

     (809,212     (78,128

(Increase) decrease in other assets

     —         671  

(Increase) decrease in prepaid directors’ fee

     63,025       —    

(Increase) decrease in prepaid expenses

     153,240       146,334  

Increase (decrease) in payable for investments purchased

     (9,559,875     —    

Increase (decrease) in due to affiliate

     —         (469,453

Increase (decrease) in management fees payable

     466,174       1,886,180  

Increase (decrease) in payable to Adviser

     (985,190     581,827  

Increase (decrease) in administrator and custodian fees payable

     66,073       163,050  

Increase (decrease) in professional fees payable

     108,491       180,291  

Increase (decrease) in miscellaneous payable

     307,227       —    

Increase (decrease) in incentive fee payable

     7,919       641,062  

Increase (decrease) in transfer agent fees payable

     2,657       16,386  

Increase (decrease) in interest and borrowing expenses payable

     358,679       77,031  

Increase (decrease) in accrued organization costs

     —         (106,510

Increase (decrease) in accrued expenses and other liabilities

     33,955       8,090  
  

 

 

   

 

 

 

Net cash provided by (used for) operating activities

     (59,973,005     (39,889,032
  

 

 

   

 

 

 

Cash flows from financing activities

 

Issuance of common stock

     51,068,587       70,854,128  

Contribution of Non-Controlling Interest into ABPCIC Equity Holdings, LLC

     7,991       2,625  

Repurchase of common stock

     (4,736,139     —    

Distributions paid

     (2,340,900     (1,541,994

Financing costs paid

     (303,156     (875,010

Borrowings on credit facility

     88,000,000       98,800,000  

Repayments of credit facility

     (60,000,000     (80,000,000

Repayments on secured borrowings

     (4,867,621     (18,870,856
  

 

 

   

 

 

 

Net cash provided by (used for) financing activities

     66,828,762       68,368,893  
  

 

 

   

 

 

 

Net increase (decrease) in cash

     6,855,757       28,479,861  

Cash and cash equivalents, beginning of period

     54,489,043       22,410,622  
  

 

 

   

 

 

 

Cash and cash equivalents, end of period

   $ 61,344,800     $ 50,890,483  
  

 

 

   

 

 

 

Supplemental and non-cash financing activities

 

Cash paid during the period for interest

   $ 3,528,077     $ 1,951,874  

Issuance of common shares pursuant to distribution reinvestment plan

   $ 5,101,704     $ 2,167,568  

State taxes paid

   $ 1,600     $ —    

See Notes to Unaudited Consolidated Financial Statements

 

7


Table of Contents

AB Private Credit Investors Corporation

Consolidated Schedule of Investments as of March 31, 2022

(Unaudited)

 

Portfolio Company

 

Industry

 

Facility Type

 

Interest

 

Maturity

  Funded
Par Amount
    Cost     Fair Value  
Investments at Fair Value—254.20% + * # ^  
U.S. Corporate Debt—240.27%  
1st Lien/Senior Secured Debt—237.36%  

AmerCareRoyal, LLC(1)

  Business Services   Delayed Draw Term Loan   6.00% (L + 5.00%; 1.00% Floor)   11/25/2025   $ 513,062     $ 509,181     $ 482,278  

AmerCareRoyal, LLC(2)

  Business Services   Term Loan   6.00% (L + 5.00%; 1.00% Floor)   11/25/2025     533,510       529,424       501,499  

AmerCareRoyal, LLC(1)

  Business Services   Term Loan   6.00% (L + 5.00%; 1.00% Floor)   11/25/2025     4,255,796       4,228,288       4,000,448  

BEP Borrower Holdco,
LLC(2) (3)

  Business Services   Delayed Draw Term Loan   5.25% (L + 4.25%; 1.00% Floor)   06/12/2024     1,264,148       1,253,885       1,264,148  

BEP Borrower Holdco,
LLC(4) (5)

  Business Services   Revolver   5.25% (L + 4.25%; 1.00% Floor)   06/12/2024     —         (2,870     —    

BEP Borrower Holdco,
LLC(1)

  Business Services   Term Loan   5.25% (L + 4.25%; 1.00% Floor)   06/12/2024     3,371,062       3,346,691       3,371,062  

Engage2Excel, Inc.(1) (4)

  Business Services   Revolver   8.25% (L + 7.25%; 1.00% Floor)   03/07/2023     312,456       310,882       308,626  

Engage2Excel, Inc.(1)

  Business Services   Term Loan   8.25% (L + 7.25%; 1.00% Floor)   03/07/2023     1,034,754       1,029,268       1,024,407  

Engage2Excel, Inc.(1)

  Business Services   Term Loan   8.25% (L + 7.25%; 1.00% Floor)   03/07/2023     2,981,852       2,968,428       2,952,034  

Global Radar Holdings,
LLC(4) (5)

  Business Services   Revolver   7.00% (L + 6.00%; 1.00% Floor)   12/31/2025     —         (1,760     —    

Global Radar Holdings,
LLC(2) (3)

  Business Services   Term Loan   7.00% (L + 6.00%; 1.00% Floor)   12/31/2025     7,475,205       7,359,318       7,475,205  

Metametrics, Inc.(4) (5)

  Business Services   Revolver   6.01% (L + 5.00%; 1.00% Floor)   09/10/2025     —         (7,547     (1,628

Metametrics, Inc.(1) (2)

  Business Services   Term Loan   6.01% (L + 5.00%; 1.00% Floor)   09/10/2025     4,731,059       4,671,818       4,719,231  

MSM Acquisitions, Inc.(4)

  Business Services   Delayed Draw Term Loan   7.00% (L + 6.00%; 1.00% Floor)   12/09/2026     35,743       21,542       35,743  

MSM Acquisitions, Inc.(2)

  Business Services   Delayed Draw Term Loan   7.00% (L + 6.00%; 1.00% Floor)   12/09/2026     3,028,113       2,976,934       3,012,972  

MSM Acquisitions, Inc.(4)

  Business Services   Revolver   8.50% (P + 5.00%; 2.00% Floor)   12/09/2026     339,950       320,635       333,825  

MSM Acquisitions, Inc.(1) (2) (3)

  Business Services   Term Loan   7.00% (L + 6.00%; 1.00% Floor)   12/09/2026     8,274,768       8,151,216       8,233,395  

Rep Tec Intermediate Holdings,
Inc.(4) (5)

  Business Services   Revolver   7.51% (L + 6.50%; 1.00% Floor)   06/19/2025     —         (12,068     (3,946

Rep Tec Intermediate Holdings,
Inc.(1) (2) (3)

  Business Services   Term Loan   7.51% (L + 6.50%; 1.00% Floor)   06/19/2025     14,679,402       14,448,977       14,606,005  

Valcourt Holdings II, LLC(1) (4)

  Business Services   Delayed Draw Term Loan   6.50% (S + 5.50%; 1.00% Floor)   01/07/2027     629,494       605,829       629,494  

Valcourt Holdings II, LLC(2)

  Business Services   Term Loan   6.50% (S + 5.50%; 1.00% Floor)   01/07/2027     1,163,958       1,140,679       1,163,958  

Valcourt Holdings II, LLC(2)

  Business Services   Term Loan   6.51% (S + 5.50%; 1.00% Floor)   01/07/2027     2,661,411       2,616,458       2,661,411  

Valcourt Holdings II, LLC(1) (2)

  Business Services   Term Loan   6.51% (S + 5.50%; 1.00% Floor)   01/07/2027     6,327,149       6,222,699       6,327,149  

AEG Holding Company, Inc.(1)

  Consumer Discretionary   Delayed Draw Term Loan   6.75% (L + 5.75%; 1.00% Floor)   11/20/2023     1,053,829       1,047,457       1,053,829  

AEG Holding Company, Inc.(4) (5)

  Consumer Discretionary   Revolver   6.75% (L + 5.75%; 1.00% Floor)   11/20/2023     —         (7,369     —    

AEG Holding Company, Inc.(3)

  Consumer Discretionary   Term Loan   6.75% (L + 5.75%; 1.00% Floor)   11/20/2023     1,833,827       1,819,478       1,833,827  

AEG Holding Company, Inc.(1)

  Consumer Discretionary   Term Loan   6.75% (L + 5.75%; 1.00% Floor)   11/20/2023     5,559,695       5,524,825       5,559,695  

Ampler QSR Holdings, LLC(2) (3)

  Consumer Non-Cyclical   Term Loan   6.88% (L + 5.88%; 1.00% Floor)   07/21/2027     12,440,575       12,219,433       11,942,952  

Blink Holdings, Inc.(1)

  Consumer Non-Cyclical   Delayed Draw Term Loan   6.50% (L + 5.50%; 1.00% Floor)   11/08/2024     1,178,697       1,172,219       1,069,668  

Blink Holdings, Inc.

  Consumer Non-Cyclical   Delayed Draw Term Loan   6.50% (L + 5.50%; 1.00% Floor)   11/08/2024     945,093       945,093       857,672  

Blink Holdings, Inc.(1)

  Consumer Non-Cyclical   Term Loan   6.50% (L + 5.50%; 1.00% Floor)   11/08/2024     1,647,736       1,638,655       1,495,320  

Captain D’s, Inc.(4) (5)

  Consumer Non-Cyclical   Revolver   5.50% (L + 4.50%; 1.00% Floor)   12/15/2023     —         (627     —    

Captain D’s, Inc.(1)

  Consumer Non-Cyclical   Term Loan   5.50% (L + 4.50%; 1.00% Floor)   12/15/2023     1,929,660       1,923,374       1,929,660  

Freddy’s Frozen Custard, L.L.C(4) (5)

  Consumer Non-Cyclical   Revolver   6.00% (L + 5.00%; 1.00% Floor)   03/03/2027     —         (4,254     —    

Freddy’s Frozen Custard, L.L.C(2) (3)

  Consumer Non-Cyclical   Term Loan   6.00% (L + 5.00%; 1.00% Floor)   03/03/2027     4,895,641       4,844,884       4,895,641  

Krispy Krunchy Foods, L.L.C(4) (5)

  Consumer Non-Cyclical   Revolver   5.75% (L + 4.75%; 1.00% Floor)   11/17/2027     —         (18,330     (19,498

Krispy Krunchy Foods, L.L.C(2) (3)

  Consumer Non-Cyclical   Term Loan   5.75% (L + 4.75%; 1.00% Floor)   11/17/2027     11,669,364       11,449,953       11,435,977  

Mathnasium LLC(4)

  Consumer Non-Cyclical   Revolver   5.75% (L + 5.00%; 0.75% Floor)   11/15/2027     87,043       74,780       73,987  

Mathnasium LLC(1) (2)

  Consumer Non-Cyclical   Term Loan   5.75% (L + 5.00%; 0.75% Floor)   11/15/2027     5,440,202       5,338,010       5,331,398  

MMP Intermediate, LLC(4) (5)

  Consumer Non-Cyclical   Revolver   7.25% (L + 6.25%; 1.00% Floor)   02/15/2027     —         (10,792     (11,058

MMP Intermediate, LLC(1) (2)

  Consumer Non-Cyclical   Term Loan   7.25% (L + 6.25%; 1.00% Floor)   02/15/2027     8,272,465       8,110,463       8,107,016  

PF Growth Partners, LLC(1)

  Consumer Non-Cyclical   Term Loan   6.50% (L + 5.50%; 1.00% Floor)   07/11/2025     118,340       114,713       114,494  

PF Growth Partners, LLC(1)

  Consumer Non-Cyclical   Term Loan   6.50% (L + 5.50%; 1.00% Floor)   07/11/2025     239,084       231,756       231,313  

PF Growth Partners, LLC(1)

  Consumer Non-Cyclical   Term Loan   6.01% (L + 5.00%; 1.00% Floor)   07/11/2025     1,986,256       1,974,370       1,921,703  

TBG Food Acquisition Corp(4) (5)

  Consumer Non-Cyclical   Delayed Draw Term Loan   5.00% (L + 4.25%; 0.75% Floor)   12/25/2027     —         (10,107     (18,482

TBG Food Acquisition Corp(4) (5)

  Consumer Non-Cyclical   Revolver   5.00% (L + 4.25%; 0.75% Floor)   12/25/2027     —         (2,527     (4,620

TBG Food Acquisition Corp(1) (2)

  Consumer Non-Cyclical   Term Loan   5.00% (L + 4.25%; 0.75% Floor)   12/25/2027     6,584,150       6,521,083       6,468,927  

5 Bars, LLC(4) (5)

  Digital Infrastructure & Services   Delayed Draw Term Loan   5.00% (L + 4.00%; 1.00% Floor)   09/27/2024     —         (25,983     —    

5 Bars, LLC(4) (5)

  Digital Infrastructure & Services   Revolver   5.00% (L + 4.00%; 1.00% Floor)   09/27/2024     —         (4,872     —    

5 Bars, LLC(3)

  Digital Infrastructure & Services   Term Loan   5.00% (L + 4.00%; 1.00% Floor)   09/27/2024     4,742,121       4,704,242       4,742,121  

 

See Notes to Unaudited Consolidated Financial Statements

 

8


Table of Contents

AB Private Credit Investors Corporation

Consolidated Schedule of Investments as of March 31, 2022 (continued)

(Unaudited)

 

Portfolio Company

 

Industry

 

Facility Type

 

Interest

 

Maturity

  Funded
Par Amount
    Cost     Fair Value  

Airwavz Solutions, Inc(4) (5)

  Digital Infrastructure & Services   Delayed Draw Term Loan   6.00% (S + 5.00%; 1.00% Floor)   03/31/2027   $ —       $ (32,620   $ (32,637

Airwavz Solutions, Inc(4) (5)

  Digital Infrastructure & Services   Revolver   6.00% (S + 5.00%; 1.00% Floor)   03/31/2027     —         (11,423     (11,423

Airwavz Solutions, Inc(3)

  Digital Infrastructure & Services   Term Loan   6.00% (S + 5.00%; 1.00% Floor)   03/31/2027     5,221,919       5,130,535       5,130,535  

Avant Communications, LLC(4) (5)

  Digital Infrastructure & Services   Revolver   6.51% (L + 5.50%; 1.00% Floor)   11/30/2026     —         (10,602     (9,921

Avant Communications, LLC(1) (2)

  Digital Infrastructure & Services   Term Loan   6.51% (L + 5.50%; 1.00% Floor)   11/30/2026     5,089,434       4,994,254       5,000,369  

Bridgepointe Technologies, LLC(4) (5)

  Digital Infrastructure & Services   Delayed Draw Term Loan   6.76% (L + 5.75%; 1.00% Floor)   12/31/2027     —         (37,276     (38,875

Bridgepointe Technologies, LLC(3) (4)

  Digital Infrastructure & Services   Delayed Draw Term Loan   6.76% (L + 5.75%; 1.00% Floor)   12/31/2027     1,872,362       1,820,158       1,830,669  

Bridgepointe Technologies, LLC(4) (5)

  Digital Infrastructure & Services   Revolver   6.76% (L + 5.75%; 1.00% Floor)   12/31/2027     —         (14,913     (15,550

Bridgepointe Technologies, LLC(1) (2)

  Digital Infrastructure & Services   Term Loan   6.76% (L + 5.75%; 1.00% Floor)   12/31/2027     4,789,366       4,696,861       4,693,578  

Coretelligent Intermediate LLC(4)

  Digital Infrastructure & Services   Delayed Draw Term Loan   7.50% (P + 4.00%; 2.00% Floor)   10/21/2027     —         —         (9,498

Coretelligent Intermediate LLC(4) (5)

  Digital Infrastructure & Services   Revolver   7.50% (P + 4.00%; 2.00% Floor)   10/21/2027     —         (17,635     (12,664

Coretelligent Intermediate LLC(1) (2) (3)

  Digital Infrastructure & Services   Term Loan   7.50% (P + 4.00%; 2.00% Floor)   10/21/2027     8,009,037       7,897,508       7,928,947  

EvolveIP, LLC

  Digital Infrastructure & Services   Delayed Draw Term Loan   6.50% (S + 5.50%; 1.00% Floor)   06/07/2025     111,957       111,384       111,117  

EvolveIP, LLC(4)

  Digital Infrastructure & Services   Revolver   6.50% (S + 5.50%; 1.00% Floor)   06/07/2025     56,687       53,804       52,435  

EvolveIP, LLC(1)

  Digital Infrastructure & Services   Term Loan   6.50% (S + 5.50%; 1.00% Floor)   06/07/2025     6,484,187       6,448,584       6,435,555  

Fatbeam, LLC(4) (5)

  Digital Infrastructure & Services   Delayed Draw Term Loan   7.25% (L + 6.25%; 1.00% Floor)   02/22/2026     —         (28,437     (64,385

Fatbeam, LLC

  Digital Infrastructure & Services   Revolver   7.25% (L + 6.25%; 1.00% Floor)   02/22/2026     643,849       632,474       618,095  

Fatbeam, LLC(2) (3)

  Digital Infrastructure & Services   Term Loan   7.25% (L + 6.25%; 1.00% Floor)   02/22/2026     6,438,490       6,323,870       6,180,951  

Firstdigital Communications LLC(4) (5)

  Digital Infrastructure & Services   Revolver   5.00% (L + 4.25%; 0.75% Floor)   12/17/2026     —         (29,961     (39,668

Firstdigital Communications LLC(2) (3)

  Digital Infrastructure & Services   Term Loan   5.00% (L + 4.25%; 0.75% Floor)   12/17/2026     13,645,840       13,388,174       13,304,694  

MBS Holdings, Inc.(4) (5)

  Digital Infrastructure & Services   Revolver   6.75% (L + 5.75%; 1.00% Floor)   04/16/2027     —         (16,474     —    

MBS Holdings, Inc.(1) (2) (3)

  Digital Infrastructure & Services   Term Loan   6.75% (L + 5.75%; 1.00% Floor)   04/16/2027     10,442,120       10,265,535       10,442,120  

MSP Global Holdings, Inc.(4) (5)

  Digital Infrastructure & Services   Delayed Draw Term Loan   6.25% (S + 5.25%; 1.00% Floor)   01/24/2027     —         (20,389     (21,148

MSP Global Holdings, Inc.(4)

  Digital Infrastructure & Services   Revolver   6.25% (S + 5.25%; 1.00% Floor)   01/24/2027     422,965       408,692       408,161  

MSP Global Holdings, Inc.(2) (3)

  Digital Infrastructure & Services   Term Loan   6.25% (S + 5.25%; 1.00% Floor)   01/24/2027     7,930,586       7,796,214       7,791,801  

NI Topco, Inc(4)

  Digital Infrastructure & Services   Revolver   4.55% (L + 4.25%)   12/28/2026     244,622       227,641       228,748  

NI Topco, Inc(2) (3)

  Digital Infrastructure & Services   Term Loan   6.50% (L + 5.75%; 0.75% Floor)   12/28/2028     6,689,537       6,543,434       6,555,746  

Single Digits, Inc.(2)

  Digital Infrastructure & Services   Delayed Draw Term Loan   7.50% (L + 6.00%; 1.00% Floor)   12/21/2023     599,981       597,587       583,481  

Single Digits, Inc.(4) (5)

  Digital Infrastructure & Services   Revolver   8.00% (L + 6.00%; 0.50% PIK; 1.00% Floor)   12/21/2023     —         (1,450     (11,444

Single Digits, Inc.(1)

  Digital Infrastructure & Services   Term Loan   8.00% (L + 6.00%; 0.50% PIK; 1.00% Floor)   12/21/2023     3,220,982       3,207,734       3,132,405  

Stratus Networks, Inc.(4) (5) (6)

  Digital Infrastructure & Services   Delayed Draw Term Loan   6.25% (L + 5.25%; 1.00% Floor)   12/15/2027     —         (37,725     (69,307

Stratus Networks, Inc.(4) (6) (7)

  Digital Infrastructure & Services   Revolver   6.25% (L + 5.25%; 1.00% Floor)   12/15/2027     369,637       350,769       352,310  

Stratus Networks, Inc.(2) (6)

  Digital Infrastructure & Services   Term Loan   6.25% (L + 5.25%; 1.00% Floor)   12/15/2027     7,920,781       7,768,806       7,782,168  

Thrive Buyer, Inc.(1) (2) (4)

  Digital Infrastructure & Services   Delayed Draw Term Loan   7.01% (L + 6.00%; 1.00% Floor)   01/22/2027     6,210,433       6,085,442       6,189,651  

Thrive Buyer, Inc.(4) (5)

  Digital Infrastructure & Services   Revolver   7.01% (L + 6.00%; 1.00% Floor)   01/22/2027     —         (18,942     (2,774

Thrive Buyer, Inc.(1) (2) (3)

  Digital Infrastructure & Services   Term Loan   7.01% (L + 6.00%; 1.00% Floor)   01/22/2027     11,855,238       11,658,423       11,825,600  

Towerco IV Holdings, LLC(1) (2) (4)

  Digital Infrastructure & Services   Delayed Draw Term Loan   5.00% (L + 4.00%; 1.00% Floor)   04/23/2026     13,598,920       13,424,007       13,391,620  

 

See Notes to Unaudited Consolidated Financial Statements

 

9


Table of Contents

AB Private Credit Investors Corporation

Consolidated Schedule of Investments as of March 31, 2022 (continued)

(Unaudited)

 

Portfolio Company

 

Industry

 

Facility Type

 

Interest

 

Maturity

  Funded
Par Amount
    Cost     Fair Value  

Transtelco Holding, Inc.(2)

  Digital Infrastructure & Services   Term Loan   6.76% (L + 5.75%; 0.50% Floor)   03/26/2026   $ 4,708,605     $ 4,678,571     $ 4,661,519  

Transtelco Holding,
Inc.(1) (2) (3)

  Digital Infrastructure & Services   Term Loan   7.26% (L + 6.25%; 0.50% Floor)   03/26/2026     4,708,605       4,679,739       4,661,519  

Accelerate Resources Operating, LLC(4) (5)

  Energy   Revolver   6.50% (L + 5.50%; 1.00% Floor)   02/24/2026     —         (5,468     —    

Accelerate Resources Operating, LLC(1)

  Energy   Term Loan   6.50% (L + 5.50%; 1.00% Floor)   02/24/2026     4,223,108       4,167,579       4,223,108  

BEXP I OG, LLC(4) (5)

  Energy   Revolver   8.00% (S + 7.00%; 1.00% Floor)   01/25/2027     —         (4,907     (5,089

BEXP I OG, LLC(4) (5)

  Energy   Term Loan   8.00% (S + 7.00%; 1.00% Floor)   01/25/2027     —         (34,348     (35,621

BEXP I OG, LLC(2)

  Energy   Term Loan   8.00% (S + 7.00%; 1.00% Floor)   01/25/2027     3,266,290       3,202,926       3,200,965  

Bowline Energy, LLC(1)

  Energy   Term Loan   7.50% (L + 6.50%; 1.00% Floor)   08/09/2025     3,441,256       3,406,103       3,441,256  

Foundation Risk Partners,
Corp.(3) (4)

  Financials   Delayed Draw Term Loan   6.50% (L + 5.75%; 0.75% Floor)   10/29/2028     1,752,909       1,736,786       1,747,566  

Foundation Risk Partners,
Corp.(4) (5)

  Financials   Revolver   6.50% (L + 5.75%; 0.75% Floor)   10/29/2027     —         (11,920     (10,381

Foundation Risk Partners,
Corp.(1) (2) (3)

  Financials   Term Loan   6.50% (L + 5.75%; 0.75% Floor)   10/29/2028     9,831,060       9,716,952       9,732,750  

Galway Borrower, LLC(4) (8)

  Financials   Delayed Draw Term Loan   6.25% (L + 5.25%; 0.75% Floor)   09/29/2028     51,250       45,781       45,572  

Galway Borrower, LLC(4) (5)

  Financials   Revolver   6.26% (L + 5.25%; 0.75% Floor)   09/30/2027     —         (4,972     (5,408

Galway Borrower, LLC(1) (2)

  Financials   Term Loan   6.26% (L + 5.25%; 0.75% Floor)   09/29/2028     3,753,363       3,688,001       3,678,296  

Higginbotham Insurance Agency, Inc.(2) (4)

  Financials   Delayed Draw Term Loan   6.25% (L + 5.50%; 0.75% Floor)   11/25/2026     407,700       391,891       407,700  

Higginbotham Insurance Agency, Inc.(1) (2) (3)

  Financials   Term Loan   6.25% (L + 5.50%; 0.75% Floor)   11/25/2026     8,104,208       8,010,361       8,104,208  

Peter C. Foy & Associates Insurance Services, LLC(4)

  Financials   Delayed Draw Term Loan   7.66% (S + 6.00%; 0.75% Floor)   11/01/2028     882,017       849,214       852,162  

Purchasing Power, LLC(1)

  Financials   Term Loan   7.75% (L + 6.75%; 1.00% Floor)   02/06/2024     2,026,771       2,011,264       2,011,570  

TA/WEG Holdings, LLC(4)

  Financials   Delayed Draw Term Loan   6.75% (L + 5.75%; 1.00% Floor)   10/04/2027     3,926,880       3,908,136       3,911,049  

TA/WEG Holdings, LLC(4)

  Financials   Revolver   6.75% (L + 5.75%; 1.00% Floor)   10/04/2027     93,989       92,375       93,039  

AAH Topco, LLC(4) (5)

  Healthcare & HCIT   Delayed Draw Term Loan   6.25% (L + 5.50%; 0.75% Floor)   12/22/2027     —         (68,723     (197,755

AAH Topco, LLC(4) (5)

  Healthcare & HCIT   Revolver   6.25% (L + 5.50%; 0.75% Floor)   12/22/2027     —         (15,051     (13,777

AAH Topco, LLC(1) (2) (3)

  Healthcare & HCIT   Term Loan   6.25% (L + 5.50%; 0.75% Floor)   12/22/2027     6,534,513       6,409,441       6,354,814  

American Physician Partners, LLC(1) (2)

  Healthcare & HCIT   Delayed Draw Term Loan   9.25% (L + 6.75%; 1.50% PIK; 1.00% Floor)   04/08/2022     961,272       961,272       961,272  

American Physician Partners, LLC(4)

  Healthcare & HCIT   Revolver   9.25% (L + 6.75%; 1.50% PIK; 1.00% Floor)   04/08/2022     346,322       346,322       346,322  

American Physician Partners, LLC(2)

  Healthcare & HCIT   Term Loan   9.25% (L + 6.75%; 1.50% PIK; 1.00% Floor)   04/08/2022     1,114,822       1,114,822       1,114,822  

American Physician Partners, LLC(1)

  Healthcare & HCIT   Term Loan   9.25% (L + 6.75%; 1.50% PIK; 1.00% Floor)   04/08/2022     5,156,410       5,152,869       5,156,410  

American Physician Partners, LLC(1) (2)

  Healthcare & HCIT   Term Loan   9.25% (L + 6.75%; 1.50% PIK; 1.00% Floor)   04/08/2022     2,053,461       2,053,461       2,053,461  

Analogic Corporation(4)

  Healthcare & HCIT   Revolver   6.25% (L + 5.25%; 1.00% Floor)   06/22/2023     152,778       151,765       146,361  

Analogic Corporation(1) (3)

  Healthcare & HCIT   Term Loan   6.25% (L + 5.25%; 1.00% Floor)   06/24/2024     2,090,764       2,074,108       2,028,041  

AOM Acquisition, LLC.(4) (5)

  Healthcare & HCIT   Revolver   6.25% (S + 5.25%; 1.00% Floor)   02/18/2027     —         (23,824     (24,372

AOM Acquisition, LLC.(1) (2)

  Healthcare & HCIT   Term Loan   6.25% (S + 5.25%; 1.00% Floor)   02/18/2027     7,514,733       7,367,429       7,364,438  

BAART Programs, Inc.(4) (9)

  Healthcare & HCIT   Delayed Draw Term Loan   6.00% (L + 5.00%; 1.00% Floor)   06/11/2027     3,504,317       3,441,607       3,403,892  

BAART Programs, Inc.(1) (2) (9)

  Healthcare & HCIT   Term Loan   6.00% (L + 5.00%; 1.00% Floor)   06/11/2027     4,757,827       4,719,099       4,686,460  

Caregiver 2, Inc.

  Healthcare & HCIT   Delayed Draw Term Loan   6.25% (L + 5.25%; 1.00% Floor)   07/24/2025     1,570,456       1,543,441       1,503,711  

Caregiver 2, Inc.(3)

  Healthcare & HCIT   Term Loan   6.25% (L + 5.25%; 1.00% Floor)   07/24/2025     675,893       666,556       647,167  

Caregiver 2, Inc.(3)

  Healthcare & HCIT   Term Loan   6.25% (L + 5.25%; 1.00% Floor)   07/24/2025     4,708,992       4,643,941       4,508,860  

Caregiver 2, Inc.(2)

  Healthcare & HCIT   Term Loan   6.25% (L + 5.25%; 1.00% Floor)   07/24/2025     644,964       633,936       617,553  

Choice Health At Home,
LLC,(4) (5)

  Healthcare & HCIT   Delayed Draw Term Loan   7.00% (L + 6.00%; 1.00% Floor)   12/29/2026     —         (16,452     (17,314

Choice Health At Home,
LLC,(1) (2)

  Healthcare & HCIT   Term Loan   7.00% (L + 6.00%; 1.00% Floor)   12/29/2026     2,697,942       2,659,199       2,657,473  

Coding Solutions Acquisition, Inc.(4) (5)

  Healthcare & HCIT   Delayed Draw Term Loan   7.25% (L + 6.25%; 1.00% Floor)   12/31/2026     —         (19,482     —    

Coding Solutions Acquisition, Inc.(4)

  Healthcare & HCIT   Revolver   7.25% (L + 6.25%; 1.00% Floor)   12/31/2025     69,828       68,067       69,828  

Coding Solutions Acquisition, Inc.(2) (3)

  Healthcare & HCIT   Term Loan   7.25% (L + 6.25%; 1.00% Floor)   12/31/2026     7,814,869       7,688,547       7,814,869  

Community Based Care Acquisition, Inc.(4)

  Healthcare & HCIT   Delayed Draw Term Loan   6.51% (L + 5.50%; 1.00% Floor)   09/16/2027     304,595       284,901       299,198  

Community Based Care Acquisition, Inc.(4) (10)

  Healthcare & HCIT   Revolver   8.00% (P + 4.50%; 2.00% Floor)   09/16/2027     475,097       459,329       466,459  

Community Based Care Acquisition, Inc.(1) (2)

  Healthcare & HCIT   Term Loan   6.51% (L + 5.50%; 1.00% Floor)   09/16/2027     5,328,862       5,230,757       5,275,574  

 

See Notes to Unaudited Consolidated Financial Statements

 

10


Table of Contents

AB Private Credit Investors Corporation

Consolidated Schedule of Investments as of March 31, 2022 (continued)

(Unaudited)

 

Portfolio Company

 

Industry

 

Facility Type

 

Interest

 

Maturity

  Funded
Par Amount
    Cost     Fair Value  

Delaware Valley Management Holdings, Inc.(4) (5)

  Healthcare & HCIT   Delayed Draw Term Loan   7.25% (L + 6.25%; 1.00% Floor)   03/21/2024   $ —       $ (18,853   $ (126,451

Delaware Valley Management Holdings, Inc.

  Healthcare & HCIT   Revolver   7.25% (L + 6.25%; 1.00% Floor)   03/21/2024     537,691       533,240       473,168  

Delaware Valley Management Holdings, Inc.

  Healthcare & HCIT   Term Loan   7.25% (L + 6.25%; 1.00% Floor)   03/21/2024     3,492,300       3,462,350       3,073,224  

Ethos Veterinary Health, LLC(1)

  Healthcare & HCIT   Delayed Draw Term Loan   5.21% (L + 4.75%)   05/15/2026     1,067,934       1,060,914       1,067,934  

Ethos Veterinary Health, LLC(1)

  Healthcare & HCIT   Term Loan   5.21% (L + 4.75%)   05/15/2026     2,262,589       2,246,926       2,262,589  

FH MD Buyer, Inc.(1) (2)

  Healthcare & HCIT   Term Loan   5.75% (L + 5.00%; 0.75% Floor)   07/22/2028     5,506,918       5,453,654       5,506,918  

GHA Buyer, Inc.(2)

  Healthcare & HCIT   Delayed Draw Term Loan   7.50% (L + 6.50%; 1.00% Floor)   06/24/2025     809,145       797,827       803,076  

GHA Buyer, Inc.(4)

  Healthcare & HCIT   Revolver   7.50% (L + 6.50%; 1.00% Floor)   06/24/2025     190,215       180,954       183,082  

GHA Buyer, Inc.(1)

  Healthcare & HCIT   Term Loan   7.50% (L + 6.50%; 1.00% Floor)   06/24/2025     558,070       550,487       553,885  

GHA Buyer, Inc.(1) (3)

  Healthcare & HCIT   Term Loan   7.50% (L + 6.50%; 1.00% Floor)   06/24/2025     5,340,204       5,258,737       5,300,153  

GHA Buyer, Inc.(3)

  Healthcare & HCIT   Term Loan   7.50% (L + 6.50%; 1.00% Floor)   06/24/2025     4,623,686       4,554,277       4,589,008  

GHA Buyer, Inc.(1)

  Healthcare & HCIT   Term Loan   7.50% (L + 6.50%; 1.00% Floor)   06/24/2025     724,226       709,849       718,794  

GHA Buyer, Inc.(1)

  Healthcare & HCIT   Term Loan   7.50% (L + 6.50%; 1.00% Floor)   06/24/2025     1,952,566       1,938,867       1,937,922  

Honor HN Buyer, Inc(4)

  Healthcare & HCIT   Delayed Draw Term Loan   7.01% (L + 6.00%; 1.00% Floor)   10/15/2027     570,447       549,809       545,574  

Honor HN Buyer, Inc(4) (5)

  Healthcare & HCIT   Revolver   7.01% (L + 6.00%; 1.00% Floor)   10/15/2027     —         (5,625     (6,082

Honor HN Buyer, Inc(1) (2)

  Healthcare & HCIT   Term Loan   7.01% (L + 6.00%; 1.00% Floor)   10/15/2027     2,636,686       2,587,861       2,583,952  

Kindeva Drug Delivery L.P.(4)

  Healthcare & HCIT   Revolver   7.00% (L + 6.00%; 1.00% Floor)   05/01/2025     1,295,008       1,272,515       1,248,035  

Kindeva Drug Delivery L.P.(1) (2) (3)

  Healthcare & HCIT   Term Loan   7.00% (L + 6.00%; 1.00% Floor)   05/01/2026     15,620,359       15,338,697       15,112,697  

Medbridge Holdings, LLC(4)

  Healthcare & HCIT   Revolver   8.00% (L + 7.00%; 1.00% Floor)   12/23/2026     458,742       436,939       458,742  

Medbridge Holdings, LLC(1) (2)

  Healthcare & HCIT   Term Loan   8.00% (L + 7.00%; 1.00% Floor)   12/23/2026     15,367,872       15,120,252       15,367,872  

Medical Management Resource Group, LLC(4) (5)

  Healthcare & HCIT   Delayed Draw Term Loan   6.76% (L + 5.75%)   09/30/2027     —         (14,537     (19,776

Medical Management Resource Group, LLC(4) (5)

  Healthcare & HCIT   Revolver   6.76% (L + 5.75%)   09/30/2026     —         (5,712     (7,119

Medical Management Resource Group, LLC(2)

  Healthcare & HCIT   Term Loan   6.76% (L + 5.75%)   09/30/2027     3,840,962       3,770,344       3,754,540  

Medsuite Purchaser, LLC(4) (5) (11)

  Healthcare & HCIT   Delayed Draw Term Loan   5.75% (L + 4.75%; 1.00% Floor)   10/22/2026     —         (11,192     (16,330

Medsuite Purchaser, LLC(4) (5) (11)

  Healthcare & HCIT   Delayed Draw Term Loan   5.75% (L + 4.75%; 1.00% Floor)   10/22/2026     —         (48,964     (71,442

Medsuite Purchaser, LLC(4) (5) (11)

  Healthcare & HCIT   Revolver   5.75% (L + 4.75%; 1.00% Floor)   10/22/2026     —         (9,329     (6,804

Medsuite Purchaser, LLC(1) (2) (11)

  Healthcare & HCIT   Term Loan   5.75% (L + 4.75%; 1.00% Floor)   10/22/2026     4,818,765       4,752,691       4,770,577  

OMH-HealthEdge Holdings, LLC(4) (5)

  Healthcare & HCIT   Revolver   7.50% (L + 6.00%; 1.00% Floor)   10/24/2024     —         (5,352     (2,294

OMH-HealthEdge Holdings, LLC(2)

  Healthcare & HCIT   Term Loan   7.50% (L + 6.00%; 1.00% Floor)   10/24/2025     2,138,092       2,100,554       2,127,401  

OMH-HealthEdge Holdings, LLC(2)

  Healthcare & HCIT   Term Loan   7.01% (L + 6.00%; 1.00% Floor)   10/24/2025     970,920       949,461       966,065  

OMH-HealthEdge Holdings, LLC(1)

  Healthcare & HCIT   Term Loan   7.50% (L + 6.00%; 1.00% Floor)   10/24/2025     3,689,834       3,636,121       3,671,385  

Pace Health Companies, LLC(4) (5)

  Healthcare & HCIT   Revolver   5.51% (L + 4.50%; 1.00% Floor)   08/02/2024     —         (3,004     —    

Pace Health Companies, LLC(1)

  Healthcare & HCIT   Term Loan   5.51% (L + 4.50%; 1.00% Floor)   08/02/2024     5,140,906       5,114,317       5,140,906  

PAW Midco, Inc.

  Healthcare & HCIT   Term Loan   11.50% (11.50% PIK)   12/22/2031     4,185,307       4,066,999       4,070,211  

Pinnacle Dermatology Management, LLC(4) (5)

  Healthcare & HCIT   Delayed Draw Term Loan   6.50% (L + 5.75%; 0.75% Floor)   12/08/2028     —         (18,377     (26,885

Pinnacle Dermatology Management, LLC(4) (12)

  Healthcare & HCIT   Revolver   5.01% (L + 4.00%; 0.75% Floor)   12/08/2026     138,265       125,001       123,478  

Pinnacle Dermatology Management, LLC(1) (2) (3)

  Healthcare & HCIT   Term Loan   6.50% (L + 5.75%; 0.75% Floor)   12/08/2028     5,376,956       5,247,898       5,242,532  

Pinnacle Treatment Centers, Inc.(2)

  Healthcare & HCIT   Delayed Draw Term Loan   6.75% (L + 5.75%; 1.00% Floor)   12/31/2022     346,272       344,366       346,272  

Pinnacle Treatment Centers, Inc.(4) (5)

  Healthcare & HCIT   Revolver   6.75% (L + 5.75%; 1.00% Floor)   12/31/2022     —         (1,663     —    

Pinnacle Treatment Centers, Inc.(2) (3)

  Healthcare & HCIT   Term Loan   6.75% (L + 5.75%; 1.00% Floor)   12/31/2022     4,117,588       4,106,968       4,117,588  

Platinum Dermatology Partners, LLC(13)

  Healthcare & HCIT   Delayed Draw Term Loan   8.26% (L + 6.25%; 1.00% PIK; 1.00% Floor)   01/03/2023     1,554,847       1,532,222       1,547,072  

Platinum Dermatology Partners, LLC(1)

  Healthcare & HCIT   Delayed Draw Term Loan   9.75% (P + 5.25%; 1.00% PIK; 2.00% Floor)   01/03/2023     2,139,111       2,116,226       2,128,416  

Platinum Dermatology Partners, LLC(14)

  Healthcare & HCIT   Revolver   9.75% (P + 5.25%; 1.00% PIK; 2.00% Floor)   01/03/2023     550,451       542,120       547,699  

Platinum Dermatology Partners, LLC(1)

  Healthcare & HCIT   Term Loan   8.25% (L + 6.25%; 1.00% PIK; 1.00% Floor)   01/03/2023     3,443,986       3,410,170       3,426,766  

RCP Encore Acquisition, Inc.(15)

  Healthcare & HCIT   Term Loan   6.00% (L + 5.00%; 1.00% Floor)   06/09/2025     3,459,179       3,408,361       864,795  

Redwood Family Care Network,
Inc.(1) (4)

  Healthcare & HCIT   Delayed Draw Term Loan   7.00% (L + 5.50%; 1.00% Floor)   06/18/2026     3,377,194       3,298,841       3,303,925  

 

See Notes to Unaudited Consolidated Financial Statements

 

11


Table of Contents

AB Private Credit Investors Corporation

Consolidated Schedule of Investments as of March 31, 2022 (continued)

(Unaudited)

 

Portfolio Company

 

Industry

 

Facility Type

 

Interest

 

Maturity

  Funded
Par Amount
    Cost     Fair Value  

Redwood Family Care Network,
Inc.(4) (5)

  Healthcare & HCIT   Revolver   7.00% (L + 5.50%; 1.00% Floor)   06/18/2026   $ —       $ (9,977   $ (7,359

Redwood Family Care Network, Inc.(3)

  Healthcare & HCIT   Term Loan   7.00% (L + 5.50%; 1.00% Floor)   06/18/2026     6,719,331       6,605,451       6,635,339  

Salisbury House, LLC(4)

  Healthcare & HCIT   Revolver   7.50% (P + 4.00%; 2.00% Floor)   08/30/2025     119,558       111,743       108,349  

Salisbury House, LLC(1)

  Healthcare & HCIT   Term Loan   6.51% (L + 5.50%; 1.00% Floor)   08/30/2025     1,145,779       1,130,613       1,117,135  

Salisbury House, LLC(1) (2)

  Healthcare & HCIT   Term Loan   6.51% (L + 5.50%; 1.00% Floor)   08/30/2025     3,934,410       3,858,804       3,836,049  

SCA Buyer, LLC(4)

  Healthcare & HCIT   Revolver   7.01% (L + 6.00%; 1.00% Floor)   01/20/2026     257,540       250,128       254,320  

SCA Buyer, LLC(2)

  Healthcare & HCIT   Term Loan   7.01% (L + 6.00%; 1.00% Floor)   01/20/2026     3,824,463       3,778,952       3,805,341  

SIS Purchaser, Inc.(4) (5)

  Healthcare & HCIT   Revolver   7.50% (L + 6.00%; 1.50% Floor)   10/15/2026     —         (15,523     (14,574

SIS Purchaser, Inc.(2)

  Healthcare & HCIT   Term Loan   7.01% (L + 6.00%; 1.00% Floor)   10/15/2026     2,424,214       2,387,024       2,393,911  

SIS Purchaser, Inc.(1) (2) (3)

  Healthcare & HCIT   Term Loan   7.50% (L + 6.00%; 1.50% Floor)   10/15/2026     12,665,138       12,491,289       12,506,824  

Smile Brands, Inc.(3)

  Healthcare & HCIT   Delayed Draw Term Loan   5.25% (L + 4.50%; 0.75% Floor)   10/12/2025     487,856       485,735       484,197  

Smile Brands, Inc.(4)

  Healthcare & HCIT   Revolver   7.00% (P + 3.50%; 1.75% Floor)   10/12/2025     9,266       8,464       7,355  

Smile Brands, Inc.(1)

  Healthcare & HCIT   Term Loan   5.25% (L + 4.50%; 0.75% Floor)   10/12/2025     1,602,733       1,595,338       1,590,712  

Spark DSO LLC(4) (5)

  Healthcare & HCIT   Delayed Draw Term Loan   7.00% (L + 6.00%; 1.00% Floor)   04/19/2026     —         (8,913     (9,215

Spark DSO LLC(4) (5)

  Healthcare & HCIT   Revolver   7.00% (L + 6.00%; 1.00% Floor)   04/19/2026     —         (16,041     (16,587

Spark DSO LLC(1) (2) (3)

  Healthcare & HCIT   Term Loan   7.00% (L + 6.00%; 1.00% Floor)   04/19/2026     8,108,905       7,991,237       7,987,272  

Taconic Biosciences, Inc.(2)

  Healthcare & HCIT   Term Loan   6.50% (L + 5.50%; 1.00% Floor)   02/01/2026     4,703,046       4,624,934       4,679,530  

The Center for Orthopedic and Research Excellence, Inc.(4)

  Healthcare & HCIT   Delayed Draw Term Loan   6.75% (S + 5.75%; 1.00% Floor)   08/15/2025     487,304       472,548       465,549  

The Center for Orthopedic and Research Excellence, Inc.(4) (5)

  Healthcare & HCIT   Delayed Draw Term Loan   6.75% (S + 5.75%; 1.00% Floor)   08/15/2025     —         (14,961     (17,098

The Center for Orthopedic and Research Excellence, Inc.(1) (2)

  Healthcare & HCIT   Delayed Draw Term Loan   6.75% (S + 5.75%; 1.00% Floor)   08/15/2025     1,150,297       1,144,761       1,130,167  

The Center for Orthopedic and Research Excellence, Inc.(4) (16)

  Healthcare & HCIT   Revolver   8.50% (P + 5.00%; 2.00% Floor)   08/15/2025     414,319       407,323       402,235  

The Center for Orthopedic and Research Excellence, Inc.(1) (3)

  Healthcare & HCIT   Term Loan   6.75% (S + 5.75%; 1.00% Floor)   08/15/2025     4,881,198       4,828,970       4,795,777  

Vardiman Black Holdings, LLC(4)

  Healthcare & HCIT   Delayed Draw Term Loan   8.50% (S + 8.00%; 0.50% Floor)   03/18/2027     139,161       123,098       123,673  

Vardiman Black Holdings, LLC(2)

  Healthcare & HCIT   Term Loan   8.50% (S + 8.00%; 0.50% Floor)   03/18/2027     2,534,401       2,509,215       2,509,057  

Activ Software Holdings, LLC(4) (5)

  Software & Tech Services   Revolver   7.50% (L + 6.50%; 1.00% Floor)   05/04/2027     —         (11,084     (3,244

Activ Software Holdings, LLC(1) (2) (3)

  Software & Tech Services   Term Loan   7.50% (L + 6.50%; 1.00% Floor)   05/04/2027     8,050,123       7,912,601       8,009,872  

AMI US Holdings, Inc.(4)

  Software & Tech Services   Revolver   5.48% (L + 5.25%)   04/01/2024     437,842       428,539       437,842  

AMI US Holdings, Inc.(1)

  Software & Tech Services   Term Loan   6.25% (L + 5.25%; 1.00% Floor)   04/01/2025     8,069,428       7,979,706       8,069,428  

Arrowstream Acquisition Co., Inc.(3) (4)

  Software & Tech Services   Delayed Draw Term Loan   7.00% (S + 6.00%; 1.00% Floor)   12/15/2025     604,235       580,796       604,235  

Arrowstream Acquisition Co., Inc.(4) (5)

  Software & Tech Services   Revolver   7.00% (S + 6.00%; 1.00% Floor)   12/15/2025     —         (5,760     —    

Arrowstream Acquisition Co., Inc.(3)

  Software & Tech Services   Term Loan   7.00% (S + 6.00%; 1.00% Floor)   12/15/2025     3,863,094       3,805,679       3,863,094  

Avetta, LLC(4) (5)

  Software & Tech Services   Revolver   7.25% (L + 6.25%; 1.00% Floor)   04/10/2024     —         (3,392     (1,236

Avetta, LLC(1) (3)

  Software & Tech Services   Term Loan   7.25% (L + 6.25%; 1.00% Floor)   04/10/2024     3,212,031       3,171,616       3,204,001  

Avetta, LLC(2)

  Software & Tech Services   Term Loan   7.25% (L + 6.25%; 1.00% Floor)   04/10/2024     6,819,748       6,718,176       6,802,699  

Avetta, LLC(1)

  Software & Tech Services   Term Loan   7.25% (L + 6.25%; 1.00% Floor)   04/10/2024     4,228,725       4,189,793       4,218,153  

Brightly Software Holdings, Inc.(3) (17)

  Software & Tech Services   Term Loan   7.26% (L + 6.25%; 1.00% Floor)   06/13/2025     3,844,006       3,772,977       3,815,176  

Brightly Software Holdings, Inc.(3) (17)

  Software & Tech Services   Term Loan   7.26% (L + 6.25%; 1.00% Floor)   06/13/2025     528,743       518,635       524,778  

Brightspot Buyer, Inc(4) (5)

  Software & Tech Services   Revolver   6.76% (L + 5.75%; 0.75% Floor)   11/16/2027     —         (12,785     (11,905

Brightspot Buyer, Inc(2)

  Software & Tech Services   Term Loan   6.76% (L + 5.75%; 0.75% Floor)   11/16/2027     5,215,571       5,117,553       5,124,299  

BusinesSolver.com, Inc.(4) (5)

  Software & Tech Services   Delayed Draw Term Loan   6.50% (L + 5.75%; 0.75% Floor)   12/01/2027     —         (9,425     (24,836

BusinesSolver.com, Inc.(2) (3)

  Software & Tech Services   Term Loan   6.50% (L + 5.75%; 0.75% Floor)   12/01/2027     7,379,963       7,309,936       7,287,713  

Community Brands Parentco, LLC(4) (5)

  Software & Tech Services   Delayed Draw Term Loan   6.50% (S + 5.75%; 0.75% Floor)   02/24/2028     —         (8,210     (8,344

Community Brands Parentco, LLC(4) (5)

  Software & Tech Services   Revolver   6.50% (S + 5.75%; 0.75% Floor)   02/24/2028     —         (8,211     (8,344

Community Brands Parentco, LLC(1) (2)

  Software & Tech Services   Term Loan   6.50% (S + 5.75%; 0.75% Floor)   02/24/2028     7,092,529       6,952,615       6,950,678  

Cybergrants Holdings, LLC(4) (5)

  Software & Tech Services   Delayed Draw Term Loan   7.25% (L + 6.50%; 0.75% Floor)   09/08/2027     —         (24,237     (25,645

Cybergrants Holdings, LLC(4)

  Software & Tech Services   Revolver   7.50% (L + 6.50%; 0.75% Floor)   09/08/2027     806,226       790,522       788,949  

Cybergrants Holdings, LLC(1) (2) (3)

  Software & Tech Services   Term Loan   7.25% (L + 6.50%; 0.75% Floor)   09/08/2027     14,922,552       14,716,218       14,698,714  

Datacor, Inc.(4) (5)

  Software & Tech Services   Delayed Draw Term Loan   5.75% (S + 4.75%; 1.00% Floor)   12/29/2025     —         (26,300     (12,726

Datacor, Inc.(4) (5)

  Software & Tech Services   Revolver   5.75% (S + 4.75%; 1.00% Floor)   12/29/2025     —         (9,642     (3,219

Datacor, Inc.(1) (2) (3)

  Software & Tech Services   Term Loan   7.25% (S + 6.25%; 1.00% Floor)   12/29/2025     13,841,011       13,579,723       13,771,806  

 

See Notes to Unaudited Consolidated Financial Statements

 

12


Table of Contents

AB Private Credit Investors Corporation

Consolidated Schedule of Investments as of March 31, 2022 (continued)

(Unaudited)

 

Portfolio Company

 

Industry

 

Facility Type

 

Interest

 

Maturity

  Funded
Par Amount
    Cost     Fair Value  

Degreed, Inc.(4) (5)

  Software & Tech Services   Delayed Draw Term Loan   6.50% (L + 5.50%; 1.00% Floor)   05/31/2025   $ —       $ (5,288   $ (6,957

Degreed, Inc.(4) (5)

  Software & Tech Services   Revolver   6.50% (L + 5.50%; 1.00% Floor)   05/31/2025     —         (2,015     (4,178

Degreed, Inc.(2)

  Software & Tech Services   Term Loan   6.50% (L + 5.50%; 1.00% Floor)   05/31/2025     2,782,788       2,761,138       2,754,960  

Degreed, Inc.(1) (3)

  Software & Tech Services   Term Loan   6.50% (L + 5.50%; 1.00% Floor)   05/31/2025     5,153,024       5,102,953       5,101,494  

Dispatch Track, LLC(4) (5)

  Software & Tech Services   Revolver   5.50% (L + 4.50%; 1.00% Floor)   03/27/2026     —         (2,492     —    

Dispatch Track, LLC(1) (2)

  Software & Tech Services   Term Loan   5.50% (L + 4.50%; 1.00% Floor)   03/25/2028     9,849,936       9,750,482       9,849,936  

Drilling Info Holdings, Inc.(1)

  Software & Tech Services   Term Loan   4.71% (L + 4.25%)   07/30/2025     3,317,927       3,309,937       3,293,042  

EET Buyer, Inc.(4) (5)

  Software & Tech Services   Revolver   6.50% (L + 5.75%; 0.75% Floor)   11/08/2027     —         (12,933     (15,543

EET Buyer, Inc.(2) (3)

  Software & Tech Services   Term Loan   6.50% (L + 5.75%; 0.75% Floor)   11/08/2027     6,907,937       6,778,603       6,752,508  

EnterpriseDB Corporation(4) (5)

  Software & Tech Services   Revolver   6.75% (L + 3.00%; 2.75% PIK; 1.00% Floor)   06/22/2026     —         (11,366     (7,597

EnterpriseDB Corporation(1) (2)

  Software & Tech Services   Term Loan   6.75% (L + 3.00%; 2.75% PIK; 1.00% Floor)   06/22/2026     6,320,423       6,204,573       6,273,020  

EnterpriseDB Corporation(1) (3)

  Software & Tech Services   Term Loan   6.75% (L + 3.00%; 2.75% PIK; 1.00% Floor)   06/22/2026     4,595,184       4,523,357       4,560,720  

EnterpriseDB Corporation(1) (2) (3)

  Software & Tech Services   Term Loan   6.75% (L + 3.00%; 2.75% PIK; 1.00% Floor)   06/22/2026     8,019,378       7,934,931       7,959,232  

Exterro, Inc.(4) (5)

  Software & Tech Services   Revolver   5.50% (L + 4.50%; 1.00% Floor)   05/31/2024     —         (1,826     —    

Exterro, Inc.(1) (2)

  Software & Tech Services   Term Loan   5.50% (L + 4.50%; 1.00% Floor)   05/31/2024     5,809,123       5,737,435       5,809,123  

Exterro, Inc.(2) (3)

  Software & Tech Services   Term Loan   5.50% (L + 4.50%; 1.00% Floor)   05/31/2024     6,237,900       6,157,541       6,237,900  

Exterro, Inc.(1)

  Software & Tech Services   Term Loan   5.50% (L + 4.50%; 1.00% Floor)   05/31/2024     2,793,450       2,772,039       2,793,450  

Faithlife, LLC(1) (2) (4)

  Software & Tech Services   Delayed Draw Term Loan   6.51% (L + 5.50%; 1.00% Floor)   09/18/2025     1,692,920       1,650,744       1,692,920  

Faithlife, LLC(4) (5)

  Software & Tech Services   Revolver   6.51% (L + 5.50%; 1.00% Floor)   09/18/2025     —         (3,891     —    

Faithlife, LLC(1) (2)

  Software & Tech Services   Term Loan   6.51% (L + 5.50%; 1.00% Floor)   09/18/2025     727,021       716,845       727,021  

Genesis Acquisition Co.(3)

  Software & Tech Services   Revolver   5.01% (L + 4.00%)   07/31/2024     202,400       200,776       197,340  

Genesis Acquisition Co.(1) (2)

  Software & Tech Services   Term Loan   5.01% (L + 4.00%)   07/31/2024     1,371,417       1,359,913       1,337,131  

Greenhouse Software, Inc.(4) (5)

  Software & Tech Services   Revolver   7.50% (L + 6.50%; 1.00% Floor)   03/01/2027     —         (22,884     (9,242

Greenhouse Software, Inc.(2) (3)

  Software & Tech Services   Term Loan   7.50% (L + 6.50%; 1.00% Floor)   03/01/2027     12,376,845       12,145,160       12,284,018  

GS AcquisitionCo, Inc.(4) (5)

  Software & Tech Services   Delayed Draw Term Loan   7.25% (L + 5.75%; 1.00% Floor)   05/22/2026     —         (3,063     (13,441

GS AcquisitionCo, Inc.(4)

  Software & Tech Services   Revolver   7.25% (L + 5.75%; 1.00% Floor)   05/22/2026     388,193       385,285       379,059  

GS AcquisitionCo, Inc.(1) (2) (3)

  Software & Tech Services   Term Loan   7.25% (L + 5.75%; 1.00% Floor)   05/22/2026     8,686,202       8,641,458       8,512,478  

Iodine Software, LLC(2) (3)

  Software & Tech Services   Delayed Draw Term Loan   7.50% (L + 6.50%; 1.00% Floor)   05/19/2027     9,035,605       8,879,662       9,035,605  

Iodine Software, LLC(4) (5)

  Software & Tech Services   Revolver   7.50% (L + 6.50%; 1.00% Floor)   05/19/2027     —         (21,120     —    

Iodine Software, LLC(1) (2)

  Software & Tech Services   Term Loan   7.50% (L + 6.50%; 1.00% Floor)   05/19/2027     5,998,525       5,895,313       5,998,525  

Kaseya, Inc.(4)

  Software & Tech Services   Delayed Draw Term Loan   7.50% (L + 5.50%; 1.00% PIK; 1.00% Floor)   05/02/2025     310,128       301,267       310,128  

Kaseya, Inc.(2)

  Software & Tech Services   Delayed Draw Term Loan   7.50% (L + 5.50%; 1.00% PIK; 1.00% Floor)   05/02/2025     555,315       551,894       555,315  

Kaseya, Inc.(2)

  Software & Tech Services   Delayed Draw Term Loan   7.50% (L + 5.50%; 1.00% PIK; 1.00% Floor)   05/02/2025     486,682       486,682       486,682  

Kaseya, Inc.(4) (5)

  Software & Tech Services   Revolver   6.50% (L + 5.50%; 1.00% Floor)   05/02/2025     —         (2,009     —    

Kaseya, Inc.(1) (2)

  Software & Tech Services   Term Loan   7.50% (L + 5.50%; 1.00% PIK; 1.00% Floor)   05/02/2025     1,270,136       1,251,350       1,270,136  

Kaseya, Inc.(1) (2) (3)

  Software & Tech Services   Term Loan   7.50% (L + 5.50%; 1.00% PIK; 1.00% Floor)   05/02/2025     5,257,467       5,226,822       5,257,467  

Mavenlink, Inc.(4) (5)

  Software & Tech Services   Revolver   6.75% (L + 6.00%; 0.75% Floor)   06/03/2027     —         (33,790     (35,796

Mavenlink, Inc.(1) (2) (3)

  Software & Tech Services   Term Loan   6.75% (L + 6.00%; 0.75% Floor)   06/03/2027     15,034,451       14,750,618       14,733,762  

Moon Buyer, Inc.(4) (5)

  Software & Tech Services   Delayed Draw Term Loan   5.76% (L + 4.75%; 1.00% Floor)   04/21/2027     —         (28,830     —    

Moon Buyer, Inc.(4) (5)

  Software & Tech Services   Revolver   5.76% (L + 4.75%; 1.00% Floor)   04/21/2027     —         (14,793     —    

Moon Buyer, Inc.(1) (2) (3)

  Software & Tech Services   Term Loan   5.76% (L + 4.75%; 1.00% Floor)   04/21/2027     6,352,855       6,272,101       6,352,855  

Mykaarma Acquisition LLC(4) (5)

  Software & Tech Services   Revolver   7.37% (S + 6.25%; 1.00% Floor)   03/21/2028     —         (11,807     (11,864

Mykaarma Acquisition LLC(2) (3)

  Software & Tech Services   Term Loan   7.37% (S + 6.25%; 1.00% Floor)   03/21/2028     5,932,148       5,813,980       5,813,505  

Navigate360, LLC(4) (5)

  Software & Tech Services   Delayed Draw Term Loan   6.00% (S + 5.00%; 1.00% Floor)   03/17/2027     —         (17,982     (18,127

Navigate360, LLC(4) (5)

  Software & Tech Services   Revolver   6.00% (S + 5.00%; 1.00% Floor)   03/17/2027     —         (11,988     (12,085

Navigate360, LLC(3)

  Software & Tech Services   Term Loan   6.00% (S + 5.00%; 1.00% Floor)   03/17/2027     4,229,646       4,145,648       4,145,053  

Netwrix Corporation And Concept Searching Inc.(2)

  Software & Tech Services   Delayed Draw Term Loan   7.00% (L + 6.00%; 1.00% Floor)   09/30/2026     495,896       488,388       495,896  

Netwrix Corporation And Concept Searching Inc.(1)

  Software & Tech Services   Delayed Draw Term Loan   7.00% (L + 6.00%; 1.00% Floor)   09/30/2026     991,792       975,176       991,792  

Netwrix Corporation And Concept Searching Inc.

  Software & Tech Services   Delayed Draw Term Loan   7.00% (L + 6.00%; 1.00% Floor)   09/30/2026     2,177,217       2,146,475       2,177,217  

Netwrix Corporation And Concept Searching Inc.(4) (5)

  Software & Tech Services   Revolver   7.00% (L + 6.00%; 1.00% Floor)   09/30/2026     —         (3,372     —    

Netwrix Corporation And Concept Searching Inc.(1)

  Software & Tech Services   Term Loan   7.00% (L + 6.00%; 1.00% Floor)   09/30/2026     1,644,691       1,611,270       1,644,691  

Netwrix Corporation And Concept Searching Inc.(2)

  Software & Tech Services   Term Loan   7.00% (L + 6.00%; 1.00% Floor)   09/30/2026     6,635,647       6,513,413       6,635,647  

PerimeterX, Inc.(4) (5)

  Software & Tech Services   Delayed Draw Term Loan   6.50% (L + 4.00%; 1.50% PIK; 1.00% Floor)   11/22/2024     —         (16,785     (16,131

 

See Notes to Unaudited Consolidated Financial Statements

 

13


Table of Contents

AB Private Credit Investors Corporation

Consolidated Schedule of Investments as of March 31, 2022 (continued)

(Unaudited)

 

Portfolio Company

 

Industry

 

Facility Type

 

Interest

 

Maturity

  Funded
Par Amount
    Cost     Fair Value  

PerimeterX, Inc.(4) (5)

  Software & Tech Services   Delayed Draw Term Loan   6.50% (L + 4.00%; 1.50% PIK; 1.00% Floor)   11/22/2024   $ —       $ (5,631   $ (10,482

PerimeterX, Inc.(4) (5)

  Software & Tech Services   Revolver   6.50% (L + 4.00%; 1.50% PIK; 1.00% Floor)   11/22/2024     —         (2,039     (4,193

PerimeterX, Inc.(3)

  Software & Tech Services   Term Loan   6.50% (L + 4.00%; 1.50% PIK; 1.00% Floor)   11/22/2024     2,853,189       2,829,945       2,810,391  

Ranger Buyer, Inc.(4)

  Software & Tech Services   Revolver   7.00% (L + 6.25%; 0.75% Floor)   11/18/2027     239,847       217,256       239,847  

Ranger Buyer, Inc.(1) (2) (3)

  Software & Tech Services   Term Loan   7.00% (L + 6.25%; 0.75% Floor)   11/18/2028     14,390,790       14,114,877       14,390,790  

Sauce Labs, Inc.(4) (5)

  Software & Tech Services   Delayed Draw Term Loan   6.50% (L + 5.50%; 1.00% Floor)   08/16/2027     —         (17,297     (14,420

Sauce Labs, Inc.(4) (5)

  Software & Tech Services   Revolver   6.50% (L + 5.50%; 1.00% Floor)   08/16/2027     —         (23,074     (22,432

Sauce Labs, Inc.(2)

  Software & Tech Services   Term Loan   6.50% (L + 5.50%; 1.00% Floor)   08/16/2027     5,127,286       5,033,551       5,037,558  

SecureLink, Inc.(4) (5)

  Software & Tech Services   Revolver   6.75% (L + 5.75%; 1.00% Floor)   10/01/2025     —         (4,625     4,395  

SecureLink, Inc.(1) (2)

  Software & Tech Services   Term Loan   6.75% (L + 5.75%; 1.00% Floor)   10/01/2025     2,931,021       2,896,000       2,960,331  

SecureLink, Inc.(1)

  Software & Tech Services   Term Loan   6.75% (L + 5.75%; 1.00% Floor)   10/01/2025     4,861,121       4,807,561       4,909,733  

Sirsi Corporation(4) (5)

  Software & Tech Services   Revolver   5.50% (L + 4.50%; 1.00% Floor)   03/15/2024     —         (3,435     (2,769

Sirsi Corporation(1) (2)

  Software & Tech Services   Term Loan   5.50% (L + 4.50%; 1.00% Floor)   03/15/2024     7,049,970       7,003,520       7,014,720  

Smartlinx Solutions, LLC(4)

  Software & Tech Services   Revolver   7.00% (L + 6.00%; 1.00% Floor)   03/04/2026     155,845       152,408       151,949  

Smartlinx Solutions, LLC(1) (2) (3)

  Software & Tech Services   Term Loan   7.01% (L + 6.00%; 1.00% Floor)   03/04/2026     5,663,671       5,588,103       5,621,194  

Streamsets, Inc.(4) (5)

  Software & Tech Services   Revolver   6.75% (L + 5.00%; 0.75% PIK; 1.00% Floor)   11/25/2024     —         (6,240     7,010  

Streamsets, Inc.(3)

  Software & Tech Services   Term Loan   6.75% (L + 5.00%; 0.75% PIK; 1.00% Floor)   11/25/2024     2,124,760       2,085,814       2,167,256  

SugarCRM, Inc.(4) (5)

  Software & Tech Services   Revolver   7.50% (L + 6.50%; 1.00% Floor)   07/31/2024     —         (2,179     (3,102

SugarCRM, Inc.(1) (3)

  Software & Tech Services   Term Loan   7.50% (L + 6.50%; 1.00% Floor)   07/31/2024     4,268,824       4,232,219       4,226,136  

Sundance Group Holdings, Inc(4) (5)

  Software & Tech Services   Delayed Draw Term Loan   7.50% (L + 6.50%; 1.00% Floor)   07/02/2027     —         (31,195     (53,209

Sundance Group Holdings, Inc(4)

  Software & Tech Services   Revolver   7.50% (L + 6.50%; 1.00% Floor)   07/02/2027     331,077       306,105       306,246  

Sundance Group Holdings, Inc(2) (3)

  Software & Tech Services   Term Loan   7.50% (L + 6.50%; 1.00% Floor)   07/02/2027     11,824,177       11,616,080       11,617,254  

Swiftpage, Inc.(4) (5)

  Software & Tech Services   Revolver   6.50% (L + 5.50%; 1.00% Floor)   06/13/2023     —         (1,100     (5,633

Swiftpage, Inc.(2)

  Software & Tech Services   Term Loan   6.50% (L + 5.50%; 1.00% Floor)   06/13/2023     2,439,756       2,428,772       2,378,762  

Swiftpage, Inc.(2)

  Software & Tech Services   Term Loan   6.50% (L + 5.50%; 1.00% Floor)   06/13/2023     224,574       223,141       218,959  

Sysnet North America, Inc.(3)

  Software & Tech Services   Delayed Draw Term Loan   6.50% (L + 5.50%; 1.00% Floor)   12/01/2026     1,287,698       1,269,039       1,287,698  

Sysnet North America, Inc.(1) (2) (3)

  Software & Tech Services   Term Loan   6.51% (L + 5.50%; 1.00% Floor)   12/01/2026     7,648,829       7,561,979       7,648,829  

Telcor Buyer, Inc.(4) (5)

  Software & Tech Services   Revolver   5.50% (L + 4.50%; 1.00% Floor)   08/20/2027     —         (3,932     (4,362

Telcor Buyer, Inc.(1) (2)

  Software & Tech Services   Term Loan   5.50% (L + 4.50%; 1.00% Floor)   08/20/2027     9,304,625       9,178,787       9,165,056  

Telesoft Holdings, LLC(4) (5)

  Software & Tech Services   Revolver   6.75% (L + 5.75%; 1.00% Floor)   12/16/2025     —         (8,389     —    

Telesoft Holdings, LLC(2) (3)

  Software & Tech Services   Term Loan   6.75% (L + 5.75%; 1.00% Floor)   12/16/2025     5,849,291       5,765,224       5,849,291  

TRGRP, Inc.(4) (5)

  Software & Tech Services   Revolver   8.01% (L + 4.50%; 2.50% PIK; 1.00% Floor)   11/01/2023     —         (2,130     —    

TRGRP, Inc.(2)

  Software & Tech Services   Term Loan   8.01% (L + 4.50%; 2.50% PIK; 1.00% Floor)   11/01/2023     2,342,548       2,301,606       2,342,548  

TRGRP, Inc.(1)

  Software & Tech Services   Term Loan   8.01% (L + 4.50%; 2.50% PIK; 1.00% Floor)   11/01/2023     1,115,169       1,106,895       1,115,169  

TRGRP, Inc.(2) (3)

  Software & Tech Services   Term Loan   8.01% (L + 4.50%; 2.50% PIK; 1.00% Floor)   11/01/2023     4,991,858       4,957,335       4,991,858  

Ungerboeck Systems International, LLC(3)

  Software & Tech Services   Delayed Draw Term Loan   7.00% (L + 6.00%; 1.00% Floor)   04/30/2027     690,794       690,794       690,794  

Ungerboeck Systems International, LLC(1)

  Software & Tech Services   Delayed Draw Term Loan   7.00% (L + 5.75%; 1.00% Floor)   04/30/2027     322,391       318,215       322,391  

Ungerboeck Systems International, LLC(4) (5)

  Software & Tech Services   Revolver   7.00% (L + 5.75%; 1.00% Floor)   04/30/2027     —         (2,059     —    

Ungerboeck Systems International, LLC(2) (3)

  Software & Tech Services   Term Loan   7.00% (L + 5.75%; 1.00% Floor)   04/30/2027     2,717,277       2,686,299       2,717,277  

Vectra AI, Inc.(4) (5)

  Software & Tech Services   Delayed Draw Term Loan   6.75% (L + 5.75%; 1.00% Floor)   03/18/2026     —         (23,115     (32,004

Vectra AI, Inc.(4) (5)

  Software & Tech Services   Revolver   6.75% (L + 5.75%; 1.00% Floor)   03/18/2026     —         (4,623     (6,401

Vectra AI, Inc.(2) (3)

  Software & Tech Services   Term Loan   6.75% (L + 5.75%; 1.00% Floor)   03/18/2026     3,258,620       3,192,640       3,169,008  

Velocity Purchaser Corporation(4) (5)

  Software & Tech Services   Revolver   7.00% (L + 6.00%; 1.00% Floor)   12/01/2022     —         (532     —    

Velocity Purchaser Corporation(1)

  Software & Tech Services   Term Loan   7.00% (L + 6.00%; 1.00% Floor)   12/01/2022     642,640       640,259       642,640  

Velocity Purchaser Corporation(1) (2)

  Software & Tech Services   Term Loan   7.00% (L + 6.00%; 1.00% Floor)   12/01/2022     5,103,176       5,066,874       5,103,176  

Velocity Purchaser Corporation(1)

  Software & Tech Services   Term Loan   7.00% (L + 6.00%; 1.00% Floor)   12/01/2022     2,583,437       2,575,691       2,583,437  

Veracross LLC(4) (5)

  Software & Tech Services   Delayed Draw Term Loan   8.50% (L + 2.00%; 5.50% PIK; 1.00% Floor)   12/28/2027     —         (15,993     (16,688

Veracross LLC(4) (5)

  Software & Tech Services   Revolver   8.50% (L + 2.00%; 5.50% PIK; 1.00% Floor)   12/28/2027     —         (21,328     (22,251

Veracross LLC(3)

  Software & Tech Services   Term Loan   8.50% (L + 2.00%; 5.50% PIK; 1.00% Floor)   12/28/2027     12,411,972       12,173,945       12,163,732  

 

See Notes to Unaudited Consolidated Financial Statements

 

14


Table of Contents

AB Private Credit Investors Corporation

Consolidated Schedule of Investments as of March 31, 2022 (continued)

(Unaudited)

 

Portfolio Company

  

Industry

  

Facility Type

  

Interest

  

Maturity

   Funded
Par Amount
     Cost     Fair Value  

Dillon Logistics, Inc.(4) (15)

   Transport & Logistics    Revolver    9.50% (P + 6.00%; 1.00% Floor)    12/11/2023    $ 789,270      $ 751,711     $ 167,182  

Dillon Logistics, Inc.(15)

   Transport & Logistics    Term Loan    8.00% (L + 7.00%; 1.00% Floor)    12/11/2023      3,061,113        2,745,474       738,340  

Dillon Logistics, Inc.(15)

   Transport & Logistics    Term Loan    8.00% (L + 7.00%; 1.00% Floor)    12/11/2023      900,307        788,991       217,154  
                 

 

 

   

 

 

 

Total U.S.1st Lien/Senior Secured Debt

           890,806,925       887,221,666  

2nd Lien/Junior Secured Debt—2.91%

 

Conterra Ultra Broadband Holdings, Inc.(1) (2)

   Digital Infrastructure & Services    Term Loan    9.50% (L + 8.50%; 1.00% Floor)    04/30/2027      6,537,710        6,467,850       6,537,710  

Brave Parent Holdings, Inc.(1)

   Software & Tech Services    Term Loan    7.96% (L + 7.50%)    04/17/2026      1,230,107        1,213,519       1,230,107  

Symplr Software, Inc.(1) (2)

   Software & Tech Services    Term Loan    8.625% (S + 7.875%; 0.75% Floor)    12/22/2028      3,130,634        3,078,550       3,099,328  
                 

 

 

   

 

 

 

Total U.S. 2nd Lien/Junior Secured Debt

           10,759,919       10,867,145  
                 

 

 

   

 

 

 

Total U.S. Corporate Debt

           901,566,844       898,088,811  

Canadian Corporate Debt—4.87%

 

1st Lien/Senior Secured Debt—4.87%

 

McNairn Holdings Ltd.(1) (18)

   Business Services    Term Loan    6.00% (L + 5.00%; 1.00% Floor)    11/25/2025      788,841        783,401       741,511  

Syntax Systems Ltd(1) (2) (18)

   Digital Infrastructure & Services    Term Loan    6.25% (L + 5.50%; 0.75% Floor)    10/29/2028      8,840,177        8,756,518       8,751,775  

Syntax Systems Ltd(4) (18)

   Digital Infrastructure & Services    Revolver    6.25% (L + 5.50%; 0.75% Floor)    10/29/2026      542,650        533,716       532,914  

Syntax Systems Ltd(4) (5) (18)

   Digital Infrastructure & Services    Delayed Draw Term Loan    6.25% (L + 5.50%; 0.75% Floor)    10/29/2028      —          (22,924     (24,342

Banneker V Acquisition, Inc.(2) (3) (18)

   Software & Tech Services    Term Loan    8.00% (L + 7.00%; 1.00% Floor)    12/04/2025      7,159,563        7,043,706       7,159,563  

Banneker V Acquisition, Inc.(4) (5) (18)

   Software & Tech Services    Revolver    8.00% (L + 7.00%; 1.00% Floor)    12/04/2025      —          (3,841     —    

Banneker V Acquisition, Inc.(2) (18)

   Software & Tech Services    Delayed Draw Term Loan    8.00% (L + 7.00%; 1.00% Floor)    12/04/2025      1,032,012        1,016,703       1,032,012  
                 

 

 

   

 

 

 

Total Canadian 1st Lien/Senior Secured Debt

           18,107,279       18,193,433  
                 

 

 

   

 

 

 

Total Canadian Corporate Debt

           18,107,279       18,193,433  

United Kingdom Corporate Debt—2.02%

 

1st Lien/Senior Secured Debt—2.02%

 

GlobalWebIndex Inc.(3) (4)

   Software & Tech Services    Delayed Draw Term Loan    7.00% (L + 6.00%; 1.00% Floor)    12/30/2024      1,841,860        1,816,375       1,915,534  

GlobalWebIndex Inc.(2) (3)

   Software & Tech Services    Term Loan    7.00% (L + 6.00%; 1.00% Floor)    12/30/2024      5,525,580        5,374,425       5,636,092  
                 

 

 

   

 

 

 

Total United Kingdom 1st Lien/Senior Secured Debt

           7,190,800       7,551,626  
                 

 

 

   

 

 

 

Total United Kingdom Corporate Debt

           7,190,800       7,551,626  

 

Portfolio Company

  

Class/Series

  

Industry

                                               Shares      Cost      Fair Value  

U.S. Preferred Stock—4.18%

 

Global Radar Holdings, LLC(19) (20)

   LLC Units    Business Services            125      $ 367,615      $ 542,786  

Bowline Topco LLC(20) (21)

   LLC Units    Energy            2,946,390        2,002,277        3,824,381  

SBS Ultimate Holdings, LP(20)

   Class A    Healthcare & HCIT            217,710        861,878        661,837  

Concerto Health AI Solutions, LLC(20) (22)

   Series B-1    Software & Tech Services            65,614        349,977        444,484  

Streamsets, Inc.(20)

   Series C-1    Software & Tech Services            109,518        295,512        912,285  

Alphasense, Inc.(18) (20)

   Series C    Software & Tech Services            23,961        369,843        358,020  

Datarobot, Inc.(20)

   Series E    Software & Tech Services            38,190        289,278        515,413  

Datarobot, Inc.(20)

   Series F    Software & Tech Services            6,715        88,248        108,006  

Degreed, Inc.(20)

   Series C-1    Software & Tech Services            43,819        278,541        606,754  

Degreed, Inc.(20)

   Series D    Software & Tech Services            16,943        278,308        278,308  

Heap, Inc.(20)

   Series C    Software & Tech Services            189,617        696,351        1,334,495  

Heap, Inc.(20)

   Series D    Software & Tech Services            17,425        147,443        147,449  

Mcafee(20) (23) (24)

   Class A    Software & Tech Services            821,396        821,396        835,432  

Netskope, Inc.(20)

   Series G    Software & Tech Services            36,144        302,536        398,391  

PerimeterX, Inc.(20)

   Series D    Software & Tech Services            282,034        838,601        844,258  

 

See Notes to Unaudited Consolidated Financial Statements

 

15


Table of Contents

AB Private Credit Investors Corporation

Consolidated Schedule of Investments as of March 31, 2022 (continued)

(Unaudited)

 

Portfolio Company

  

Class/Series

  

Industry

                                               Shares      Cost      Fair Value  

Phenom People, Inc.(20)

   Series C    Software & Tech Services            35,055      $ 220,610      $ 528,066  

Protoscale Rubrik, LLC(20)

   Class B    Software & Tech Services            25,397        598,212        638,049  

Swyft Parent Holdings LP(25)

   LP Interests    Software & Tech Services            850,470        811,438        807,946  

Symplr Software Intermediate Holdings, Inc.(20)

   Series A    Software & Tech Services            1,196        1,160,532        1,737,384  

Vectra AI, Inc(20)

   Series F    Software & Tech Services            17,064        131,095        118,707  
                 

 

 

    

 

 

 

Total U.S. Preferred Stock

                 10,909,691        15,642,451  
U.S. Common Stock—2.50%                  

Leeds FEG Investors, LLC(20)

   Class A    Consumer Discretionary            320      $ 321,309      $ 236,969  

Pacific Bells, LLC(20) (26)

   LP Interests    Consumer Non-Cyclical            802,902        802,902        798,764  

Freddy’s Frozen Custard, LLC(20) (27)

   LP Interests    Consumer Non-Cyclical            72,483        72,483        112,017  

Nestle Waters North America,
Inc.(20) (24) (28)

   LP Interests    Consumer Non-Cyclical            341,592        98,394        98,394  

8x8, Inc.(18) (20) (29)

   Common Units    Digital Infrastructure & Services            7,886        170,890        99,285  

Avant Communications, LLC(20) (30)

   Class A    Digital Infrastructure & Services            220,542        220,542        226,648  

Avant Communications, LLC.(20) (30)

   Class A Capital    Digital Infrastructure & Services            220,542        —          —    

MSP Global Holdings, Inc(20)

   Class A    Digital Infrastructure & Services            333,937        333,937        333,937  

NEPCORE Parent Holdings, LLC(20)

   Class A    Digital Infrastructure & Services            82        81,530        84,236  

Neutral Connect, LLC(20) (31)

   LLC Units    Digital Infrastructure & Services            396,513        439,931        408,583  

Thrive Parent, LLC(20)

   Class L    Digital Infrastructure & Services            100,219        263,195        342,293  

Agape Care Group(20) (32)

   LP Interests    Healthcare & HCIT            590,203        590,203        625,565  

Community Based Care Holdings, LP(20)

   LP Interests    Healthcare & HCIT            161        160,506        160,510  

Health Platform Group, Inc(20)

   Earn Out    Healthcare & HCIT            16,502        —          —    

Healthcare Services Acquisition(18) (20)

   Class B    Healthcare & HCIT            15,183        46        46  

Healthcare Services Acquisition(18) (20) (29)

   Class A    Healthcare & HCIT            28,158        281,580        279,933  

INH Group Holdings, Inc.(20)

   Class A    Healthcare & HCIT            484,552        484,552        386,206  

Medical Management Resource Group, LLC(20) (33)

   Class B    Healthcare & HCIT            34,492        34,492        35,235  

nThrive(20)

   LP Interests    Healthcare & HCIT            812,734        812,734        812,734  

Redwood Family Care Network, Inc.(20)

   Class A    Healthcare & HCIT            66        66,000        71,735  

REP AOM Holdings, LLC(20) (34)

   Class A    Healthcare & HCIT            290,393        290,393        290,393  

American Safety Holdings Corp.(20) (35)

   LP Interests    Software & Tech Services            167,509        190,658        274,465  

Brightspot Holdco, LLC(20)

   LLC Units    Software & Tech Services            433,207        433,207        433,454  

EnterpriseDB Corporation(20) (24) (36)

   LLC Units    Software & Tech Services            417,813        417,813        1,363,718  

Moon Topco L.P.(20)

   Class A    Software & Tech Services            36        35,999        51,830  

Mykaarma Acquisition LLC(20)

   Class A    Software & Tech Services            257,031        257,031        257,031  

Ranger Lexipol Holdings, LLC(20) (24)

   Class A    Software & Tech Services            433        433,207        434,369  

Ranger Lexipol Holdings, LLC(20) (24)

   Class B    Software & Tech Services            433        —          2,235  

Samsara Networks, Inc.(18) (20) (29)

   Class A    Software & Tech Services            33,451        369,998        535,885  

Stripe, Inc.(20)

   Class B    Software & Tech Services            4,158        166,854        155,301  

Swyft Parent Holdings LP(20) (25)

   LP Interests    Software & Tech Services            4,485        —          —    

Omni Logistics, LLC(37)

   LP Interests    Transport & Logistics            193,770        193,770        432,481  
                 

 

 

    

 

 

 

Total U.S. Common Stock

                 8,024,156        9,344,252  
Canadian Common Stock—0.07%                  

Auvik Topco Holdings, Inc(18) (20) (24) (38)

   LP Interests    Software & Tech Services            244,920        244,920        244,920  
                 

 

 

    

 

 

 

Total Canadian Common Stock

                 244,920        244,920  

 

See Notes to Unaudited Consolidated Financial Statements

 

16


Table of Contents

AB Private Credit Investors Corporation

Consolidated Schedule of Investments as of March 31, 2022 (continued)

(Unaudited)

 

Portfolio Company

   Class/Series      Industry                   Shares      Cost      Fair Value  

U.S. Warrants—0.18%

 

Healthcare Services Acquisition, expire 12/31/2027(18) (20)

     Class B        Healthcare & HCIT             14,079      $ —        $ —    

Healthcare Services Acquisition, expire 12/31/2027(18) (20) (29)

     Class A        Healthcare & HCIT             23,721        23,721        8,065  

SBS Ultimate Holdings, LP, expire 09/18/2030(20)

     Class A        Healthcare & HCIT             17,419        —          —    

Alphasense, Inc., expire 05/29/2027(18) (20)

     Series B        Software & Tech Services             40,394        35,185        202,008  

Degreed, Inc., expire 04/11/2028(20)

     Series D        Software & Tech Services             7,624               39,694  

Degreed, Inc., expire 05/31/2026(20)

     Series C -1        Software & Tech Services             26,294        46,823        215,954  

PerimeterX, Inc., expire 12/31/2031(20)

     Series D        Software & Tech Services             10,850        7,595        7,077  

Streamsets, Inc., expire 11/25/2027(20)

     Series C-1        Software & Tech Services             23,382        16,367        131,641  

Vectra AI, Inc., expire 03/18/2031(20)

     Series F        Software & Tech Services             35,156        58,190        86,702  
                

 

 

    

 

 

 

Total U.S. Warrants

                   187,881        691,141  

United Kingdom Warrants—0.11%

 

GlobalWebIndex, Inc., expire 12/30/2027(20)

     Preferred Units        Software & Tech Services             8,832        159,859        429,270  
                

 

 

    

 

 

 

Total United Kingdom Warrants

                   159,859        429,270  

TOTAL INVESTMENTS—254.20%(39)

 

   $ 946,391,430      $ 950,185,904  
                

 

 

    

 

 

 

Cash Equivalents—7.37%

 

U.S. Investment Companies—7.37%

 

Blackrock T Fund I(29) (40)

     Money Market        Money Market Portfolio        0.02% (41)          27,552,318      $ 27,552,318      $ 27,552,318  
                

 

 

    

 

 

 

Total U.S. Investment Companies

                   27,552,318        27,552,318  
                

 

 

    

 

 

 

Total Cash Equivalents

                   27,552,318        27,552,318  

LIABILITIES IN EXCESS OF OTHER ASSETS—(161.57%)

 

   $ (603,947,352
                   

 

 

 

NET ASSETS—100.00%

 

   $ 373,790,870  
                   

 

 

 

 

+ 

As of March 31, 2022, qualifying assets represented 97.34% of total assets. Under the 1940 Act we may not acquire any non-qualifying assets unless, at the time the acquisition is made, qualifying assets represent at least 70% of our total assets.

* 

Unless otherwise indicated, all securities are valued using significant unobservable inputs, which are categorized as Level 3 assets under the definition of Financial Accounting Standards Board’s Accounting Standards Codification 820 fair value hierarchy.

# 

Percentages are based on net assets.

^ 

Generally, the interest rate on floating interest rate investments is at benchmark rate plus spread. The borrower has an option to choose the benchmark rate, such as the London Interbank Offered Rate (“LIBOR”), Secured Overnight Financing Rate including adjustment, if any (“SOFR”) or the U.S. Prime rate. The spread may change based on the type of rate used. The terms in the Consolidated Schedule of Investments disclose the actual interest rate in effect as of the reporting period. LIBOR and SOFR loans are typically indexed to 30-day, 60-day, 90-day or 180-day rates (1M, 3M or 6M, respectively) at the borrower’s option. LIBOR and SOFR loans may be subject to interest floors. As of March 31, 2022, rates for weekly 1M L, 3M L 6M L, 1M S, 3M S and 6M S are 0.45%, 0.96%, 1.47%, 0.16%, 0.09% and 0.07%, respectively. As of March 31, 2022, the U.S. Prime rate was 3.50%.

(1) 

Position, or a portion thereof, has been segregated to collateralize ABPCI Direct Lending Fund CLO VI Ltd.

(2) 

Position, or a portion thereof, has been segregated to collateralize ABPCIC Funding III, LLC.

(3) 

Position, or a portion thereof, has been segregated to collateralize ABPCIC Funding II, LLC.

(4) 

Position or portion thereof is an unfunded loan commitment, and no interest is being earned on the unfunded portion. The unfunded loan commitment may be subject to a commitment termination date, that may expire prior to the maturity date stated. See Note 6 “Commitments and Contingencies”.

(5) 

The negative cost is the result of the capitalized discount being greater than the principal amount outstanding on the loan. The negative fair value is the result of the capitalized discount on the loan.

(6) 

Saturn Borrower Inc. has been renamed to Stratus Networks, Inc. in 2022.

(7) 

$30,725 of the funded par amount accrues interest at 7.75% (P + 4.25%; 2.00% Floor).

(8) 

$128 of the funded par amount accrues interest at 7.75% (P + 4.25%; 2.00% Floor).

(9) 

MedMark Services, Inc. has been renamed to BAART Programs, Inc. in 2022.

(10) 

$86,381 of the funded par amount accrues interest at 6.50% (L + 5.50%; 1.00% Floor).

(11) 

Millin Purchaser LLC. has been renamed to Medsuite Purchaser, LLC in 2022.

(12) 

$30,725 of the funded par amount accrues interest at 6.50% (P + 3.00%; 2.00% Floor).

(13) 

$320,384 of the funded par amount accrues interest at 9.50% (P + 5.25%; 1.00% PIK; 2.00% Floor).

(14) 

$137,298 of the funded par amount accrues interest at 8.25% (L + 6.25%; 1.00% PIK; 1.00% Floor).

(15) 

The investment is on non-accrual status. See Note 2 “Significant Accounting Policies.”

(16) 

$172,633 of the funded par amount accrues interest at 7.49% (L + 5.75%; 1.00% Floor).

(17) 

Dude Solutions Holdings, Inc. has been renamed to Brightly Software Holdings, Inc. in 2022.

(18) 

Positions considered non-qualified assets therefore excluded from the qualifying assets calculation as noted in footnote + above.

(19) 

Position or portion thereof is held by Global Radar Acquisition Holdings, LLC which is held by ABPCIC Global Radar LLC, an affiliate of the Fund.

(20) 

Non-income producing investment.

(21) 

Bowline Topco LLC is held through ABPCIC BE Holdings, LLC, an affiliate of the Fund.

(22) 

Concerto Health AI Solutions, LLC is held through ABPCIC Concerto Holdings LLC, an affiliate of the Fund.

(23) 

Position or portion thereof is held by Magenta Blocker Aggregator LP, which is held by ABPCIC Equity Holdings, LLC.

 

See Notes to Unaudited Consolidated Financial Statements

 

17


Table of Contents

AB Private Credit Investors Corporation

Consolidated Schedule of Investments as of March 31, 2022 (continued)

(Unaudited)

 

(24) 

Excluded from the ASC 820 fair value hierarchy as fair value is measured using the net asset value per share practical expedient.

(25) 

Position or portion thereof is held by ABPCIC Swyft Holdings LLC, an affiliate of the Fund, which is held by ABPCIC Equity Holdings, LLC.

(26) 

Position or portion thereof is held by Orangewood WWB Co-Invest, L.P. which is held by ABPCIC Equity Holdings, LLC.

(27) 

Position or portion thereof is held by Freddy’s Acquisition, LP.

(28) 

Position or portion thereof is held by ORCP III Triton Co-Investors, L.P. which is held by ABPCIC Equity Holdings, LLC.

(29) 

Categorized as Level 1 assets under the definition of ASC 820 fair value hierarchy.

(30) 

Position or portion thereof is held by Pamlico Avant Holdings L.P. which is held by ABPCIC Avant, LLC, an affiliate of the Fund.

(31) 

Neutral Connect, LLC is held through ABPCIC NC Holdings LLC, an affiliate of the Fund.

(32) 

Position or portion thereof is held by REP Coinvest III AGP Blocker, L.P. which is held by ABPCIC Equity Holdings, LLC.

(33) 

Medical Management Resource Group, LLC is held through Advantage AVP Parent Holdings, L.P.

(34) 

Position or portion thereof is held by ABPCIC AOM LLC, an affiliate of the Fund.

(35) 

Position or portion thereof is held by REP Coinvest III Tec, L.P. which is held by ABPCIC Equity Holdings, LLC.

(36) 

Position or portion thereof is held by GHP E Aggregator, LLC.

(37) 

Position or portion thereof is held by REP Coinvest III-A Omni, L.P. which is held by ABPCIC Equity Holdings, LLC.

(38) 

Position or portion thereof is held by GHP SPV-2, L.P., which is held by ABPCIC Equity Holdings, LLC.

(39) 

Aggregate gross unrealized appreciation for federal income tax purposes is $13,692,581; aggregate gross unrealized depreciation for federal income tax purposes is $9,898,107. Net unrealized appreciation is $3,794,474 based upon a tax cost basis of $946,391,430.

(40) 

Included within ‘Cash and cash equivalents’ on the Consolidated Statements of Assets and Liabilities.

(41) 

The rate shown is the annualized seven-day yield as of March 31, 2022.

 

L   -   LIBOR
P   -   Prime
PIK   -   Payment-In-Kind
S   -   SOFR

 

See Notes to Unaudited Consolidated Financial Statements

 

18


Table of Contents

AB Private Credit Investors Corporation

Consolidated Schedule of Investments as of December 31, 2021

 

Portfolio Company

 

Industry

 

Facility Type

 

Interest

 

Maturity

  Funded
Par Amount
    Cost     Fair Value  
Investments at Fair Value—257.77% + * # ^  
U.S. Corporate Debt—244.00%  
1st Lien/Senior Secured Debt—240.92%  

AmerCareRoyal, LLC(1)

  Business Services   Delayed Draw Term Loan   6.00% (L + 5.00%; 1.00% Floor)   11/25/2025   $ 526,726     $ 522,476     $ 492,489  

AmerCareRoyal, LLC(2)

  Business Services   Term Loan   6.00% (L + 5.00%; 1.00% Floor)   11/25/2025     542,157       537,783       506,917  

AmerCareRoyal, LLC(1)

  Business Services   Term Loan   6.00% (L + 5.00%; 1.00% Floor)   11/25/2025     4,369,977       4,340,035       4,085,928  

BEP Borrower Holdco, LLC(2) (3)

  Business Services   Delayed Draw Term Loan   5.25% (L + 4.25%; 1.00% Floor)   06/12/2024     1,272,200       1,260,728       1,272,200  

BEP Borrower Holdco, LLC(4) (5)

  Business Services   Revolver   5.25% (L + 4.25%; 1.00% Floor)   06/12/2024     —         (3,190     —    

BEP Borrower Holdco, LLC(1)

  Business Services   Term Loan   5.25% (L + 4.25%; 1.00% Floor)   06/12/2024     3,392,534       3,365,460       3,392,534  

Engage2Excel, Inc.(1) (4)

  Business Services   Revolver   9.00% (L + 6.00%; 2.00% PIK; 1.00% Floor)   03/07/2023     373,874       371,898       370,041  

Engage2Excel, Inc.(1)

  Business Services   Term Loan   9.00% (L + 6.00%; 2.00% PIK; 1.00% Floor)   03/07/2023     1,037,292       1,030,411       1,026,919  

Engage2Excel, Inc.(1)

  Business Services   Term Loan   9.00% (L + 6.00%; 2.00% PIK; 1.00% Floor)   03/07/2023     2,989,244       2,972,409       2,959,351  

Global Radar Holdings, LLC(4) (5)

  Business Services   Revolver   7.50% (L + 6.50%; 1.00% Floor)   12/31/2025     —         (1,874     —    

Global Radar Holdings, LLC(2) (3)

  Business Services   Term Loan   7.50% (L + 6.50%; 1.00% Floor)   12/31/2025     7,494,115       7,370,436       7,494,115  

Metametrics, Inc.(4)

  Business Services   Revolver   6.00% (L + 5.00%; 1.00% Floor)   09/10/2025     260,473       252,392       260,473  

Metametrics, Inc.(1) (2)

  Business Services   Term Loan   6.00% (L + 5.00%; 1.00% Floor)   09/10/2025     4,731,059       4,668,040       4,731,059  

MSM Acquisitions, Inc.(4) (5)

  Business Services   Delayed Draw Term Loan   7.00% (L + 6.00%; 1.00% Floor)   12/09/2026     —         (14,764     —    

MSM Acquisitions, Inc.(2)

  Business Services   Delayed Draw Term Loan   7.00% (L + 6.00%; 1.00% Floor)   12/09/2026     3,035,769       2,982,201       3,020,590  

MSM Acquisitions, Inc.(4)

  Business Services   Revolver   8.25% (P + 5.00%; 2.00% Floor)   12/09/2026     113,317       93,015       107,191  

MSM Acquisitions, Inc.(1) (2) (3)

  Business Services   Term Loan   7.00% (L + 6.00%; 1.00% Floor)   12/09/2026     8,295,612       8,164,830       8,254,134  

Rep Tec Intermediate Holdings,
Inc.(4) (5)

  Business Services   Revolver   7.50% (L + 6.50%; 1.00% Floor)   12/01/2027     —         (12,973     —    

Rep Tec Intermediate Holdings,
Inc.(1) (2) (3)

  Business Services   Term Loan   7.50% (L + 6.50%; 1.00% Floor)   12/01/2027     14,386,927       14,150,969       14,386,927  

Valcourt Holdings II, LLC(1) (4)

  Business Services   Delayed Draw Term Loan   6.50% (L + 5.50%; 1.00% Floor)   01/07/2027     629,494       604,560       629,494  

Valcourt Holdings II, LLC(2)

  Business Services   Term Loan   6.50% (L + 5.50%; 1.00% Floor)   01/07/2027     2,668,148       2,620,810       2,668,148  

Valcourt Holdings II, LLC(1) (2)

  Business Services   Term Loan   6.50% (L + 5.50%; 1.00% Floor)   01/07/2027     6,343,167       6,233,173       6,343,167  

AEG Holding Company, Inc.(1)

  Consumer Discretionary   Delayed Draw Term Loan   6.50% (L + 5.50%; 1.00% Floor)   11/20/2023     1,056,538       1,049,248       1,056,538  

AEG Holding Company, Inc.(4) (5)

  Consumer Discretionary   Revolver   6.50% (L + 5.50%; 1.00% Floor)   11/20/2023     —         (8,444     —    

AEG Holding Company, Inc.(3)

  Consumer Discretionary   Term Loan   6.50% (L + 5.50%; 1.00% Floor)   11/20/2023     1,838,542       1,821,998       1,838,542  

AEG Holding Company, Inc.(1)

  Consumer Discretionary   Term Loan   6.50% (L + 5.50%; 1.00% Floor)   11/20/2023     5,710,726       5,669,850       5,710,726  

Ampler QSR Holdings, LLC(2) (3)

  Consumer Non-Cyclical   Term Loan   6.88% (L + 5.88%; 1.00% Floor)   07/21/2027     12,471,832       12,240,157       12,284,755  

Blink Holdings, Inc.(1)

  Consumer Non-Cyclical   Delayed Draw Term Loan   6.50% (L + 5.50%; 1.00% Floor)   11/08/2024     1,178,697       1,171,653       1,046,094  

Blink Holdings, Inc.

  Consumer Non-Cyclical   Delayed Draw Term Loan   6.50% (L + 5.50%; 1.00% Floor)   11/08/2024     945,093       944,188       838,770  

Blink Holdings, Inc.(1)

  Consumer Non-Cyclical   Term Loan   6.50% (L + 5.50%; 1.00% Floor)   11/08/2024     1,647,736       1,637,867       1,462,365  

Captain D’s, Inc.(4) (5)

  Consumer Non-Cyclical   Revolver   5.50% (L + 4.50%; 1.00% Floor)   12/15/2023     —         (713     —    

Captain D’s, Inc.(1)

  Consumer Non-Cyclical   Term Loan   5.50% (L + 4.50%; 1.00% Floor)   12/15/2023     1,929,660       1,922,514       1,929,660  

Freddy’s Frozen Custard,
L.L.C(4) (5)

  Consumer Non-Cyclical   Revolver   6.00% (L + 5.00%; 1.00% Floor)   03/03/2027     —         (4,461     —    

Freddy’s Frozen Custard,
L.L.C(2) (3)

  Consumer Non-Cyclical   Term Loan   6.00% (L + 5.00%; 1.00% Floor)   03/03/2027     4,908,524       4,855,157       4,908,524  

Krispy Krunchy Foods, L.L.C(4) (5)

  Consumer Non-Cyclical   Revolver   5.75% (L + 4.75%; 1.00% Floor)   11/17/2027     —         (19,108     (19,498

Krispy Krunchy Foods, L.L.C(2) (3)

  Consumer Non-Cyclical   Term Loan   5.75% (L + 4.75%; 1.00% Floor)   11/17/2027     11,698,611       11,469,309       11,464,639  

Mathnasium LLC(4)

  Consumer Non-Cyclical   Revolver   5.75% (L + 5.00%; 0.75% Floor)   11/15/2027     87,043       74,259       73,987  

Mathnasium LLC(1) (2)

  Consumer Non-Cyclical   Term Loan   5.75% (L + 5.00%; 0.75% Floor)   11/15/2027     5,440,202       5,333,666       5,331,398  

PF Growth Partners, LLC

  Consumer Non-Cyclical   Term Loan   6.50% (L + 5.50%; 1.00% Floor)   07/11/2025     118,340       114,494       114,494  

PF Growth Partners, LLC

  Consumer Non-Cyclical   Term Loan   6.50% (L + 5.50%; 1.00% Floor)   07/11/2025     239,084       231,313       231,313  

PF Growth Partners, LLC(1)

  Consumer Non-Cyclical   Term Loan   6.50% (L + 5.50%; 1.00% Floor)   07/11/2025     1,991,362       1,978,641       1,926,643  

TBG Food Acquisition Corp(4) (5)

  Consumer Non-Cyclical   Delayed Draw Term Loan   5.00% (L + 4.25%; 0.75% Floor)   12/25/2027     —         (10,528     (10,561

TBG Food Acquisition Corp(4) (5)

  Consumer Non-Cyclical   Revolver   5.00% (L + 4.25%; 0.75% Floor)   12/25/2027     —         (2,632     (2,640

TBG Food Acquisition Corp(1) (2)

  Consumer Non-Cyclical   Term Loan   5.00% (L + 4.25%; 0.75% Floor)   12/25/2027     6,600,651       6,534,791       6,534,645  

5 Bars, LLC(4) (5)

  Digital Infrastructure & Services   Delayed Draw Term Loan   5.50% (L + 4.50%; 1.00% Floor)   09/27/2024     —         (28,548     —    

5 Bars, LLC(4) (5)

  Digital Infrastructure & Services   Revolver   5.50% (L + 4.50%; 1.00% Floor)   09/27/2024     —         (5,353     —    

5 Bars, LLC(3)

  Digital Infrastructure & Services   Term Loan   5.50% (L + 4.50%; 1.00% Floor)   09/27/2024     4,742,121       4,700,796       4,742,121  

Avant Communications, LLC(4) (5)

  Digital Infrastructure & Services   Revolver   6.50% (L + 5.50%; 1.00% Floor)   11/30/2026     —         (11,145     (11,338

Avant Communications, LLC(1) (2)

  Digital Infrastructure & Services   Term Loan   6.50% (L + 5.50%; 1.00% Floor)   11/30/2026     5,102,189       5,001,883       5,000,145  

Bridgepointe Technologies,
LLC(4) (5)

  Digital Infrastructure & Services   Delayed Draw Term Loan   6.75% (L + 5.75%; 1.00% Floor)   12/31/2027     —         (38,875     (77,749

Bridgepointe Technologies,
LLC(4) (5)

  Digital Infrastructure & Services   Delayed Draw Term Loan   6.75% (L + 5.75%; 1.00% Floor)   12/31/2027     —         (27,795     (55,591

Bridgepointe Technologies,
LLC(4) (5)

  Digital Infrastructure & Services   Revolver   6.75% (L + 5.75%; 1.00% Floor)   12/31/2027     —         (15,550     (15,550

Bridgepointe Technologies,
LLC(1) (2)

  Digital Infrastructure & Services   Term Loan   6.75% (L + 5.75%; 1.00% Floor)   12/31/2027     4,789,366       4,693,578       4,693,578  

Coretelligent Intermediate
LLC(4)

  Digital Infrastructure & Services   Delayed Draw Term Loan   6.50% (L + 5.50%; 1.00% Floor)   10/21/2027     —         —         —    

Coretelligent Intermediate
LLC(4) (5)

  Digital Infrastructure & Services   Revolver   6.50% (L + 5.50%; 1.00% Floor)   10/21/2027     —         (18,391     (18,996

Coretelligent Intermediate
LLC(1) (2) (3)

  Digital Infrastructure & Services   Term Loan   6.50% (L + 5.50%; 1.00% Floor)   10/21/2027     8,029,110       7,912,508       7,908,673  

EvolveIP, LLC

  Digital Infrastructure & Services   Delayed Draw Term Loan   6.50% (L + 5.50%; 1.00% Floor)   06/07/2025     112,240       111,547       111,679  

 

See Notes to Unaudited Consolidated Financial Statements

 

19


Table of Contents

AB Private Credit Investors Corporation

Consolidated Schedule of Investments as of December 31, 2021 (continued)

 

Portfolio Company

 

Industry

 

Facility Type

 

Interest

 

Maturity

  Funded
Par Amount
    Cost     Fair Value  

EvolveIP, LLC(4)

  Digital Infrastructure & Services   Revolver   6.50% (L + 5.50%; 1.00% Floor)   06/07/2025   $ 56,687     $ 53,206     $ 53,852  

EvolveIP, LLC(1)

  Digital Infrastructure & Services   Term Loan   6.50% (L + 5.50%; 1.00% Floor)   06/07/2025     6,500,813       6,458,027       6,468,309  

Fatbeam, LLC(4) (5)

  Digital Infrastructure & Services   Delayed Draw Term Loan   7.25% (L + 6.25%; 1.00% Floor)   02/22/2026     —         (30,181     (64,385

Fatbeam, LLC(4) (5)

  Digital Infrastructure & Services   Delayed Draw Term Loan   7.25% (L + 6.25%; 1.00% Floor)   02/22/2026     —         (30,181     (64,385

Fatbeam, LLC(4)

  Digital Infrastructure & Services   Revolver   7.25% (L + 6.25%; 1.00% Floor)   02/22/2026     257,540       245,467       231,786  

Fatbeam, LLC(2) (3)

  Digital Infrastructure & Services   Term Loan   7.25% (L + 6.25%; 1.00% Floor)   02/22/2026     6,438,490       6,316,842       6,180,951  

Firstdigital Communications LLC(4) (5)

  Digital Infrastructure & Services   Revolver   5.00% (L + 4.25%; 0.75% Floor)   12/17/2026     —         (31,481     (31,735

Firstdigital Communications LLC(2) (3)

  Digital Infrastructure & Services   Term Loan   5.00% (L + 4.25%; 0.75% Floor)   12/17/2026     13,645,840       13,375,102       13,372,924  

Fuze, Inc.(2) (3)

  Digital Infrastructure & Services   Delayed Draw Term Loan   9.675% (L + 5.625%; 2.30% PIK; 1.75% Floor)   09/20/2024     2,249,398       1,882,144       2,606,495  

Fuze, Inc.(4) (5)

  Digital Infrastructure & Services   Revolver   9.675% (L + 5.625%; 2.30% PIK; 1.75% Floor)   09/20/2024     —         (3,038     29,436  

Fuze, Inc.(1) (3)

  Digital Infrastructure & Services   Term Loan   9.675% (L + 5.625%; 2.30% PIK; 1.75% Floor)   09/20/2024     9,593,090       9,562,149       11,289,986  

MBS Holdings, Inc.(4) (5)

  Digital Infrastructure & Services   Revolver   6.75% (L + 5.75%; 1.00% Floor)   04/16/2027     —         (17,253     (4,871

MBS Holdings, Inc.(1) (2) (3)

  Digital Infrastructure & Services   Term Loan   6.75% (L + 5.75%; 1.00% Floor)   04/16/2027     10,468,423       10,283,024       10,416,080  

NI Topco, Inc(4)

  Digital Infrastructure & Services   Revolver   4.35% (L + 4.25%)   12/28/2026     244,622       226,764       226,764  

NI Topco, Inc(2) (3)

  Digital Infrastructure & Services   Term Loan   6.50% (L + 5.75%; 0.75% Floor)   12/28/2028     6,689,537       6,539,022       6,539,022  

Saturn Borrower Inc(4) (5)

  Digital Infrastructure & Services   Delayed Draw Term Loan   6.25% (L + 5.25%; 1.00% Floor)   12/15/2027     —         (39,305     (79,208

Saturn Borrower Inc(4)

  Digital Infrastructure & Services   Revolver   6.25% (L + 5.25%; 1.00% Floor)   12/15/2027     244,224       224,571       224,422  

Saturn Borrower Inc(2)

  Digital Infrastructure & Services   Term Loan   6.25% (L + 5.25%; 1.00% Floor)   12/15/2027     7,920,781       7,762,366       7,762,366  

Single Digits, Inc.(2)

  Digital Infrastructure & Services   Delayed Draw Term Loan   7.00% (L + 6.00%; 1.00% Floor)   12/21/2023     601,500       599,101       595,485  

Single Digits, Inc.(4) (5)

  Digital Infrastructure & Services   Revolver   7.00% (L + 6.00%; 1.00% Floor)   12/21/2023     —         (1,656     (4,161

Single Digits, Inc.(1)

  Digital Infrastructure & Services   Term Loan   7.00% (L + 6.00%; 1.00% Floor)   12/21/2023     3,229,305       3,214,249       3,197,012  

Thrive Buyer, Inc.(1) (2) (4)

  Digital Infrastructure & Services   Delayed Draw Term Loan   7.00% (L + 6.00%; 1.00% Floor)   01/22/2027     4,699,600       4,543,576       4,678,788  

Thrive Buyer, Inc.(4) (5)

  Digital Infrastructure & Services   Revolver   7.00% (L + 6.00%; 1.00% Floor)   01/22/2027     —         (19,914     (2,774

Thrive Buyer, Inc.(1) (2) (3)

  Digital Infrastructure & Services   Term Loan   7.00% (L + 6.00%; 1.00% Floor)   01/22/2027     11,885,159       11,678,026       11,855,446  

Towerco IV Holdings, LLC(1) (2) (4)

  Digital Infrastructure & Services   Delayed Draw Term Loan   6.63% (L + 5.63%; 1.00% Floor)   04/23/2026     13,200,903       13,015,634       13,035,063  

Transtelco Holding, Inc.(2)

  Digital Infrastructure & Services   Term Loan   6.25% (L + 5.75%; 0.50% Floor)   03/26/2026     4,756,166       4,708,605       4,708,605  

Transtelco Holding, Inc.(1) (2) (3)

  Digital Infrastructure & Services   Term Loan   6.25% (L + 5.75%; 0.50% Floor)   03/26/2026     4,756,166       4,708,605       4,708,605  

Accelerate Resources Operating, LLC(4) (5)

  Energy   Revolver   6.50% (L + 5.50%; 1.00% Floor)   02/24/2026     —         (5,804     —    

Accelerate Resources Operating, LLC(1)

  Energy   Term Loan   6.50% (L + 5.50%; 1.00% Floor)   02/24/2026     4,233,665       4,174,582       4,233,665  

Bowline Energy, LLC(1)

  Energy   Term Loan   7.50% (L + 6.50%; 1.00% Floor)   08/09/2025     3,501,384       3,463,180       3,501,384  

Foundation Risk Partners, Corp.(4)

  Financials   Delayed Draw Term Loan   6.50% (L + 5.75%; 0.75% Floor)   10/29/2028     1,221,250       1,208,400       1,205,221  

Foundation Risk Partners, Corp.(4) (5)

  Financials   Revolver   6.50% (L + 5.75%; 0.75% Floor)   10/29/2027     —         (12,430     (12,976

Foundation Risk Partners,
Corp.(1) (2) (3)

  Financials   Term Loan   6.50% (L + 5.75%; 0.75% Floor)   10/29/2028     9,831,060       9,712,835       9,708,172  

Galway Borrower, LLC(4) (5)

  Financials   Delayed Draw Term Loan   6.00% (L + 5.25%; 0.75% Floor)   09/29/2028     —         (5,470     (5,679

Galway Borrower, LLC(4) (5)

  Financials   Revolver   6.00% (L + 5.25%; 0.75% Floor)   09/30/2027     —         (5,186     (5,408

Galway Borrower, LLC(1) (2)

  Financials   Term Loan   6.00% (L + 5.25%; 0.75% Floor)   09/29/2028     3,762,793       3,694,870       3,687,538  

Higginbotham Insurance Agency,
Inc.(2) (4)

  Financials   Delayed Draw Term Loan   6.25% (L + 5.50%; 0.75% Floor)   11/25/2026     408,722       392,084       389,995  

Higginbotham Insurance Agency,
Inc.(1) (2) (3)

  Financials   Term Loan   6.25% (L + 5.50%; 0.75% Floor)   11/25/2026     8,124,520       8,025,805       8,043,274  

Purchasing Power, LLC(1)

  Financials   Term Loan   7.75% (L + 6.75%; 1.00% Floor)   02/06/2024     2,143,137       2,124,747       2,137,779  

TA/WEG Holdings, LLC(4)

  Financials   Delayed Draw Term Loan   6.75% (L + 5.75%; 1.00% Floor)   10/04/2027     3,369,460       3,349,421       3,369,460  

TA/WEG Holdings, LLC(4)

  Financials   Revolver   6.75% (L + 5.75%; 1.00% Floor)   10/04/2027     146,272       144,546       146,272  

AAH Topco, LLC(4) (5)

  Healthcare & HCIT   Delayed Draw Term Loan   6.25% (L + 5.50%; 0.75% Floor)   12/22/2027     —         (80,707     (162,172

AAH Topco, LLC(4) (5)

  Healthcare & HCIT   Revolver   6.25% (L + 5.50%; 0.75% Floor)   12/22/2027     —         (15,672     (7,873

AAH Topco, LLC(1) (2) (3)

  Healthcare & HCIT   Term Loan   6.25% (L + 5.50%; 0.75% Floor)   12/22/2027     7,651,890       7,499,432       7,498,853  

American Physician Partners,
LLC(1) (2)

  Healthcare & HCIT   Delayed Draw Term Loan   9.25% (L + 6.75%; 1.50% PIK; 1.00% Floor)   02/22/2022     968,734       968,067       968,734  

American Physician Partners, LLC(4)

  Healthcare & HCIT   Revolver   9.25% (L + 6.75%; 1.50% PIK; 1.00% Floor)   02/22/2022     346,322       346,034       346,322  

 

See Notes to Unaudited Consolidated Financial Statements

 

20


Table of Contents

AB Private Credit Investors Corporation

Consolidated Schedule of Investments as of December 31, 2021 (continued)

 

Portfolio Company

 

Industry

 

Facility Type

 

Interest

 

Maturity

  Funded
Par Amount
    Cost     Fair Value  

American Physician Partners, LLC(2)

  Healthcare & HCIT   Term Loan   9.25% (L + 6.75%; 1.50% PIK; 1.00% Floor)   02/22/2022   $ 1,110,657     $ 1,110,051     $ 1,110,657  

American Physician Partners, LLC(1)

  Healthcare & HCIT   Term Loan   9.25% (L + 6.75%; 1.50% PIK; 1.00% Floor)   02/22/2022     5,135,852       5,132,311       5,135,852  

American Physician Partners, LLC(1) (2)

  Healthcare & HCIT   Term Loan   9.25% (L + 6.75%; 1.50% PIK; 1.00% Floor)   02/22/2022     2,061,589       2,046,516       2,061,589  

Analogic Corporation(4)

  Healthcare & HCIT   Revolver   6.25% (L + 5.25%; 1.00% Floor)   06/22/2023     122,222       121,007       115,271  

Analogic Corporation(1) (3)

  Healthcare & HCIT   Term Loan   6.25% (L + 5.25%; 1.00% Floor)   06/24/2024     2,096,111       2,077,718       2,027,987  

Caregiver 2, Inc.(4)

  Healthcare & HCIT   Delayed Draw Term Loan   6.25% (L + 5.25%; 1.00% Floor)   07/24/2025     1,302,812       1,273,771       1,275,272  

Caregiver 2, Inc.(3)

  Healthcare & HCIT   Term Loan   6.25% (L + 5.25%; 1.00% Floor)   07/24/2025     677,662       667,618       665,803  

Caregiver 2, Inc.(3)

  Healthcare & HCIT   Term Loan   6.25% (L + 5.25%; 1.00% Floor)   07/24/2025     4,721,319       4,651,344       4,638,696  

Caregiver 2, Inc.(2)

  Healthcare & HCIT   Term Loan   6.25% (L + 5.25%; 1.00% Floor)   07/24/2025     646,610       635,095       635,294  

Choice Health At Home,
LLC,(4) (5)

  Healthcare & HCIT   Delayed Draw Term Loan   7.00% (L + 6.00%; 1.00% Floor)   12/29/2026     —         (17,314     (34,628

Choice Health At Home,
LLC,(1) (2)

  Healthcare & HCIT   Term Loan   7.00% (L + 6.00%; 1.00% Floor)   12/29/2026     2,697,942       2,657,473       2,657,473  

Coding Solutions Acquisition, Inc.(4) (5)

  Healthcare & HCIT   Delayed Draw Term Loan   7.25% (L + 6.25%; 1.00% Floor)   12/31/2026     —         (20,474     (18,330

Coding Solutions Acquisition, Inc.(4)

  Healthcare & HCIT   Revolver   7.25% (L + 6.25%; 1.00% Floor)   12/31/2025     69,828       67,954       68,955  

Coding Solutions Acquisition, Inc.(2) (3)

  Healthcare & HCIT   Term Loan   7.25% (L + 6.25%; 1.00% Floor)   12/31/2026     7,834,654       7,701,591       7,775,894  

Community Based Care Acquisition, Inc.(4)

  Healthcare & HCIT   Delayed Draw Term Loan   6.50% (L + 5.50%; 1.00% Floor)   09/16/2027     305,358       284,793       305,358  

Community Based Care Acquisition, Inc.(4) (6)

  Healthcare & HCIT   Revolver   7.75% (P + 4.50%; 2.00% Floor)   09/16/2027     475,097       458,641       468,619  

Community Based Care Acquisition, Inc.(1) (2)

  Healthcare & HCIT   Term Loan   6.50% (L + 5.50%; 1.00% Floor)   09/16/2027     5,342,252       5,237,300       5,302,185  

Delaware Valley Management Holdings, Inc.(4) (5)

  Healthcare & HCIT   Delayed Draw Term Loan   7.25% (L + 6.25%; 1.00% Floor)   03/21/2024     —         (21,173     (121,182

Delaware Valley Management Holdings, Inc.

  Healthcare & HCIT   Revolver   7.25% (L + 6.25%; 1.00% Floor)   03/21/2024     537,691       532,717       475,856  

Delaware Valley Management Holdings, Inc.

  Healthcare & HCIT   Term Loan   7.25% (L + 6.25%; 1.00% Floor)   03/21/2024     3,492,300       3,458,909       3,090,686  

Ethos Veterinary Health, LLC(1)

  Healthcare & HCIT   Delayed Draw Term Loan   4.85% (L + 4.75%)   05/15/2026     1,067,934       1,060,499       1,067,934  

Ethos Veterinary Health, LLC(1)

  Healthcare & HCIT   Term Loan   4.85% (L + 4.75%)   05/15/2026     2,268,405       2,252,839       2,268,405  

FH MD Buyer, Inc.(1) (2)

  Healthcare & HCIT   Term Loan   5.75% (L + 5.00%; 0.75% Floor)   07/24/2028     5,520,754       5,466,660       5,479,349  

GHA Buyer, Inc.(2)

  Healthcare & HCIT   Delayed Draw Term Loan   8.50% (L + 6.50%; 2.00% Floor)   06/24/2025     811,193       798,999       811,193  

GHA Buyer, Inc.(4)

  Healthcare & HCIT   Revolver   8.50% (L + 6.50%; 2.00% Floor)   06/24/2025     317,026       306,311       317,026  

GHA Buyer, Inc.(1)

  Healthcare & HCIT   Term Loan   8.50% (L + 6.50%; 2.00% Floor)   06/24/2025     559,497       551,505       559,497  

GHA Buyer, Inc.(1) (3)

  Healthcare & HCIT   Term Loan   8.50% (L + 6.50%; 2.00% Floor)   06/24/2025     5,353,792       5,271,375       5,353,792  

GHA Buyer, Inc.(3)

  Healthcare & HCIT   Term Loan   8.50% (L + 6.50%; 2.00% Floor)   06/24/2025     4,635,391       4,561,173       4,635,391  

GHA Buyer, Inc.(1)

  Healthcare & HCIT   Term Loan   8.50% (L + 6.50%; 2.00% Floor)   06/24/2025     1,957,629       1,941,868       1,957,629  

Honor HN Buyer, Inc(4) (5)

  Healthcare & HCIT   Delayed Draw Term Loan   7.00% (L + 6.00%; 1.00% Floor)   10/15/2027     —         (16,022     (16,596

Honor HN Buyer, Inc(4) (5)

  Healthcare & HCIT   Revolver   7.00% (L + 6.00%; 1.00% Floor)   10/15/2027     —         (6,082     (6,082

Honor HN Buyer, Inc(1) (2)

  Healthcare & HCIT   Term Loan   7.00% (L + 6.00%; 1.00% Floor)   10/15/2027     2,643,294       2,592,248       2,590,429  

Kindeva Drug Delivery L.P.(4)

  Healthcare & HCIT   Revolver   7.00% (L + 6.00%; 1.00% Floor)   05/01/2025     687,973       663,697       641,000  

Kindeva Drug Delivery
L.P.(1) (2) (3)

  Healthcare & HCIT   Term Loan   7.00% (L + 6.00%; 1.00% Floor)   05/01/2026     15,660,091       15,362,567       15,151,138  

Medbridge Holdings, LLC(4)

  Healthcare & HCIT   Revolver   8.00% (L + 7.00%; 1.00% Floor)   12/23/2026     458,742       435,821       458,742  

Medbridge Holdings, LLC(1) (2)

  Healthcare & HCIT   Term Loan   8.00% (L + 7.00%; 1.00% Floor)   12/23/2026     15,367,872       15,108,285       15,367,872  

Medical Management Resource Group, LLC(4) (5)

  Healthcare & HCIT   Delayed Draw Term Loan   6.50% (L + 5.75%; 0.75% Floor)   09/30/2027     —         (15,821     (11,866

Medical Management Resource Group, LLC(4) (5)

  Healthcare & HCIT   Revolver   6.50% (L + 5.75%; 0.75% Floor)   09/30/2026     —         (6,015     (5,537

Medical Management Resource Group, LLC(2)

  Healthcare & HCIT   Term Loan   6.50% (L + 5.75%; 0.75% Floor)   09/30/2027     3,850,613       3,776,760       3,783,227  

MedMark Services, Inc.(4)

  Healthcare & HCIT   Delayed Draw Term Loan   6.00% (L + 5.00%; 1.00% Floor)   06/11/2027     2,175,411       2,106,921       2,105,126  

MedMark Services, Inc.(1) (2)

  Healthcare & HCIT   Term Loan   6.00% (L + 5.00%; 1.00% Floor)   06/11/2027     4,436,254       4,395,637       4,391,892  

Millin Purchaser LLC(4) (5)

  Healthcare & HCIT   Delayed Draw Term Loan   5.75% (L + 4.75%; 1.00% Floor)   10/22/2026     —         (11,782     (12,247

Millin Purchaser LLC(4) (5)

  Healthcare & HCIT   Delayed Draw Term Loan   5.75% (L + 4.75%; 1.00% Floor)   10/22/2026     —         (51,545     (53,582

Millin Purchaser LLC(4) (5)

  Healthcare & HCIT   Revolver   5.75% (L + 4.75%; 1.00% Floor)   10/22/2026     —         (9,819     (10,206

Millin Purchaser LLC(1) (2)

  Healthcare & HCIT   Term Loan   5.75% (L + 4.75%; 1.00% Floor)   10/22/2026     4,830,842       4,761,124       4,758,379  

OMH-HealthEdge Holdings, LLC(4) (5)

  Healthcare & HCIT   Revolver   6.50% (L + 5.50%; 1.00% Floor)   10/24/2024     —         (5,861     (2,294

OMH-HealthEdge Holdings, LLC(2)

  Healthcare & HCIT   Term Loan   6.50% (L + 5.50%; 1.00% Floor)   10/24/2025     2,143,505       2,103,337       2,132,787  

OMH-HealthEdge Holdings, LLC(1)

  Healthcare & HCIT   Term Loan   6.50% (L + 5.50%; 1.00% Floor)   10/24/2025     3,699,295       3,642,231       3,680,799  

Pace Health Companies,
LLC(4) (5)

  Healthcare & HCIT   Revolver   5.50% (L + 4.50%; 1.00% Floor)   08/02/2024     —         (3,316     —    

Pace Health Companies,
LLC(1)

  Healthcare & HCIT   Term Loan   5.50% (L + 4.50%; 1.00% Floor)   08/02/2024     5,304,701       5,274,593       5,304,701  

PAW Midco, Inc

  Healthcare & HCIT   Term Loan   11.50% (11.50% PIK)   12/22/2031     5,328,115       5,168,684       5,168,271  

Pinnacle Dermatology Management, LLC(4) (5)

  Healthcare & HCIT   Delayed Draw Term Loan   6.50% (L + 5.75%; 0.75% Floor)   12/08/2028     —         (19,022     (38,407

Pinnacle Dermatology Management, LLC(4) (5)

  Healthcare & HCIT   Revolver   6.50% (L + 5.75%; 0.75% Floor)   12/08/2026     —         (13,264     (6,721

Pinnacle Dermatology Management, LLC(1) (2) (3)

  Healthcare & HCIT   Term Loan   6.50% (L + 5.75%; 0.75% Floor)   12/08/2028     5,376,956       5,243,342       5,242,532  

Pinnacle Treatment Centers,
Inc.(2)

  Healthcare & HCIT   Delayed Draw Term Loan   6.75% (L + 5.75%; 1.00% Floor)   12/31/2022     347,151       345,134       347,151  

Pinnacle Treatment Centers,
Inc.(4) (5)

  Healthcare & HCIT   Delayed Draw Term Loan   6.75% (L + 5.75%; 1.00% Floor)   12/31/2022     —         (1,225     —    

Pinnacle Treatment Centers,
Inc.(4) (5)

  Healthcare & HCIT   Revolver   6.75% (L + 5.75%; 1.00% Floor)   12/31/2022     —         (1,808     —    

Pinnacle Treatment Centers,
Inc.(2) (3)

  Healthcare & HCIT   Term Loan   6.75% (L + 5.75%; 1.00% Floor)   12/31/2022     4,128,092       4,113,924       4,128,092  

 

See Notes to Unaudited Consolidated Financial Statements

 

21


Table of Contents

AB Private Credit Investors Corporation

Consolidated Schedule of Investments as of December 31, 2021 (continued)

 

Portfolio Company

 

Industry

 

Facility Type

 

Interest

 

Maturity

  Funded
Par Amount
    Cost     Fair Value  

Platinum Dermatology Partners, LLC(7)

  Healthcare & HCIT   Delayed Draw Term Loan   8.25% (L + 6.25%; 1.00% PIK; 1.00% Floor)   01/03/2023   $ 1,554,536     $ 1,535,303     $ 1,511,786  

Platinum Dermatology Partners, LLC(1)

  Healthcare & HCIT   Delayed Draw Term Loan   9.50% (P + 5.25%; 1.00% PIK; 2.00% Floor)   01/03/2023     2,138,823       2,115,584       2,080,006  

Platinum Dermatology Partners, LLC(8)

  Healthcare & HCIT   Revolver   9.50% (P + 5.25%; 1.00% PIK; 2.00% Floor)   01/03/2023     547,119       539,255       532,073  

Platinum Dermatology Partners, LLC(1)

  Healthcare & HCIT   Term Loan   8.25% (L + 6.25%; 1.00% PIK; 1.00% Floor)   01/03/2023     3,416,629       3,371,987       3,322,672  

RCP Encore Acquisition, Inc.(1)

  Healthcare & HCIT   Term Loan   6.00% (L + 5.00%; 1.00% Floor)   06/09/2025     3,468,095       3,446,550       1,387,238  

Redwood Family Care Network, Inc.(1) (4)

  Healthcare & HCIT   Delayed Draw Term Loan   6.50% (L + 5.50%; 1.00% Floor)   06/18/2026     3,385,701       3,302,759       3,371,026  

Redwood Family Care Network, Inc.(4) (5)

  Healthcare & HCIT   Revolver   6.50% (L + 5.50%; 1.00% Floor)   06/18/2026     —         (10,545     (1,472

Redwood Family Care Network, Inc.(3)

  Healthcare & HCIT   Term Loan   6.50% (L + 5.50%; 1.00% Floor)   06/18/2026     6,736,256       6,615,591       6,719,416  

Salisbury House, LLC(4) (5)

  Healthcare & HCIT   Revolver   6.50% (L + 5.50%; 1.00% Floor)   08/30/2025     —         (8,365     (6,725

Salisbury House, LLC(1)

  Healthcare & HCIT   Term Loan   6.50% (L + 5.50%; 1.00% Floor)   08/30/2025     1,148,658       1,132,381       1,131,428  

Salisbury House, LLC(1) (2)

  Healthcare & HCIT   Term Loan   6.50% (L + 5.50%; 1.00% Floor)   08/30/2025     3,934,410       3,853,666       3,875,393  

SCA Buyer, LLC(4)

  Healthcare & HCIT   Revolver   7.50% (L + 6.50%; 1.00% Floor)   01/20/2026     257,540       249,657       255,930  

SCA Buyer, LLC(2)

  Healthcare & HCIT   Term Loan   7.50% (L + 6.50%; 1.00% Floor)   01/20/2026     3,834,121       3,785,598       3,834,121  

SIS Purchaser, Inc.(4) (5)

  Healthcare & HCIT   Revolver   7.00% (L + 6.00%; 1.00% Floor)   10/15/2026     —         (16,352     —    

SIS Purchaser, Inc.(2)

  Healthcare & HCIT   Term Loan   7.00% (L + 6.00%; 1.00% Floor)   10/15/2026     2,430,305       2,391,057       2,430,305  

SIS Purchaser, Inc.(1) (2) (3)

  Healthcare & HCIT   Term Loan   7.00% (L + 6.00%; 1.00% Floor)   10/15/2026     12,697,202       12,514,261       12,697,202  

Smile Brands, Inc.(3)

  Healthcare & HCIT   Delayed Draw Term Loan   5.25% (L + 4.50%; 0.75% Floor)   10/12/2025     487,856       485,531       482,977  

Smile Brands, Inc.(4)

  Healthcare & HCIT   Revolver   6.75% (P + 3.50%; 1.75% Floor)   10/12/2025     13,899       12,969       11,351  

Smile Brands, Inc.(1)

  Healthcare & HCIT   Term Loan   5.25% (L + 4.50%; 0.75% Floor)   10/12/2025     1,606,770       1,598,701       1,590,702  

Taconic Biosciences, Inc.(2)

  Healthcare & HCIT   Term Loan   6.50% (L + 5.50%; 1.00% Floor)   02/01/2026     4,733,001       4,649,471       4,685,671  

The Center for Orthopedic and Research Excellence, Inc.(4)

  Healthcare & HCIT   Delayed Draw Term Loan   6.75% (L + 5.75%; 1.00% Floor)   08/15/2025     299,344       285,084       294,993  

The Center for Orthopedic and Research Excellence, Inc.(1) (2)

  Healthcare & HCIT   Delayed Draw Term Loan   6.75% (L + 5.75%; 1.00% Floor)   08/15/2025     1,153,201       1,147,274       1,147,435  

The Center for Orthopedic and Research Excellence, Inc.(4) (9)

  Healthcare & HCIT   Revolver   6.75% (L + 5.75%; 1.00% Floor)   08/15/2025     310,739       303,248       307,287  

The Center for Orthopedic and Research Excellence, Inc.(1) (3)

  Healthcare & HCIT   Term Loan   6.75% (L + 5.75%; 1.00% Floor)   08/15/2025     4,893,714       4,837,943       4,869,245  

Activ Software Holdings,
LLC(4) (5)

  Software & Tech Services   Revolver   7.25% (L + 6.25%; 1.00% Floor)   05/04/2027     —         (11,606     (3,244

Activ Software Holdings,
LLC(1) (2) (3)

  Software & Tech Services   Term Loan   7.25% (L + 6.25%; 1.00% Floor)   05/04/2027     8,070,237       7,925,881       8,029,885  

Alphasense, Inc.(2) (10)

  Software & Tech Services   Delayed Draw Term Loan   8.50% (L + 7.50%; 1.00% Floor)   05/29/2024     645,972       640,161       642,742  

Alphasense, Inc.(4) (5) (10)

  Software & Tech Services   Revolver   8.50% (L + 7.50%; 1.00% Floor)   05/29/2024     —         (7,625     (4,362

Alphasense, Inc.(3) (10)

  Software & Tech Services   Term Loan   8.50% (L + 7.50%; 1.00% Floor)   05/29/2024     7,269,628       7,206,103       7,233,279  

AMI US Holdings, Inc.(4)

  Software & Tech Services   Revolver   5.35% (L + 5.25%)   04/01/2024     437,842       427,443       437,842  

AMI US Holdings, Inc.(1)

  Software & Tech Services   Term Loan   6.25% (L + 5.25%; 1.00% Floor)   04/01/2025     8,090,225       7,993,780       8,090,225  

Arrowstream Acquisition Co., Inc.(4) (5)

  Software & Tech Services   Revolver   7.50% (L + 6.50%; 1.00% Floor)   12/15/2025     —         (6,138     (2,897

Arrowstream Acquisition Co., Inc.(3)

  Software & Tech Services   Term Loan   7.50% (L + 6.50%; 1.00% Floor)   12/15/2025     3,863,094       3,801,878       3,834,121  

Avetta, LLC(4) (5)

  Software & Tech Services   Revolver   7.25% (L + 6.25%; 1.00% Floor)   04/10/2024     —         (3,802     (1,236

Avetta, LLC(1) (3)

  Software & Tech Services   Term Loan   7.25% (L + 6.25%; 1.00% Floor)   04/10/2024     3,220,374       3,175,362       3,212,323  

Avetta, LLC(2)

  Software & Tech Services   Term Loan   7.25% (L + 6.25%; 1.00% Floor)   04/10/2024     6,836,841       6,722,844       6,819,748  

Avetta, LLC(1)

  Software & Tech Services   Term Loan   7.25% (L + 6.25%; 1.00% Floor)   04/10/2024     4,239,624       4,196,267       4,229,025  

Brightspot Buyer, Inc(4) (5)

  Software & Tech Services   Revolver   6.50% (L + 5.75%; 0.75% Floor)   11/16/2027     —         (13,328     (13,606

Brightspot Buyer, Inc(2)

  Software & Tech Services   Term Loan   6.50% (L + 5.75%; 0.75% Floor)   11/16/2027     5,215,571       5,113,388       5,111,260  

BusinesSolver.com, Inc.(4) (5)

  Software & Tech Services   Delayed Draw Term Loan   6.50% (L + 5.75%; 0.75% Floor)   12/01/2027     —         (9,824     (19,869

BusinesSolver.com, Inc.(2) (3)

  Software & Tech Services   Term Loan   6.50% (L + 5.75%; 0.75% Floor)   12/01/2027     7,379,963       7,306,983       7,306,163  

Cybergrants Holdings, LLC(4) (5)

  Software & Tech Services   Delayed Draw Term Loan   7.25% (L + 6.50%; 0.75% Floor)   09/08/2027     —         (8,195     (11,518

Cybergrants Holdings, LLC(4) (5)

  Software & Tech Services   Revolver   7.25% (L + 6.50%; 0.75% Floor)   09/08/2027     —         (16,393     (11,518

Cybergrants Holdings, LLC(1) (2)

  Software & Tech Services   Term Loan   7.25% (L + 6.50%; 0.75% Floor)   09/08/2027     11,747,857       11,580,502       11,630,378  

Datacor, Inc.(4) (5)

  Software & Tech Services   Delayed Draw Term Loan   6.25% (L + 5.25%; 1.00% Floor)   12/29/2025     —         (28,023     —    

Datacor, Inc.(4) (5)

  Software & Tech Services   Revolver   6.25% (L + 5.25%; 1.00% Floor)   12/29/2025     —         (10,280     (3,219

Datacor, Inc.(1) (3)

  Software & Tech Services   Term Loan   6.25% (L + 5.25%; 1.00% Floor)   12/29/2025     7,983,728       7,834,533       7,943,809  

Degreed, Inc.(4) (5)

  Software & Tech Services   Delayed Draw Term Loan   6.50% (L + 5.50%; 1.00% Floor)   05/31/2025     —         (5,693     (3,478

Degreed, Inc.(4) (5)

  Software & Tech Services   Revolver   6.50% (L + 5.50%; 1.00% Floor)   05/31/2025     —         (2,169     (3,134

Degreed, Inc.(2)

  Software & Tech Services   Term Loan   6.50% (L + 5.50%; 1.00% Floor)   05/31/2025     2,782,788       2,759,481       2,761,917  

Degreed, Inc.(1) (3)

  Software & Tech Services   Term Loan   6.50% (L + 5.50%; 1.00% Floor)   05/31/2025     5,153,024       5,097,775       5,114,376  

Dispatch Track, LLC(4) (5)

  Software & Tech Services   Revolver   5.50% (L + 4.50%; 1.00% Floor)   12/17/2026     —         (2,716     (755

Dispatch Track, LLC(1) (2)

  Software & Tech Services   Term Loan   5.50% (L + 4.50%; 1.00% Floor)   12/17/2026     9,849,936       9,741,587       9,825,312  

Drilling Info Holdings, Inc.(1)

  Software & Tech Services   Term Loan   4.35% (L + 4.25%)   07/30/2025     3,326,513       3,317,966       3,318,197  

Dude Solutions Holdings, Inc.(3)

  Software & Tech Services   Term Loan   7.25% (L + 6.25%; 1.00% Floor)   06/13/2025     3,853,725       3,779,486       3,815,188  

Dude Solutions Holdings, Inc.(3)

  Software & Tech Services   Term Loan   7.25% (L + 6.25%; 1.00% Floor)   06/13/2025     530,072       519,517       524,771  

EET Buyer, Inc.(4) (5)

  Software & Tech Services   Revolver   6.50% (L + 5.75%; 0.75% Floor)   11/08/2027     —         (13,485     (13,816

EET Buyer, Inc.(2) (3)

  Software & Tech Services   Term Loan   6.50% (L + 5.75%; 0.75% Floor)   11/08/2027     6,907,937       6,773,088       6,769,778  

EnterpriseDB Corporation(4) (5)

  Software & Tech Services   Revolver   6.75% (L + 3.00%; 2.75% PIK; 1.00% Floor)   06/22/2026     —         (12,616     (2,532

EnterpriseDB Corporation(1) (2)

  Software & Tech Services   Term Loan   6.75% (L + 3.00%; 2.75% PIK; 1.00% Floor)   06/22/2026     6,277,267       6,157,445       6,261,574  

EnterpriseDB
Corporation(1) (2) (3)

  Software & Tech Services   Term Loan   6.75% (L + 3.00%; 2.75% PIK; 1.00% Floor)   06/22/2026     7,964,621       7,874,000       7,944,709  

EnterpriseDB Corporation(1) (3)

  Software & Tech Services   Term Loan   6.75% (L + 3.00%; 2.75% PIK; 1.00% Floor)   06/22/2026     4,563,807       4,488,855       4,552,398  

Exterro, Inc.(4) (5)

  Software & Tech Services   Revolver   6.50% (L + 5.50%; 1.00% Floor)   05/31/2024     —         (2,032     —    

Exterro, Inc.(1) (2)

  Software & Tech Services   Term Loan   6.50% (L + 5.50%; 1.00% Floor)   05/31/2024     5,809,123       5,732,506       5,809,123  

 

See Notes to Unaudited Consolidated Financial Statements

 

22


Table of Contents

AB Private Credit Investors Corporation

Consolidated Schedule of Investments as of December 31, 2021 (continued)

 

Portfolio Company

   Industry    Facility Type   

Interest

   Maturity      Funded
Par Amount
     Cost     Fair Value  

Exterro, Inc.(2) (3)

   Software & Tech
Services
   Term Loan    6.50% (L + 5.50%; 1.00% Floor)      05/31/2024      $ 6,237,900      $ 6,148,977     $ 6,237,900  

Exterro, Inc.(1)

   Software & Tech
Services
   Term Loan    6.50% (L + 5.50%; 1.00% Floor)      05/31/2024        2,793,450        2,769,803       2,793,450  

Faithlife, LLC(1) (2) (4)

   Software & Tech
Services
   Delayed Draw Term
Loan
   6.50% (L + 5.50%; 1.00% Floor)      09/18/2025        1,697,185        1,651,986       1,697,185  

Faithlife, LLC(4) (5)

   Software & Tech
Services
   Revolver    6.50% (L + 5.50%; 1.00% Floor)      09/18/2025        —          (4,165     —    

Faithlife, LLC(1) (2)

   Software & Tech
Services
   Term Loan    6.50% (L + 5.50%; 1.00% Floor)      09/18/2025        728,853        717,940       728,853  

Genesis Acquisition Co.(3)

   Software & Tech
Services
   Revolver    4.13% (L + 4.00%)      07/31/2024        202,400        195,642       196,834  

Genesis Acquisition Co.(1) (2)

   Software & Tech
Services
   Term Loan    4.13% (L + 4.00%)      07/31/2024        1,374,959        1,362,298       1,337,148  

Greenhouse Software, Inc.(4) (5)

   Software & Tech
Services
   Revolver    7.50% (L + 6.50%; 1.00% Floor)      03/01/2027        —          (23,993     (6,161

Greenhouse Software, Inc.(2) (3)

   Software & Tech
Services
   Term Loan    7.50% (L + 6.50%; 1.00% Floor)      03/01/2027        12,376,845        12,133,927       12,314,961  

GS AcquisitionCo, Inc.(4) (5)

   Software & Tech
Services
   Delayed Draw Term
Loan
   6.75% (L + 5.75%; 1.00% Floor)      05/22/2026        —          (3,243     —    

GS AcquisitionCo, Inc.(4)

   Software & Tech
Services
   Revolver    6.75% (L + 5.75%; 1.00% Floor)      05/22/2026        216,932        213,702       214,648  

GS AcquisitionCo, Inc.(1) (2) (3)

   Software & Tech
Services
   Term Loan    6.75% (L + 5.75%; 1.00% Floor)      05/22/2026        8,708,367        8,658,965       8,664,825  

Iodine Software, LLC(2) (3)

   Software & Tech
Services
   Delayed Draw Term
Loan
   7.50% (L + 6.50%; 1.00% Floor)      05/19/2027        9,058,308        8,894,669       9,058,308  

Iodine Software, LLC(4) (5)

   Software & Tech
Services
   Revolver    7.50% (L + 6.50%; 1.00% Floor)      05/19/2027        —          (22,107     —    

Iodine Software, LLC(1) (2)

   Software & Tech
Services
   Term Loan    7.50% (L + 6.50%; 1.00% Floor)      05/19/2027        6,013,669        5,905,362       6,013,669  

Kaseya, Inc.(4)

   Software & Tech
Services
   Delayed Draw Term
Loan
   7.50% (L + 5.50%; 1.00% PIK; 1.00% Floor)      05/02/2025        250,488        240,932       250,488  

Kaseya, Inc.(2)

   Software & Tech
Services
   Delayed Draw Term
Loan
   7.50% (L + 5.50%; 1.00% PIK; 1.00% Floor)      05/02/2025        553,854        550,163       553,854  

Kaseya, Inc.(2)

   Software & Tech
Services
   Delayed Draw Term
Loan
   7.50% (L + 5.50%; 1.00% PIK; 1.00% Floor)      05/02/2025        485,401        485,401       485,401  

Kaseya, Inc.(4) (5)

   Software & Tech
Services
   Revolver    7.50% (L + 5.50%; 1.00% Floor)      05/02/2025        —          (2,163     —    

Kaseya, Inc.(1) (2)

   Software & Tech
Services
   Term Loan    7.50% (L + 5.50%; 1.00% PIK; 1.00% Floor)      05/02/2025        1,266,793        1,246,533       1,266,793  

Kaseya, Inc.(1) (2) (3)

   Software & Tech
Services
   Term Loan    7.50% (L + 5.50%; 1.00% PIK; 1.00% Floor)      05/02/2025        5,243,629        5,210,799       5,243,629  

Mavenlink, Inc(4) (5)

   Software & Tech
Services
   Revolver    6.75% (L + 6.00%; 0.75% Floor)      06/03/2027        —          (35,347     (35,796

Mavenlink, Inc(1) (2) (3)

   Software & Tech
Services
   Term Loan    6.75% (L + 6.00%; 0.75% Floor)      06/03/2027        15,034,451        14,737,540       14,733,762  

Ministry Brands, LLC(2)

   Software & Tech
Services
   Delayed Draw Term
Loan
   5.00% (L + 4.00%; 1.00% Floor)      12/02/2022        644,345        643,659       644,345  

Ministry Brands, LLC(2)

   Software & Tech
Services
   Term Loan    5.00% (L + 4.00%; 1.00% Floor)      12/02/2022        3,080,740        3,077,478       3,080,740  

Moon Buyer, Inc.(4) (5)

   Software & Tech
Services
   Delayed Draw Term
Loan
   5.75% (L + 4.75%; 1.00% Floor)      04/21/2027        —          (30,197     —    

Moon Buyer, Inc.(4) (5)

   Software & Tech
Services
   Revolver    5.75% (L + 4.75%; 1.00% Floor)      04/21/2027        —          (15,493     —    

Moon Buyer, Inc.(1) (2) (3)

   Software & Tech
Services
   Term Loan    5.75% (L + 4.75%; 1.00% Floor)      04/21/2027        6,368,857        6,284,074       6,368,857  

Netwrix Corporation And Concept Searching
Inc.(2)

   Software & Tech
Services
   Delayed Draw Term
Loan
   7.00% (L + 6.00%; 1.00% Floor)      09/30/2026        497,148        489,221       497,148  

Netwrix Corporation And Concept Searching
Inc.(1)

   Software & Tech
Services
   Delayed Draw Term
Loan
   7.00% (L + 6.00%; 1.00% Floor)      09/30/2026        994,297        976,754       994,297  

Netwrix Corporation And Concept Searching
Inc.(4)

   Software & Tech
Services
   Delayed Draw Term
Loan
   7.00% (L + 6.00%; 1.00% Floor)      09/30/2026        1,380,166        1,350,432       1,380,166  

Netwrix Corporation And Concept Searching
Inc.(4) (5)

   Software & Tech
Services
   Revolver    7.00% (L + 6.00%; 1.00% Floor)      09/30/2026        —          (3,553     —    

Netwrix Corporation And Concept Searching
Inc.(1)

   Software & Tech
Services
   Term Loan    7.00% (L + 6.00%; 1.00% Floor)      09/30/2026        1,648,855        1,613,573       1,648,855  

Netwrix Corporation And Concept Searching
Inc.(2)

   Software & Tech
Services
   Term Loan    7.00% (L + 6.00%; 1.00% Floor)      09/30/2026        6,652,404        6,523,360       6,652,404  

PerimeterX, Inc.(4) (5)

   Software & Tech
Services
   Delayed Draw Term
Loan
   6.50% (L + 4.00%; 1.50% PIK; 1.00% Floor)      11/22/2024        —          (18,332     (10,754

PerimeterX, Inc.(4) (5)

   Software & Tech
Services
   Delayed Draw Term
Loan
   6.50% (L + 4.00%; 1.50% PIK; 1.00% Floor)      11/22/2024        —          (5,880     (6,988

PerimeterX, Inc.(4) (5)

   Software & Tech
Services
   Revolver    6.50% (L + 4.00%; 1.50% PIK; 1.00% Floor)      11/22/2024        —          (2,178     (2,795

PerimeterX, Inc.(3)

   Software & Tech
Services
   Term Loan    6.50% (L + 4.00%; 1.50% PIK; 1.00% Floor)      11/22/2024        2,842,516        2,818,385       2,814,091  

Ranger Buyer Inc(4)

   Software & Tech
Services
   Revolver    7.00% (L + 6.25%; 0.75% Floor)      11/18/2027        239,847        215,862       215,862  

Ranger Buyer Inc(1) (2) (3)

   Software & Tech
Services
   Term Loan    7.00% (L + 6.25%; 0.75% Floor)      11/18/2028        14,390,790        14,102,974       14,102,974  

Sauce Labs, Inc.(4) (5)

   Software & Tech
Services
   Delayed Draw Term
Loan
   6.50% (L + 5.50%; 1.00% Floor)      08/16/2027        —          (18,064     (24,034

Sauce Labs, Inc.(4) (5)

   Software & Tech
Services
   Revolver    6.50% (L + 5.50%; 1.00% Floor)      08/16/2027        —          (24,093     (19,227

Sauce Labs, Inc.(2)

   Software & Tech
Services
   Term Loan    6.50% (L + 5.50%; 1.00% Floor)      08/16/2027        5,127,286        5,024,740       5,050,376  

SecureLink, Inc.(4) (5)

   Software & Tech
Services
   Revolver    7.25% (L + 6.25%; 1.00% Floor)      10/01/2025        —          (4,950     —    

SecureLink, Inc.(1) (2)

   Software & Tech
Services
   Term Loan    7.25% (L + 6.25%; 1.00% Floor)      10/01/2025        2,938,404        2,900,881       2,938,404  

SecureLink, Inc.(1)

   Software & Tech
Services
   Term Loan    7.25% (L + 6.25%; 1.00% Floor)      10/01/2025        4,873,428        4,816,425       4,873,428  

Sirsi Corporation(4) (5)

   Software & Tech
Services
   Revolver    5.50% (L + 4.50%; 1.00% Floor)      03/15/2024        —          (3,852     (1,384

Sirsi Corporation(1) (2)

   Software & Tech
Services
   Term Loan    5.50% (L + 4.50%; 1.00% Floor)      03/15/2024        7,326,840        7,272,820       7,308,523  

Smartlinx Solutions, LLC(4) (5)

   Software & Tech
Services
   Revolver    7.00% (L + 6.00%; 1.00% Floor)      03/04/2026        —          (3,648     (2,597

Smartlinx Solutions, LLC(1) (2) (3)

   Software & Tech
Services
   Term Loan    7.00% (L + 6.00%; 1.00% Floor)      03/04/2026        5,678,119        5,597,713       5,649,729  

Streamsets, Inc.(4) (5)

   Software & Tech
Services
   Revolver    6.75% (L + 5.00%; 0.75% PIK; 1.00% Floor)      11/25/2024        —          (6,816     (12,268

Streamsets, Inc.(3)

   Software & Tech
Services
   Term Loan    6.75% (L + 5.00%; 0.75% PIK; 1.00% Floor)      11/25/2024        2,120,781        2,078,548       2,046,554  

SugarCRM, Inc.(4) (5)

   Software & Tech
Services
   Revolver    7.50% (L + 6.50%; 1.00% Floor)      07/31/2024        —          (2,407     —    

SugarCRM, Inc.(1) (3)

   Software & Tech
Services
   Term Loan    7.50% (L + 6.50%; 1.00% Floor)      07/31/2024        4,268,824        4,228,733       4,268,824  

Sundance Group Holdings, Inc(4) (5)

   Software & Tech
Services
   Delayed Draw Term
Loan
   7.75% (L + 6.75%; 1.00% Floor)      07/02/2027        —          (32,626     (26,604

Sundance Group Holdings, Inc(4)

   Software & Tech
Services
   Revolver    7.75% (L + 6.75%; 1.00% Floor)      07/02/2027        425,670        399,558       404,387  

Sundance Group Holdings, Inc(2) (3)

   Software & Tech
Services
   Term Loan    7.75% (L + 6.75%; 1.00% Floor)      07/02/2027        11,824,177        11,606,577       11,646,815  

Swiftpage, Inc.(4) (5)

   Software & Tech
Services
   Revolver    6.50% (L + 5.50%; 1.00% Floor)      06/13/2023        —          (1,326     (1,690

Swiftpage, Inc.(2)

   Software & Tech
Services
   Term Loan    6.50% (L + 5.50%; 1.00% Floor)      06/13/2023        2,446,093        2,432,907       2,427,747  

Swiftpage, Inc.(2)

   Software & Tech
Services
   Term Loan    6.50% (L + 5.50%; 1.00% Floor)      06/13/2023        225,154        223,434       223,465  

Sysnet North America, Inc.

   Software & Tech
Services
   Delayed Draw Term
Loan
   6.50% (L + 5.50%; 1.00% Floor)      12/01/2026        1,287,698        1,274,256       1,268,383  

Sysnet North America, Inc.(1) (2) (3)

   Software & Tech
Services
   Term Loan    6.50% (L + 5.50%; 1.00% Floor)      12/01/2026        7,668,193        7,576,635       7,514,830  

Telcor Buyer, Inc.(4) (5)

   Software & Tech
Services
   Revolver    5.75% (L + 4.75%; 1.00% Floor)      08/20/2027        —          (4,106     (2,181

Telcor Buyer, Inc.(1) (2)

   Software & Tech
Services
   Term Loan    5.75% (L + 4.75%; 1.00% Floor)      08/20/2027        9,304,625        9,173,236       9,234,840  

Telesoft Holdings, LLC(4) (5)

   Software & Tech
Services
   Revolver    6.75% (L + 5.75%; 1.00% Floor)      12/16/2025        —          (8,939     (2,984

 

See Notes to Unaudited Consolidated Financial Statements

 

23


Table of Contents

AB Private Credit Investors Corporation

Consolidated Schedule of Investments as of December 31, 2021 (continued)

 

Portfolio Company

   Industry    Facility Type   

Interest

   Maturity      Funded
Par Amount
     Cost     Fair Value  

Telesoft Holdings, LLC(2) (3)

   Software &
Tech Services
   Term Loan    6.75% (L + 5.75%; 1.00% Floor)      12/16/2025      $ 5,864,213      $ 5,774,460     $ 5,834,892  

TRGRP, Inc.(4) (5)

   Software &
Tech Services
   Revolver    8.00% (L + 4.50%; 2.50% PIK; 1.00% Floor)      11/01/2023        —          (2,462     —    

TRGRP, Inc.(2)

   Software &
Tech Services
   Term Loan    8.00% (L + 4.50%; 2.50% PIK; 1.00% Floor)      11/01/2023        2,333,710        2,292,698       2,333,710  

TRGRP, Inc.(1)

   Software &
Tech Services
   Term Loan    8.00% (L + 4.50%; 2.50% PIK; 1.00% Floor)      11/01/2023        1,110,872        1,101,354       1,110,872  

TRGRP, Inc.(2) (3)

   Software &
Tech Services
   Term Loan    8.00% (L + 4.50%; 2.50% PIK; 1.00% Floor)      11/01/2023        4,972,446        4,933,912       4,972,446  

Ungerboeck Systems International, LLC

   Software &
Tech Services
   Delayed Draw
Term Loan
   7.00% (L + 6.00%; 1.00% Floor)      04/30/2027        690,794        690,794       690,794  

Ungerboeck Systems International, LLC(1)

   Software &
Tech Services
   Delayed Draw
Term Loan
   6.75% (L + 5.75%; 1.00% Floor)      04/30/2027        322,391        318,018       322,391  

Ungerboeck Systems International, LLC(4) (5)

   Software &
Tech Services
   Revolver    6.75% (L + 5.75%; 1.00% Floor)      04/30/2027        —          (2,156     —    

Ungerboeck Systems International, LLC(2) (3)

   Software &
Tech Services
   Term Loan    6.75% (L + 5.75%; 1.00% Floor)      04/30/2027        2,717,277        2,680,448       2,717,277  

Vectra AI, Inc.(4) (5)

   Software &
Tech Services
   Delayed Draw
Term Loan
   6.75% (L + 5.75%; 1.00% Floor)      03/18/2026        —          (49,091     (58,190

Vectra AI, Inc.(4) (5)

   Software &
Tech Services
   Revolver    6.75% (L + 5.75%; 1.00% Floor)      03/18/2026        —          (4,909     (5,819

Vectra AI, Inc.(2) (3)

   Software &
Tech Services
   Term Loan    6.75% (L + 5.75%; 1.00% Floor)      03/18/2026        3,258,620        3,188,883       3,177,155  

Velocity Purchaser Corporation(4) (5)

   Software &
Tech Services
   Revolver    7.00% (L + 6.00%; 1.00% Floor)      12/01/2022        —          (728     —    

Velocity Purchaser Corporation(1)

   Software &
Tech Services
   Term Loan    7.00% (L + 6.00%; 1.00% Floor)      12/01/2022        647,042        643,783       647,042  

Velocity Purchaser Corporation(1) (2)

   Software &
Tech Services
   Term Loan    7.00% (L + 6.00%; 1.00% Floor)      12/01/2022        5,116,095        5,066,567       5,116,095  

Velocity Purchaser Corporation(1)

   Software &
Tech Services
   Term Loan    7.00% (L + 6.00%; 1.00% Floor)      12/01/2022        2,601,503        2,590,901       2,601,503  

Veracross LLC(4) (5)

   Software &
Tech Services
   Delayed Draw
Term Loan
   8.50% (L + 2.00%; 5.50% PIK; 1.00% Floor)      12/28/2027        —          (16,659     (16,688

Veracross LLC(4) (5)

   Software &
Tech Services
   Revolver    8.50% (L + 2.00%; 5.50% PIK; 1.00% Floor)      12/28/2027        —          (22,212     (22,251

Veracross LLC(3)

   Software &
Tech Services
   Term Loan    8.50% (L + 2.00%; 5.50% PIK; 1.00% Floor)      12/28/2027        12,238,089        11,993,759       11,993,327  

Dillon Logistics, Inc.(4) (11)

   Transport &
Logistics
   Revolver    9.25% (P + 6.00%; 1.00% Floor)      12/11/2023        779,728        757,176       167,554  

Dillon Logistics, Inc.(11)

   Transport &
Logistics
   Term Loan    8.00% (L + 7.00%; 1.00% Floor)      12/11/2023        3,024,587        2,742,506       739,511  

Dillon Logistics, Inc.(11)

   Transport &
Logistics
   Term Loan    8.00% (L + 7.00%; 1.00% Floor)      12/11/2023        889,565        787,261       217,499  
                 

 

 

   

 

 

 

Total U.S. 1st Lien/Senior Secured Debt

           833,353,917       834,232,033  

2nd Lien/Junior Secured Debt—3.08%

 

Conterra Ultra Broadband Holdings, Inc.(1) (2)

   Digital
Infrastructure &
Services
   Term Loan    9.50% (L + 8.50%; 1.00% Floor)      04/30/2027        6,537,710        6,465,035       6,537,710  

Brave Parent Holdings, Inc.(1)

   Software &
Tech Services
   Term Loan    7.58% (L + 7.50%)      04/17/2026        1,230,107        1,212,535       1,230,107  

Symplr Software, Inc.(1)

   Software &
Tech Services
   Term Loan    8.625% (L + 7.875%; 0.75% Floor)      12/22/2028        2,909,482        2,857,031       2,909,482  
                 

 

 

   

 

 

 

Total U.S. 2nd Lien/Junior Secured Debt

           10,534,601       10,677,299  
                 

 

 

   

 

 

 

Total U.S. Corporate Debt

           843,888,518       844,909,332  

Canadian Corporate Debt—5.24%

 

1st Lien/Senior Secured Debt—5.24%

 

McNairn Holdings Ltd.(1) (10)

   Business
Services
   Term Loan    6.00% (L + 5.00%; 1.00% Floor)      11/25/2025        809,967        804,385       757,319  

Syntax Systems Ltd(1) (2) (10)

   Digital
Infrastructure &
Services
   Term Loan    6.25% (L + 5.50%; 0.75% Floor)      10/29/2028        8,862,389        8,774,869       8,773,765  

Syntax Systems Ltd(4) (10)

   Digital
Infrastructure &
Services
   Revolver    6.25% (L + 5.50%; 0.75% Floor)      10/29/2026        425,812        416,408       416,075  

Syntax Systems Ltd(4) (5) (10)

   Digital
Infrastructure &
Services
   Delayed Draw
Term Loan
   6.25% (L + 5.50%; 0.75% Floor)      10/29/2028        —          (23,752     (24,341

Banneker V Acquisition, Inc.(2) (3) (10)

   Software &
Tech Services
   Term Loan    8.00% (L + 7.00%; 1.00% Floor)      12/04/2025        7,177,672        7,054,712       7,177,672  

Banneker V Acquisition, Inc.(4) (5) (10)

   Software &
Tech Services
   Revolver    8.00% (L + 7.00%; 1.00% Floor)      12/04/2025        —          (4,095     —    

Banneker V Acquisition, Inc.(2) (10)

   Software &
Tech Services
   Delayed Draw
Term Loan
   8.00% (L + 7.00%; 1.00% Floor)      12/04/2025        1,034,605        1,018,253       1,034,605  
                 

 

 

   

 

 

 
Total Canadian 1st Lien/Senior Secured Debt                     18,040,780       18,135,095  
                 

 

 

   

 

 

 
Total Canadian Corporate Debt                     18,040,780       18,135,095  

United Kingdom Corporate Debt—2.03%

 

1st Lien/Senior Secured Debt—2.03%

 

GlobalWebIndex Inc.(3) (4)

   Software &
Tech Services
   Delayed Draw
Term Loan
   7.00% (L + 6.00%; 1.00% Floor)      12/30/2024        1,841,860        1,813,899       1,712,930  

GlobalWebIndex Inc.(2) (3)

   Software &
Tech Services
   Term Loan    7.00% (L + 6.00%; 1.00% Floor)      12/30/2024        5,525,580        5,361,193       5,332,185  
                 

 

 

   

 

 

 

Total United Kingdom 1st Lien/Senior Secured Debt

           7,175,092       7,045,115  
                 

 

 

   

 

 

 

Total United Kingdom Corporate Debt

           7,175,092       7,045,115  

Portfolio Company

   Class/Series    Industry                Shares      Cost     Fair Value  

U.S. Preferred Stock—3.87%

 

Global Radar Holdings, LLC(12)

   LLC Units    Business Services            125      $ 367,615     $ 549,041  

Bowline Topco LLC(13) (14)

   LLC Units    Energy            2,946,390        2,002,277       2,600,575  

SBS Ultimate Holdings, LP(14)

   Class A    Healthcare & HCIT            217,710        861,879       705,379  

Concerto Health AI Solutions, LLC (14) (15)

   Series B-1    Software & Tech
Services
           65,614        349,977       460,537  

Streamsets, Inc.(14)

   Series C-1    Software & Tech
Services
           109,518        295,512       301,406  

 

See Notes to Unaudited Consolidated Financial Statements

 

24


Table of Contents

AB Private Credit Investors Corporation

Consolidated Schedule of Investments as of December 31, 2021 (continued)

 

Portfolio Company

  

Class/Series

  

Industry

             Shares      Cost      Fair Value  

Alphasense, Inc.(10) (14)

   Series C    Software & Tech Services            23,961      $ 369,843      $ 371,362  

Datarobot, Inc.(14)

   Series F    Software & Tech Services            6,715        88,248        117,326  

Datarobot, Inc.(14)

   Series E    Software & Tech Services            38,190        289,278        570,282  

Degreed, Inc.(14)

   Series D    Software & Tech Services            16,943        278,308        278,308  

Degreed, Inc.(14)

   Series C-1    Software & Tech Services            43,819        278,541        718,478  

Heap, Inc.(14)

   Series D    Software & Tech Services            17,425        147,443        147,527  

Heap, Inc.(14)

   Series C    Software & Tech Services            189,617        696,351        1,444,013  

Mcafee(14) (16) (19)

   Class A    Software & Tech Services            821,396        821,396        835,432  

Netskope, Inc.(14)

   Series G    Software & Tech Services            36,144        302,536        400,047  

PerimeterX, Inc.(14)

   Series D    Software & Tech Services            282,034        838,601        870,048  

Phenom People, Inc.(14)

   Series C    Software & Tech Services            35,055        220,610        552,848  

Protoscale Rubrik, LLC (14)

   Class B    Software & Tech Services            25,397        598,212        635,044  

Symplr Software Intermediate Holdings, Inc.(14)

   Series A    Software & Tech Services            1,196        1,160,532        1,718,402  

Vectra AI, Inc(14)

   Series F    Software & Tech Services            17,064        131,095        123,291  
                 

 

 

    

 

 

 

Total U.S. Preferred Stock

                 10,098,254        13,399,346  

U.S. Common Stock—2.23%

 

Leeds FEG Investors, LLC(14)

   Class A    Consumer Discretionary            320      $ 321,309      $ 290,338  

Pacific Bells, LLC(14) (17)

   LP Interests    Consumer Non-Cyclical            802,902        802,902        802,902  

Freddy’s Frozen Custard, LLC(14) (31)

   LP Interests    Consumer Non-Cyclical            72,483        72,483        108,415  

Nestle Waters North America, Inc.(14) (18) (19)

   LP Interests    Consumer Non-Cyclical            341,592        98,394        98,394  

Avant Communications, LLC(14) (20)

   Class A    Digital Infrastructure & Services            220,542        220,542        220,542  

Avant Communications, LLC.(14) (20)

   Class A Capital    Digital Infrastructure & Services            220,542        —          —    

NEPCORE Parent Holdings, LLC(14)

   Class A    Digital Infrastructure & Services            82        81,530        81,530  

Neutral Connect, LLC(14) (21)

   LLC Units    Digital Infrastructure & Services            396,513        439,931        439,931  

Thrive Parent, LLC(14)

   Class L    Digital Infrastructure & Services            100,219        263,195        307,955  

Agape Care Group(14) (22)

   LP Interests    Healthcare & HCIT            590,203        590,203        590,203  

Health Platform Group, Inc.(14)

   Earn Out    Healthcare & HCIT            16,502        —          —    

Healthcare Services Acquisition(10) (14)

   Class B    Healthcare & HCIT            15,183        46        46  

Healthcare Services Acquisition(10) (14) (23)

   Class A    Healthcare & HCIT            28,158        281,580        279,891  

INH Group Holdings, Inc.(14)

   Class A    Healthcare & HCIT            484,552      $ 484,552      $ 315,872  

Medical Management Resource Group, LLC(14) (24)

   Class B    Healthcare & HCIT            34,492        34,492        34,321  

Millin Purchaser LLC(14) (32)

   Class A    Healthcare & HCIT            86,555        86,555        86,555  

Redwood Family Care Network, Inc.(14)

   Class A    Healthcare & HCIT            66        66,000        76,527  

EnterpriseDB Corporation(14) (19) (33)

   LLC Units    Software & Tech Services            417,813        417,813        1,282,685  

American Safety Holdings Corp.(14) (25)

   LP Interests    Software & Tech Services            167,509        190,658        270,241  

Brightspot Holdco, LLC (14)

   LLC Units    Software & Tech Services            433,207        433,207        433,207  

Moon Topco L.P.(14)

   Class A    Software & Tech Services            36        35,999        40,471  

Ranger Lexipol Holdings, LLC(14)

   Class A    Software & Tech Services            433        433,207        433,207  

Ranger Lexipol Holdings, LLC(14)

   Class B    Software & Tech Services            433        —          —    

Samsara Networks, Inc.(10) (14) (23)

   Class A    Software & Tech Services            33,451        369,998        940,308  

Stripe, Inc.(14)

   Class B    Software & Tech Services            4,158        166,854        163,472  

Omni Logistics, LLC(19) (26)

   LP Interests    Transport & Logistics            193,770        193,770        426,294  
                 

 

 

    

 

 

 

Total U.S. Common Stock

                 6,085,220        7,723,307  

Canadian Common Stock—0.07%

 

Auvik Topco Holdings, Inc.(10) (14) (19) (27)

   LP Interests    Software & Tech Services            244,920        244,920        244,920  
                 

 

 

    

 

 

 

Total Canadian Common Stock

                 244,920        244,920  

U.S. Warrants—0.26%

 

Fuze, Inc., expire 04/26/2031(14)

   Series A    Digital Infrastructure & Services            613,241        —          227,619  

 

See Notes to Unaudited Consolidated Financial Statements

 

25


Table of Contents

AB Private Credit Investors Corporation

Consolidated Schedule of Investments as of December 31, 2021 (continued)

 

Portfolio Company

  

Class/Series

  

Industry

             Shares      Cost      Fair Value  

Healthcare Services Acquisition, expire 12/31/2027(10) (14)

   Class B    Healthcare & HCIT            14,079      $ —        $ —    

Healthcare Services Acquisition, expire 12/31/2027(10) (14) (23)

   Class A    Healthcare & HCIT            23,721        23,721        12,335  

SBS Ultimate Holdings, LP, expire 09/18/2030(14)

   Class A    Healthcare & HCIT            17,419        —          —    

Alphasense, Inc., expire 05/29/2027(10) (14)

   Series B    Software & Tech Services            38,346        35,185        206,363  

Alphasense, Inc., expire 12/22/2027(10) (14)

   Series C    Software & Tech Services            2,049        —          12,235  

Degreed, Inc., expire 04/11/2028(14)

   Series D    Software & Tech Services            7,624        —          38,358  

Degreed, Inc., expire 05/31/2026(14)

   Series C-1    Software & Tech Services            26,294        46,823        279,001  

PerimeterX, Inc., expire 12/31/2031(14)

   Series D    Software & Tech Services            10,850        7,595        7,595  

Streamsets, Inc., expire 11/25/2027(14)

   Series C-1    Software & Tech Services            23,382        16,367        15,965  

Vectra AI, Inc., expire 03/18/2031(14)

   Series F    Software & Tech Services            35,156        58,190        100,824  
                 

 

 

    

 

 

 

Total U.S. Warrants

                 187,881        900,295  

United Kingdom Warrants—0.07%

 

GlobalWebIndex, Inc., expire 12/30/2027(14)

   Preferred Units    Software & Tech Services            8,832        159,859        223,583  
                 

 

 

    

 

 

 

Total United Kingdom Warrants

                 159,859        223,583  

TOTAL INVESTMENTS—257.77%(28)

 

   $  885,880,524      $ 892,580,993  
                 

 

 

    

 

 

 

Cash Equivalents—4.95%

 

U.S. Investment Companies—4.95%

 

Blackrock T Fund I(23) (29)

   Money Market    Money Market Portfolio    0.01% (30)         17,156,786      $ 17,156,786      $ 17,156,786  
                 

 

 

    

 

 

 

Total U.S. Investment Companies

                 17,156,786        17,156,786  
                 

 

 

    

 

 

 

Total Cash Equivalents

                 17,156,786        17,156,786  
                 

 

 

    

 

 

 

LIABILITIES IN EXCESS OF OTHER ASSETS—(162.72%)

         $  (563,461,099
                    

 

 

 

NET ASSETS—100.00%

                     $ 346,276,680  
                 

 

 

 

 

+ 

As of December 31, 2021, qualifying assets represented 96.32% of total assets. Under the 1940 Act we may not acquire any non-qualifying assets unless, at the time the acquisition is made, qualifying assets represent at least 70% of our total assets.

* 

Unless otherwise indicated, all securities are valued using significant unobservable inputs, which are categorized as Level 3 assets under the definition of Financial Accounting Standards Board’s Accounting Standards Codification 820 fair value hierarchy.

# 

Percentages are based on net assets.

^ 

Generally, the interest rate on floating interest rate investments is at benchmark rate plus spread. The borrower has an option to choose the benchmark rate, such as the London Interbank Offered Rate (“LIBOR”) or the U.S. Prime rate. The spread may change based on the type of rate used. The terms in the Consolidated Schedule of Investments disclose the actual interest rate in effect as of the reporting period. LIBOR loans are typically indexed to 30-day, 60-day, 90-day or 180-day LIBOR rates (1M L, 2M L, 3M L or 6M L, respectively) at the borrower’s option. LIBOR loans may be subject to interest floors. As of December 31, 2021, rates for weekly 1M L, 2M L, 3M L and 6M L are 0.10%, 0.15%, 0.21% and 0.34%, respectively. As of December 31, 2021, the U.S. Prime rate was 3.25%.

(1) 

Position, or a portion thereof, has been segregated to collateralize ABPCI Direct Lending Fund CLO VI Ltd.

(2) 

Position, or a portion thereof, has been segregated to collateralize ABPCIC Funding III, LLC.

(3) 

Position, or a portion thereof, has been segregated to collateralize ABPCIC Funding II, LLC.

(4) 

Position or portion thereof is an unfunded loan commitment, and no interest is being earned on the unfunded portion. The unfunded loan commitment may be subject to a commitment termination date, that may expire prior to the maturity date stated. See Note 6 “Commitments and Contingencies”.

(5) 

The negative cost is the result of the capitalized discount being greater than the principal amount outstanding on the loan. The negative fair value is the result of the capitalized discount on the loan.

(6) 

$86,381 of the funded par amount accrues interest at 6.50% (L + 5.50%; 1.00% Floor).

(7) 

$320,329 of the funded par amount accrues interest at 9.50% (P + 5.25%; 1.00% PIK; 2.00% Floor).

(8) 

$135,993 of the funded par amount accrues interest at 8.25% (L + 6.25%; 1.00% PIK; 1.00% Floor).

(9) 

$138,106 of the funded par amount accrues interest at 8.00% (P + 4.75%; 2.00% Floor).

(10) 

Positions considered non-qualified assets therefore excluded from the qualifying assets calculation as noted in footnote + above.

(11) 

The investment is on non-accrual status. See Note 2 “Significant Accounting Policies.”

(12) 

Position or portion thereof is held by Global Radar Acquisition Holdings, LLC which is held by ABPCIC Global Radar LLC

(13) 

Bowline Topco LLC is held through ABPCIC BE Holdings, LLC.

(14) 

Non-income producing investment.

(15) 

Concerto Health AI Solutions, LLC is held through ABPCIC Concerto Holdings LLC.

(16) 

Position or portion thereof is held by Magenta Blocker Aggregator LP, which is held by ABPCIC Equity Holdings, LLC.

(17) 

Position or portion thereof is held by Orangewood WWB Co-Invest, L.P. which is held by ABPCIC Equity Holdings, LLC.

(18) 

Position or portion thereof is held by ORCP III Triton Co-Investors, L.P. which is held by ABPCIC Equity Holdings, LLC.

(19) 

Excluded from the ASC 820 fair value hierarchy as fair value is measured using the net asset value per share practical expedient.

(20) 

Position or portion thereof is held by Pamlico Avant Holdings L.P. which is held by ABPCIC Avant, LLC.

(21) 

Neutral Connect, LLC is held through ABPCIC NC Holdings LLC.

(22) 

Position or portion thereof is held by REP Coinvest III AGP Blocker, L.P. which is held by ABPCIC Equity Holdings, LLC.

(23) 

Categorized as Level 1 assets under the definition of ASC 820 fair value hierarchy.

(24) 

Medical Management Resource Group, LLC is held through Advantage AVP Parent Holdings, L.P.

(25) 

Position or portion thereof is held by REP Coinvest III Tec, L.P. which is held by ABPCIC Equity Holdings, LLC.

(26) 

Position or portion thereof is held by REP Coinvest III-A Omni, L.P. which is held by ABPCIC Equity Holdings, LLC.

(27) 

Position or portion thereof is held by GHP SPV-2, L.P., which is held by ABPCIC Equity Holdings, LLC.

(28) 

Aggregate gross unrealized appreciation for federal income tax purposes is $14,943,797; aggregate gross unrealized depreciation for federal income tax purposes is $8,243,328. Net unrealized appreciation is $6,700,469 based upon a tax cost basis of $885,880,524.

(29) 

Included within ‘Cash and cash equivalents’ on the Consolidated Statements of Assets and Liabilities.

(30) 

The rate shown is the annualized seven-day yield as of December 31, 2021.

(31) 

Position or portion thereof is held by Freddy’s Acquisition, LP.

(32) 

Position or portion thereof is held by GSV MedSuite Investments, LLC.

(33) 

Position or portion thereof is held by GHP E Aggregator, LLC.

 

L   -    LIBOR
P   -    Prime
PIK   -    Payment-In-Kind

 

See Notes to Unaudited Consolidated Financial Statements

 

26


Table of Contents

AB Private Credit Investors Corporation

Notes to Unaudited Consolidated Financial Statements

March 31, 2022

1. Organization

AB Private Credit Investors Corporation (the “Fund,” “we,” “our,” and “us”), an externally managed, non-diversified, closed-end, management investment company that elected to be regulated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “1940 Act”), was incorporated under the laws of the state of Maryland on February 6, 2015. The Fund was formed to invest in primary-issue middle-market credit opportunities that are directly sourced and privately negotiated. AB Private Credit Investors LLC serves as the Fund’s external investment adviser (the “Adviser”).

Prior to 2017, there were no significant operations other than the sale and issuance of 100 shares of common stock of the Fund, par value $0.01 (“Shares”), on June 27, 2016, at an aggregate purchase price of $1,000 ($10.00 per Share) to the Adviser. The sale of Shares was approved by the unanimous consent of the Fund’s Board of Directors (the “Board”). In addition, prior to commencing operations in 2017, on May 26, 2017, the Fund issued and sold an additional 2,400 Shares at an aggregate purchase price of $24,000 ($10.00 per Share) to the Adviser. That sale was also approved by the unanimous consent of the Fund’s Board.

The Fund is conducting private offerings (each a “Private Offering”) of its common stock to investors in reliance on an exemption from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”). At the closing of any Private Offering, each investor will make a capital commitment (a “Capital Commitment”) to purchase Shares pursuant to a subscription agreement entered into with the Fund. All investors will be committed to the Fund for at least three years from the date of their initial Capital Commitment, subject to the terms described in the Fund’s Private Placement Memorandum. Investors will be required to fund drawdowns to purchase Shares up to the amount of their respective Capital Commitment on an as-needed basis each time the Fund delivers a capital draw-down notice to its investors.

On September 29, 2017, the Fund completed the initial closing (“Initial Closing”) of its Private Offering after entering into subscription agreements (collectively, the “Subscription Agreements”) with several investors, providing for the private placement of Shares. At March 31, 2022, the Fund had total Capital Commitments of $515,060,614, of which 25% is unfunded. Capital Commitments may be drawn down by the Fund on a pro rata basis, as needed (including follow-on investments), for paying the Fund’s expenses, including fees under the Amended and Restated Advisory Agreement (as defined below), and/or maintaining a reserve account for the payment of future expenses or liabilities.

There were no operating activities from February 6, 2015 to November 15, 2017. As described above, the Fund completed its Initial Closing on September 29, 2017, and commenced operations on November 15, 2017 by issuing its first capital call on December 1, 2017. The Fund’s fiscal year ends on December 31.

On June 14, 2019, the Adviser established ABPCI Direct Lending Fund CLO VI Ltd (“CLO VI”), an exempted company incorporated with limited liability under the laws of the Cayman Islands. CLO VI is 100% owned by the Fund and is consolidated in the Fund’s consolidated financial statements. CLO VI issued Class B, Class C and Subordinated Notes to the Fund through AB PCI Direct Lending Fund CLO VI Depositor LLC, a wholly-owned subsidiary of the Fund established on August 9, 2019.

On February 7, 2020, the Fund and an affiliate of Abbott Capital Management, LLC (“Abbott”) became members of, ABPCIC Equity Holdings, LLC (“ABPCICE”), a Delaware limited liability company and a special purpose vehicle designed to invest in private equity investments sourced by Abbott. The Fund is the managing member and owns 100% of the Class L Units and 93% of the Class A Units of ABPCICE. As a result, the Fund consolidates ABPCICE in its consolidated financial statements and records a non-controlling interest of the equity interests in ABPCICE not held by the Fund.

On July 30, 2020, the Adviser established ABPCIC Funding II LLC (“ABPCIC Funding II”), a Delaware limited liability company. ABPCIC Funding II is 100% owned by the Fund and is consolidated in the Fund’s consolidated financial statements commencing from the date of its formation.

On February 11, 2021, the Adviser established ABPCIC Funding III LLC (“ABPCIC Funding III”), a Delaware limited liability company. ABPCIC Funding III is 100% owned by the Fund and is consolidated in the Fund’s consolidated financial statements commencing from the date of its formation.

The Fund has established certain consolidated subsidiaries that are subject to U.S. federal and state corporate level income taxes to hold certain equity or equity-like investments in portfolio companies.

 

27


Table of Contents

2. Significant Accounting Policies

The Fund is an investment company under accounting principles generally accepted in the United States of America (“GAAP”) and follows the accounting and reporting guidance applicable to investment companies in the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 946, Financial Services – Investment Companies. The Fund has prepared the consolidated financial statements and related financial information pursuant to the requirements for reporting on Form 10-Q and Articles 6 and 10 of Regulation S-X. Accordingly, we have not included in this quarterly report all of the information and notes required by GAAP for annual financial statements. In the opinion of management, the unaudited financial information for the interim period presented in this report reflects all normal and recurring adjustments necessary for a fair statement of financial position and results from operations. Operating results for interim periods are not necessarily indicative of operating results for an entire year.

The functional currency of the Fund is U.S. dollars and these consolidated financial statements have been prepared in that currency.

Consolidation

The Fund will generally consolidate any wholly or substantially owned subsidiary when the design and purpose of the subsidiary is to act as an extension of the Fund’s investment operations and to facilitate the execution of the Fund’s investment strategy. Accordingly, the Fund consolidated the results of its wholly or substantially owned subsidiaries in its consolidated financial statements. The portion of net assets that is attributable to non-controlling interest in ABPCICE is presented as “Non-Controlling Interest in ABPCIC Equity Holdings, LLC”, a component of total equity, on the Fund’s consolidated statements of assets and liabilities. All intercompany balances and transactions have been eliminated in consolidation.

Reclassifications

Certain prior period amounts have been reclassified to conform to the current presentation, with no significant effect on our financial condition, results of operations or cash flows.

Valuation of Investment Companies

Investments in investment companies are valued at fair value. Fair values are generally determined utilizing the net asset value (“NAV”) supplied by, or on behalf of, management of each investment company, which is net of management and incentive fees or allocations charged by the investment company and is in accordance with the “practical expedient”, as defined by ASC 820. NAVs received by, or on behalf of, management of each investment company are based on the fair value of the investment company’s underlying investments in accordance with policies established by management of each investment company, as described in each of their financial statements and offering memorandum.

Cash and Cash Equivalents

Cash consists of demand deposits and money market accounts. Cash is carried at cost, which approximates fair value. The Fund maintains deposits of its cash with financial institutions, and, at times, cash held in bank accounts may exceed the Federal Deposit Insurance Corporation insured limit. The Fund considers all highly liquid investments, with original maturities of less than ninety days, as cash equivalents.

Revenue Recognition

Investment transactions are recorded on a trade-date basis. Interest income is recognized on an accrual basis. Interest income on debt instruments is accrued and recognized for those issuers who are currently paying in full or expected to pay in full. For those issuers who are in default or expected to default, interest is not accrued and is only recognized when received. Generally, when interest and/or principal payments on a loan become past due, or if the Fund otherwise does not expect the borrower to be able to service its debt and other obligations, the Fund will place the loan on non-accrual status and will cease recognizing interest income on that loan for financial reporting purposes until all principal and interest have been brought current through payment or due to restructuring such that the interest income is deemed to be collectible. The Fund generally restores non-accrual loans to accrual status when past due principal and interest is paid and, in the management’s judgment, is likely to remain current. Interest income and expense include discounts accreted and premiums amortized on certain debt instruments as determined in good faith by the Adviser and calculated using the effective interest method. Loan origination fees, original issue discounts and market discounts or premiums are capitalized as part of the underlying cost of the investments and accreted or amortized over the life of the investment as interest income.

 

28


Table of Contents

Realized gains and losses on investment transactions are determined on the specific identification method.

Certain investments in debt securities may contain a contractual payment-in-kind (“PIK”) interest provision. The PIK provisions generally feature the obligation, or the option, at each interest payment date of making interest payments in (i) cash, (ii) additional debt or (iii) a combination of cash and additional debt. PIK interest, computed at the contractual rate specified in the investment’s credit agreement, is accrued as interest income and recorded as interest receivable up to the interest payment date. On the interest payment date, the accrued interest receivable attributable to PIK is added to the principal balance of the investment. When additional debt is received on the interest payment date, it typically has the same terms, including maturity dates and interest rates, as the original loan. PIK interest generally becomes due on the investment’s maturity date or call date.

The Fund may earn various fees during the life of the loans. Such fees include, but are not limited to, syndication, commitment, administration, prepayment and amendment fees, some of which are paid to the Fund on an ongoing basis. These fees and any other income are recognized as earned. Upon prepayment of a loan or debt security, any prepayment premiums, unamortized upfront loan origination fees and unamortized discounts are recorded as interest income.

Non-Accrual Investments

Investments are placed on non-accrual status when it is probable that principal, interest or dividends will not be collected according to the contractual terms. Accrued interest or dividends generally are reversed when an investment is placed on non-accrual status. Interest or dividend payments received on non-accrual investments may be recognized as income or applied to principal depending upon management’s judgment. Non-accrual investments are restored to accrual status when past due principal and interest or dividends are paid and, in management’s judgment, principal and interest or dividend payments are likely to remain current. The Fund may make exceptions to this treatment if an investment has sufficient collateral value and is in the process of collection. As of March 31, 2022, the Fund had certain investments held in two portfolio companies on non-accrual status, which represented 0.81% and 0.21% of the total investments (excluding investments in cash equivalents, if any) at amortized cost and at fair value. As of December 31, 2021, the Fund had certain investments held in one portfolio company on non-accrual status, which represented 0.48% and 0.13% of the total investments (excluding investments in cash equivalents, if any) at amortized cost and at fair value.

Credit Facility Related Costs, Expenses and Deferred Financing Costs

The Revolving Credit Facilities (as defined in Note 4) are recorded at carrying value, which approximates fair value. Interest expense and unused commitment fees on the Revolving Credit Facilities are recorded on an accrual basis. Unused commitment fees are included in interest and borrowing expenses in the consolidated statements of operations. Deferred financing costs include capitalized expenses related to the closing of the Revolving Credit Facilities. Amortization of deferred financing costs is computed on the straight-line basis over the contractual term. The amortization of such costs is included in interest and borrowing expenses in the consolidated statements of operations, with any unamortized amounts included in deferred financing costs on the consolidated statements of assets and liabilities.

Notes Payable Related Costs, Expenses and Unamortized Debt Issuance Costs

The Notes (as defined in Note 4) are recorded at carrying value. Interest expense on notes payable is recorded on an accrual basis. Debt issuance costs relating to notes payable are amortized on a straight-line basis over the contractual term and included in interest and borrowing expenses in the consolidated statements of operations. The unamortized debt issuance costs are included as a direct reduction of the carrying value of the notes payable (i.e. a contra liability).

Upon early termination or partial principal pay down of the Notes, the unamortized costs related to the Notes are accelerated into interest and borrowing expenses on the Fund’s consolidated statements of operations.    

Secured Borrowings

The Fund may finance the purchase of certain investments through sale/buy-back agreements. In a sale/buy-back agreement, the Fund enters into a trade to sell an investment and contemporaneously enters into a trade to buy the same investment back on a specified date in the future with the same counterparty. The Fund uses sale/buy-back agreements as a short-term financing alternative to its existing Revolving Credit Facilities. The Fund accounts for its sale/buy-back agreements (the “Secured Borrowings”) as secured borrowings and continues to present the investment as an asset and the obligation to return the cash received as a liability within secured borrowings on the consolidated statements of assets and liabilities. Interest income earned on investments pledged under sale/buy-back agreements and financing charges associated with the sale/buy-back agreements are included within interest income and interest and borrowing expenses, respectively, on the consolidated statements of operations. Accrued interest receivable on investments and accrued financing charges on the sale/buy-back agreements are included within interest receivable and interest and borrowing expenses payable, respectively, on the consolidated statements of assets and liabilities.

 

29


Table of Contents

Income Taxes

ASC 740, “Accounting for Uncertainty in Income Taxes” (“ASC 740”) provides guidance on the accounting for and disclosure of uncertainty in tax positions. ASC 740 requires the evaluation of tax positions taken or expected to be taken in the course of preparing the Fund’s tax returns to determine whether the tax positions are “more-likely-than-not” of being sustained by the applicable tax authority. Tax positions deemed to meet the more-likely-than-not threshold are recorded as a tax benefit or expense in the current year. Based on its analysis of its tax position for all open tax years (the current and prior two years), the Fund has concluded that it does not have any uncertain tax positions that met the recognition or measurement criteria of ASC 740. Such open tax years remain subject to examination and adjustment by tax authorities.

The Fund has elected to be treated and intends to continue to be treated for federal income tax purposes as a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”). So long as the Fund is able to maintain its status as a RIC, it intends not to be subject to U.S. federal income tax on the portion of its taxable income and gains distributed to stockholders, if any. To qualify for RIC tax treatment, the Fund is required to distribute at least 90% of its investment company taxable income annually, meet diversification and income requirements quarterly, meet gross income requirements annually and file Form 1120-RIC, as provided by the Code. In order for the Fund not to be subject to U.S. federal excise taxes, it must distribute annually an amount at least equal to the sum of (i) 98% of its net ordinary income (taking into account certain deferrals and elections) for the calendar year, (ii) 98.2% of its capital gains in excess of capital losses for the one-year period ending on October 31 of the calendar year and (iii) any net ordinary income and capital gains in excess of capital losses for preceding years that were not distributed during such years. The Fund, at its discretion, may carry forward taxable income in excess of calendar year dividends and pay a 4% nondeductible U.S. federal excise tax on this income. The Fund will accrue excise tax on estimated undistributed taxable income as required. For the three months ended March 31, 2022 and 2021, the Fund accrued excise taxes of $0 and $0, respectively. As of March 31, 2022, and December 31, 2021, $0 and $0, respectively, of accrued excise taxes remained payable. For the three months ended March 31, 2022 and 2021, the Fund accrued income taxes of $308,827 and $0, respectively.

The Fund may be subject to taxes imposed by countries in which the Fund invests. Such taxes are generally based on income and/or capital gains earned or repatriated. Taxes are accrued and applied to net investment income, net realized gains and net unrealized gain (loss) as such income and/or gains are earned.

The Fund remains subject to examination by U.S. federal and state jurisdictions, as well as international jurisdictions, and upon completion of these examinations (if undertaken by the taxing jurisdiction) tax adjustments may be necessary and retroactive to all open tax years.

Certain of the Fund’s consolidated subsidiaries are subject to U.S. federal and state corporate-level income taxes.

Use of Estimates

The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities, if any, at the date of the consolidated financial statements, and the reported amounts of revenues and expenses recorded during the reporting period. Actual results could differ from those estimates and such differences could be material.

Distributions

Distributions from net investment income and net realized capital gains are determined in accordance with U.S. federal income tax regulations, which may differ from those amounts determined in accordance with GAAP. The Fund may pay distributions in excess of its taxable net investment income. This excess would be a tax-free return of capital in the period and reduce the stockholder’s tax basis in its Shares. These book/tax differences are either temporary or permanent in nature. To the extent these differences are permanent they are charged or credited to paid-in capital in excess of par, accumulated undistributed net investment income or accumulated net realized gain (loss), as appropriate, in the period that the differences arise. Temporary and permanent differences are primarily attributable to differences in the tax treatment of certain loans and the tax characterization of income and non-deductible expenses. These differences are generally determined in conjunction with the preparation of the Fund’s annual RIC tax return. Distributions to common stockholders are recorded on the ex-dividend date. The amount to be paid out as a distribution is determined by the Board each quarter and is generally based upon the earnings estimated by the Adviser. The Fund may pay distributions to its stockholders in a year in excess of its net ordinary income and capital gains for that year and, accordingly, a portion of such distributions may constitute a return of capital for U.S. federal income tax purposes. The Fund intends to timely distribute to its stockholders substantially all of its annual taxable income for each year, except that the Fund may retain certain net capital gains for reinvestment and, depending upon the level of the Fund’s taxable income earned in a year, the Fund may choose to carry forward taxable income for distribution in the following year and pay any applicable U.S. federal excise tax. The specific tax characteristics of the Fund’s distributions will be reported to stockholders after the end of the calendar year. All distributions will be subject to available funds, and no assurance can be given that the Fund will be able to declare such distributions in future periods.

 

30


Table of Contents

The Fund has adopted a dividend reinvestment plan that provides for stockholders to receive dividends or other distributions declared by the Board in cash unless a stockholder elects to “opt in” to the dividend reinvestment plan. As a result, if the Board declares a cash distribution, then the stockholders who have “opted in” to the dividend reinvestment plan will have their cash distributions automatically reinvested in additional Shares, rather than receiving the cash distribution.

Recent Accounting Pronouncements

In March 2020, the FASB issued Accounting Standards Update 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting (“ASU 2020-04”). This update provides optional expedients and exceptions for applying GAAP to contract modifications, hedging relationships, and other transactions affected by reference rate reform, if certain criteria are met. The amendments in this update are optional and effective from March 12, 2020 through December 31, 2022. Management is currently evaluating whether to employ the optional expedients or exceptions in ASU 2020-04, and have not used the expedients or exceptions for the three months ended March 31, 2022.

3. Related Party Transactions

Advisory Agreement

On November 13, 2019, the Fund entered into the amended and restated advisory agreement (the “Amended and Restated Advisory Agreement”), replacing the advisory agreement the Fund entered into with the Adviser on July 27, 2017 (the “Advisory Agreement”), pursuant to which the Fund will pay the Adviser, quarterly in arrears, a base management fee calculated at an annual rate of 1.50%. The base management fee is calculated based on a percentage of the average outstanding assets of the Fund (which equals the gross value of equity and debt instruments, including investments made utilizing leverage), excluding cash and cash equivalents, during such fiscal quarter. The average outstanding assets is calculated by taking the average of the amount of assets of the Fund at the beginning and end of each month that occurs during the calculation period. The base management fee is calculated and paid quarterly in arrears but will be accrued monthly by the Fund over the fiscal quarter for which such base management fee is paid.

On March 24, 2022, the Fund entered in to the second amended and restated investment advisory agreement (the “Second Amended and Restated Advisory Agreement”), replacing the Amended and Restated Advisory Agreement pursuant to which effective March 24, 2022 the base management fee shall be calculated at an annual rate of 1.375%. On March 24, 2022, the Fund and the Adviser also entered into a fee waiver letter pursuant to which the Adviser has agreed to waive a portion of the management fee in excess of the base management fee calculated at the reduced annual rate of 1.375% for the period January 1, 2022 through March 24, 2022.

For the three months ended March 31, 2022, the Fund incurred a management fee of $3,402,792, of which $283,566 was waived by the Adviser. For the three months ended March 31, 2021, the Fund incurred a management fee of $2,069,181, of which $183,001 was voluntarily waived by the Adviser. As of March 31, 2022, and December 31, 2021, $3,119,226 and $2,653,052, respectively, of accrued management fee remained payable.

The Fund will also pay the Adviser an incentive fee that provides the Adviser with a share of the income that the Adviser generates for the Fund. The incentive fee will consist of an income-based incentive fee component and a capital-gains component, which are largely independent of each other, with the result that one component may be payable even if the other is not.

Income-Based Incentive Fee: The income-based incentive fee is calculated and payable quarterly in arrears based on the Fund’s net investment income prior to any deductions with respect to such income-based incentive fees and capital gains incentive fees (“Pre-incentive Fee Net Investment Income” or “PIFNII”) for the quarter, as further described below. PIFNII means interest income, dividend income and any other income (including any other fees, such as commitment, origination, structuring, diligence, managerial and consulting fees or other fees the Fund receives from portfolio companies) that the Fund accrues during the fiscal quarter, minus the Fund’s operating expenses for the quarter (including the base management fee, expenses payable under the administration agreement (the “Administration Agreement”) we have entered into with State Street Bank and Trust (the “Administrator”), and any interest expense and dividends paid on any issued and outstanding indebtedness or preferred stock, respectively, but excluding, for avoidance of doubt, the income-based incentive fee, as well as the capital gains incentive fee (described below), accrued under GAAP). PIFNII also includes, in the case of investments with a deferred interest feature (such as original issue discount, debt instruments with pay-in-kind interest and zero-coupon securities), accrued income that the Fund has not yet received in cash. The Adviser is not under any obligation to reimburse the Fund for any part of the income-based incentive fees it received that was based on accrued interest that the Fund never actually received.

PIFNII does not include any realized capital gains, realized capital losses or unrealized capital appreciation or depreciation. Because of the structure of the income-based incentive fee, it is possible that the Fund may accrue such income-based incentive fee in a quarter where the Fund incurs a net loss. For example, if the Fund receives PIFNII in excess of a hurdle rate (as defined below) for a

 

31


Table of Contents

quarter, the Fund will accrue the applicable income-based incentive fee even if the Fund has incurred a realized and/or unrealized capital loss in that quarter. However, cash payment of the income-based incentive fee may be deferred in this situation, subject to the restrictions detailed at the end of this section.

PIFNII, expressed as a rate of return on the average value of the Fund’s net assets (defined as total assets, less indebtedness and before taking into account any incentive fees payable during the period) as of the first day of each month during the course of the immediately preceding calendar quarter, will be compared to various “hurdle rates,” with the income-based incentive fee rate of return increasing at each hurdle rate.

Description of Quarterly Incentive Fee Calculations

The Fund pays the Adviser an income-based incentive fee with respect to PIFNII in each calendar quarter as follows:

 

   

No income-based incentive fee in any calendar quarter in which PIFNII does not exceed 1.5% per quarter (6% per annum), the “6% Hurdle Rate”;

 

   

100% of PIFNII with respect to that portion of such PIFNII, if any, that exceeds the 6% Hurdle Rate but is less than 1.67% in any calendar quarter (the “6% Catch-up Cap”), approximately 6.67% per annum. This portion of PIFNII (which exceeds the 6% Hurdle Rate but is less than the 6% Catch-up Cap) is referred to as the “6% Catch-up.” The 6% Catch-up is meant to provide the Adviser with 10.0% of the PIFNII as if hurdle rate did not apply if this net investment income exceeded 1.67% but was less than 1.94% in any calendar quarter; and

 

   

10.0% of the amount of PIFNII, if any, that exceeds the 6% Catch-up Cap, but is less than 1.94% (the “7% Hurdle Rate”), approximately 7.78% per annum. The 7% Hurdle Rate is meant to limit the Adviser to 10% of the PIFNII until the amount of PIFNII exceeds 1.94%, approximately 7.78% per annum; and

 

   

100% of PIFNII with respect to that portion of such PIFNII, if any, that exceeds the 7% Hurdle Rate but is less than 2.06% in any calendar quarter (the “7% Catch-up Cap”), approximately 8.24% per annum. This portion of PIFNII (which exceeds the 7% Hurdle Rate but is less than the 7% Catch-up Cap) is referred to as the “7% Catch-up.” The 7% Catch-up is meant to provide the Adviser with 15.0% of the PIFNII as if a hurdle rate did not apply if this net investment income exceeded 2.06% but was less than 2.35% in any calendar quarter; and

 

   

15.0% of the amount of PIFNII, if any, that exceeds the 7% Catch-up Cap, but is less than 2.35% (the “8% Hurdle Rate”, approximately 9.41% per annum). The 8% Hurdle Rate is meant to limit the Adviser to 15% of the PIFNII until the amount of PIFNII exceeds 2.35%, approximately 9.41% per annum; and

 

   

100% of PIFNII with respect to that portion of such PIFNII, if any, that exceeds the 8% Hurdle Rate but is less than 2.50% in any calendar quarter (the “8% Catch-up Cap”), approximately 10% per annum. This portion of PIFNII (which exceeds the 8% Hurdle Rate but is less than the 8% Catch-up cap) is referred to as the “8% Catch-up”. The 8% Catch-up is meant to provide the Adviser with 20.0% of the PIFNII as if a hurdle rate did not apply if this net investment income exceeded 2.50% in any calendar quarter; and

 

   

20.0% of the amount of PIFNII, if any, that exceeds 2.50% in any calendar quarter.

For the three months ended March 31, 2022 and March 31, 2021, the Fund incurred income – based incentive fees of $1,931,939 and $641,062, respectively. As of March 31, 2022 and December 31, 2021, $1,931,939 and $1,377,288, respectively, of accrued income-based incentive fees remained payable.

The capital gains fee shall be determined and payable in arrears as of the end of each calendar year (or upon termination of this Agreement as set forth below), and will equal 20.0% of the Company’s aggregate cumulative realized capital gains, if any, from the date of the Company’s election to be regulated as a BDC through the end of each calendar year, computed net of all aggregate cumulative realized capital losses and aggregate cumulative unrealized capital depreciation, less the aggregate amount of any previously paid capital gain Incentive Fees, with respect to each of the investments in the Company’s portfolio. The Company’s “aggregate cumulative realized capital gains” will not include any unrealized appreciation. The capital gains fee is not subject to any minimum return to stockholders. If such amount is negative, then no Capital Gains Fee will be payable for such year. In the event that this Agreement shall terminate as of a date that is not a calendar year end, the termination date shall be treated as though it were a calendar year end for purposes of calculating and paying a Capital Gains Fee.

 

32


Table of Contents

For the three months ended March 31, 2022, the Fund reduced the previously recognized capital gains incentive fee under GAAP by $(546,733), which was not realized. There was no capital gains incentive fee under GAAP recognized for the three months ended March 31, 2021.

The amount of capital gains incentive fee expense related to a hypothetical liquidation of the portfolio (and assuming no other changes in realized or unrealized gains and losses) would only become payable to the Adviser in the event of a complete liquidation of the Fund’s portfolio as of period end and the termination of the Amended and Restated Advisory Agreement on such date. Also, it should be noted that the capital gains incentive fee expense fluctuates with the Fund’s overall investment results.

The Fund will defer cash payment of any income-based incentive fee and/or any capital gains incentive fee otherwise earned by the Adviser if during the most recent four full fiscal quarter periods ending on or prior to the date such payment is to be made, the sum of (a) the PIFNII, and (b) the realized capital gain / loss and (c) unrealized capital appreciation/ depreciation expressed as a rate of return on the value of our net assets, is less than 6.0%. Any such deferred fees are carried over for payment in subsequent calculation periods to the extent such payment is payable under the Amended and Restated Advisory Agreement.

Administration Agreement and Expense Reimbursement Agreement

We have entered into the Administration Agreement with the Administrator and a separate expense reimbursement agreement with the Adviser (the “Expense Reimbursement Agreement”) under which any allocable portion of the cost of our Chief Compliance Officer and Chief Financial Officer and their respective staffs will be reimbursed by the Fund. Under the Administration Agreement, the Administrator will be responsible for providing us with clerical, bookkeeping, recordkeeping and other administrative services. We will reimburse the Adviser an amount equal to our allocable portion (subject to the review of our Board) of its overhead resulting from its obligations under the Expense Reimbursement Agreement, including the allocable portion of the cost of our Chief Compliance Officer and Chief Financial Officer and their respective staffs.

Expense Support and Conditional Reimbursement Agreement

On September 29, 2017, the Fund and the Adviser entered into an agreement (the “Expense Support and Conditional Reimbursement Agreement”) to limit certain of the Fund’s Operating Expenses, as defined below, to no more than 1.5% of the Fund’s average quarterly gross assets. To achieve this percentage limitation, the Adviser has agreed to reimburse the Fund for certain Operating Expenses on a quarterly basis (any such payment by the Adviser, an “Expense Payment”) and the Fund has agreed to later repay such amounts (any such payment by the Fund, a “Reimbursement Payment”), pursuant to the terms of the Expense Support and Conditional Reimbursement Agreement. The actual percentage of Operating Expenses paid by the Fund in any quarter after deducting any Expense Payment, as a percentage of the Fund’s average quarterly gross assets, is referred to as the “Percentage Limit.”

Any Expense Payment by the Adviser pursuant to the Expense Support and Conditional Reimbursement Agreement will be subject to repayment by the Fund on a quarterly basis within the three years following the fiscal quarter of the Fund in which the Operating Expenses were paid or absorbed, if the total Operating Expenses for the current quarter, including Reimbursement Payments, expressed as a percentage of the Fund’s average gross assets during such quarter is less than the then-current Percentage Limit, if any, and the Percentage Limit that was in effect at the time when the Adviser reimbursed the Operating Expenses that are the subject of the repayment, subject to certain provisions of the Expense Support and Conditional Reimbursement Agreement, as described below. For purposes of the Expense Support and Conditional Reimbursement Agreement, “Operating Expenses” means the Fund’s Total Operating Expenses (as defined below), excluding base management fees, incentive fees, distribution and stockholder servicing fees, financing fees and costs, interest expense, brokerage commissions and extraordinary expenses and “Total Operating Expenses” means all of the Fund’s operating costs and expenses incurred, as determined in accordance with generally accepted accounting principles for investment companies.

However, no Reimbursement Payment for any quarter will be made if: (1) the Effective Rate of Distributions Per Share (as defined below) declared by the Fund at the time of such Reimbursement Payment is less than or equal to the Effective Rate of Distributions Per Share at the time the Expense Payment was made to which such Reimbursement Payment relates, or (2) the Fund’s Operating Expense Ratio at the time of such Reimbursement Payment is greater than or equal to the Operating Expense Ratio (as defined below) at the time the Expense Payment was made to which such Reimbursement Payment relates. For purposes of the Expense Support and Conditional Reimbursement Agreement, “Effective Rate of Distributions Per Share” means the annualized rate (based on a 365- day year) of regular cash distributions per Share exclusive of returns of capital, distribution rate reductions due to distribution and stockholder fees, and declared special dividends or special distributions, if any. The “Operating Expense Ratio” is calculated by dividing Operating Expenses in any quarter by the Fund’s average net assets in such quarter.

The specific amount of expenses paid by the Adviser, if any, will be determined at the end of each quarter. The Fund or the Adviser may terminate the Expense Support and Conditional Reimbursement Agreement at any time, with or without notice. The Expense Support and Conditional Reimbursement Agreement will automatically terminate in the event of (a) the termination of the Amended and Restated Advisory Agreement, or (b) the Board of the Fund making a determination to dissolve or liquidate the Fund.

 

33


Table of Contents

Upon termination of the Expense Support and Conditional Reimbursement Agreement, the Fund will be required to fund any Expense Payments, subject to the aforementioned requirements per the Expense Support and Conditional Reimbursement Agreement, that have not been reimbursed by the Fund to the Adviser.

As of March 31, 2022, the amount of Expense Payments provided by the Adviser since inception is $4,874,139. The following table reflects the Expense Payments that may be subject to reimbursement pursuant to the Expense Agreement:

 

For the Quarters Ended

   Amount of
Expense Support
     Amount of
Reimbursement
Payment
     Amount of
Unreimbursed
Expense
Support
     Effective Rate of
Distribution
per Share (1)
    Reimbursement Eligibility
Expiration
     Percentage
Limit (2)
 

September 30, 2017

   $ 1,002,147      $ 1,002,147      $ —          n/a       September 30, 2020        1.5

December 31, 2017

     1,027,398        1,027,398        —          n/a       December 31, 2020        1.5

March 31, 2018

     503,592        503,592        —          n/a       March 31, 2021        1.5

June 30, 2018

     1,086,482        755,992        330,490        4.787     June 30, 2021        1.0

September 30, 2018

     462,465        462,465        —          4.715     September 30, 2021        1.0

December 31, 2018

     254,742        —          254,742        6.762     December 31, 2021        1.0

March 31, 2019

     156,418        156,418        —          5.599     March 31, 2022        1.0

June 30, 2019

     259,263        259,263        —          6.057     June 30, 2022        1.0

September 30, 2019

     31,875        31,875        —          5.154     September 30, 2022        1.0

December 31, 2019

     —          —          —          6.423     December 31, 2022        1.0

March 31, 2020

     89,757        —          89,757        10.170     March 31, 2023        1.0

June 30, 2020

     —          —          —          5.662     June 30, 2023        1.5

September 30, 2020

     —          —          —          6.063     September 30, 2023        1.5

December 31, 2020

     —          —          —          6.266     December 31, 2023        1.5

March 31, 2021

     —          —          —          6.241     March 31, 2024        1.0

June 30, 2021

     —          —          —          6.219     June 30, 2024        1.0

September 30, 2021

     —          —          —          6.503     September 30, 2024        1.0

December 31, 2021

     —          —          —          5.706     December 31, 2024        1.0

March 31, 2022

     —          —          —          9.483     March 31, 2025        1.0
  

 

 

    

 

 

    

 

 

         

Total

   $ 4,874,139      $ 4,199,150      $ 674,989          
  

 

 

    

 

 

    

 

 

         

 

(1)

The effective rate of distribution per Share is expressed as a percentage equal to the projected annualized distribution amount as of the end of the applicable period (which is calculated by annualizing the regular quarterly cash distributions per Share as of such date without compounding), divided by the Fund’s gross offering price per Share as of such date.

(2)

Represents the actual percentage of Operating Expenses paid by the Fund in any quarter after deducting any Expense Payment, as a percentage of the Fund’s average quarterly gross assets.

Transfer Agency Agreement

On September 26, 2017, the Fund and Alliance Bernstein Investor Services, Inc. (“ABIS”), an affiliate of the Fund, entered into an agreement pursuant to which ABIS will provide transfer agent services to the Fund. The Fund bears the expenses related to the agreement with ABIS.

For the three months ended March 31, 2022 and March 31, 2021, the Fund accrued $25,676 and $16,386, respectively, in transfer agent fees. As of March 31, 2022 and December 31, 2021, $25,676 and $23,019, respectively, of accrued transfer agent fees remained payable.

4. Borrowings

Credit Facilities

On November 15, 2017, the Fund entered into a credit agreement (the “HSBC Credit Agreement”) to establish a revolving credit facility (the “HSBC Credit Facility”) with HSBC Bank USA, National Association (“HSBC”) as administrative agent (the “HSBC Administrative Agent”). The maximum commitment amount (the “HSBC Maximum Commitment”) under the HSBC Credit Facility was initially $30 million and may be increased in a minimum amount of $10 million and in $5 million increments thereof with the consent of HSBC or reduced upon request of the Fund. As of January 31, 2019, the Fund has increased the HSBC Maximum Commitment to $50 million. So long as no request for borrowing is outstanding, the Fund may terminate the lenders’ commitments (the “Commitments”) or reduce the HSBC Maximum Commitment by giving prior irrevocable written notice to the HSBC Administrative Agent. Any reduction of the HSBC Maximum Commitment shall be in an amount equal to $10 million or multiples thereof; and in no event shall a reduction by the Fund reduce the Commitments to $35 million or less (in each defined terms to says HSBC case, except for a termination of all the Commitments).    

 

34


Table of Contents

Borrowings under the HSBC Credit Agreement bear interest, at the Fund’s election at the time of drawdown, at a rate per annum equal to (i) with respect to LIBOR Rate Loans (as defined in the HSBC Credit Agreement), Adjusted LIBOR (as defined in the HSBC Credit Agreement) for the applicable Interest Period (as defined in the HSBC Credit Agreement); and (ii) with respect to Reference Rate Loans (as defined in the HSBC Credit Agreement), the greatest of: (x) the rate of interest per annum publicly announced from time to time by HSBC as its prime rate, (y) the rate per annum equal to the weighted average of the rates on overnight Federal funds transactions with members of the Federal Reserve System arranged by Federal funds brokers on such day, plus two hundred basis points (2.00%), provided that if such rate is not so published for any day that is a Business Day (as defined in the HSBC Credit Agreement), the average of the quotation for such day on such transactions received by the HSBC Administrative Agent, from three (3) Federal funds brokers of recognized standing selected by the HSBC Administrative Agent and, upon request of Borrowers (as defined in the HSBC Credit Agreement), with notice of such quotations to the Borrowers and (z) except during any period of time during which LIBOR is unavailable, one-month Adjusted LIBOR plus one hundred ninety basis points (1.90%). The Fund will also pay an unused commitment fee of 35 basis points (0.35%) on any unused commitments.

On November 10, 2020, the Fund entered into an amendment to the HSBC Credit Agreement (the “HSBC Credit Agreement Amendment”) concerning the HSBC Credit Facility. The HSBC Credit Agreement Amendment (i) extended the maturity date of the HSBC Credit Facility from November 11, 2020 to November 9, 2021, and (ii) inserted a provision permitting the Fund and the HSBC Administrative Agent to, upon the occurrence of certain conditions, amend the HSBC Credit Agreement to replace references to LIBOR with references to an alternate benchmark rate that may include a forward-looking rate based on the Secured Overnight Financing Rate or another alternate benchmark rate subject to certain conditions.

On July 8, 2021, the Fund terminated the HSBC Credit Agreement and all outstanding loans thereunder were repaid and all obligations thereunder were released and terminated. Concurrent with the termination of the HSBC Credit Agreement, the Fund entered into Joinder and Third Amendment to Revolving Credit Agreement (the “HSBC Joinder”), with HSBC as administrative agent and a lender, and each of the parties listed thereto, pursuant to which the Fund became party to a subscription financing facility (the “2021 HSBC Credit Facility”) evidenced by Revolving Credit Agreement, dated as of June 14, 2019 (as amended, restated, supplemented or otherwise modified from time to time, the “2021 HSBC Credit Agreement”), by and among AB-Abbott Private Equity Investors 2019 (Delaware) Fund L.P., an affiliate of the Fund, as initial borrower, AB-Abbott Private Equity Investors G.P. L.P., an affiliate of the Fund, as initial general partner, the banks and financial institutions from time to time party thereto as lenders, and HSBC as administrative agent. The Fund Group Facility Sublimit (as defined in the 2021 HSBC Credit Agreement) applicable to the Fund under the 2021 HSBC Credit Facility is $50 million. Borrowings under the 2021 HSBC Credit Facility bear interest at a rate per annum equal to (i) with respect to LIBOR Rate Loans, Adjusted LIBOR (as defined in the 2021 HSBC Credit Agreement) for the applicable Interest Period (as defined in the 2021 HSBC Credit Agreement) and (ii) with respect to Reference Rate Loans (as defined in the 2021 HSBC Credit Agreement), the Reference Rate (as defined in the 2021 HSBC Credit Agreement) in effect from day to day. The Fund will also pay an unused commitment fee of 0.35%. Proceeds under the 2021 HSBC Credit Agreement may be used for any purpose permitted under the Fund’s organizational documents, including general corporate purposes such as the making of investments. The 2021 HSBC Credit Agreement contains certain customary covenants and events of default, with customary cure and notice provisions. As of March 31, 2022, the Fund is in compliance with these covenants. The Fund’s obligations under the 2021 HSBC Credit Agreement are secured by the Capital Commitments and capital contributions. The 2021 HSBC Credit Agreement will mature on June 10, 2022.

On October 15, 2020, ABPCIC Funding II entered into a revolving credit facility (the “Synovus Credit Facility”) with Synovus Bank, Specialty Finance Division (“Synovus”), as facility agent, and U.S. Bank, National Association (“U.S. Bank”), as collateral agent (in such capacity, the “Synovus Collateral Agent”), collateral custodian (in such capacity, the “Synovus Collateral Custodian”) and securities intermediary (in such capacity, the “Synovus Securities Intermediary”). On April 16, 2021, pursuant to an amendment to the loan financing and servicing agreement (the “Synovus Loan Agreement”), the Fund increased the commitment of the existing lender by $20,000,000 from $100,000,000 to $120,000,000 and added WebBank as an additional lender with a commitment of $30,000,000.

On December 31, 2021, pursuant to an amendment to the Synovus Loan Agreement, ABPCIC Funding II added Axos Bank as an additional lender with a commitment of $50,000,000.

The Synovus Credit Facility provides for borrowings in an aggregate amount up to $200,000,000. Borrowings under the Synovus Credit Facility bear interest based on an annual adjusted LIBOR for the relevant interest period or the applicable replacement thereto provided, plus an applicable spread. Interest is payable quarterly in arrears. Any amounts borrowed under the Synovus Credit Facility will mature, and all accrued and unpaid interest thereunder will be due and payable, on the earlier of (i) October 15, 2025 (or such later date mutually agreed to by ABPCIC Funding II and Synovus) or (ii) upon certain events which result in accelerated maturity under the agreements establishing the Synovus Credit Facility. Borrowing under the Synovus Credit Facility is subject to certain restrictions contained in the 1940 Act.

 

35


Table of Contents

Borrowings under the Synovus Credit Facility are secured by all of the assets held by ABPCIC Funding II. Pursuant to the agreements establishing the Synovus Credit Facility, the Adviser will perform certain duties with respect to the purchase and management of the assets securing the Synovus Credit Facility. The Adviser will not receive a fee for these services so long as the Adviser or an affiliate thereof continues providing such services. ABPCIC Funding II will reimburse all reasonable expenses, disbursements and advances incurred or made by the Adviser in the performance of its obligations relating to the Synovus Credit Facility.

All of the collateral pledged to the lenders by ABPCIC Funding II under the Synovus Credit Facility is held in the custody of the Synovus Collateral Custodian or the Synovus Securities Intermediary. The Synovus Collateral Custodian will maintain and perform certain custodial services with respect to the collateral pledged to support the Synovus Credit Facility. As compensation for the services rendered by U.S. Bank in its capacities as Synovus Collateral Custodian and Synovus Collateral Agent, ABPCIC Funding II will pay U.S. Bank, on a quarterly basis, customary fee amounts and reimburse U.S. Bank for its reasonable out-of-pocket expenses. The Synovus Credit Facility contains certain customary covenants and events of default, with customary cure and notice provisions. As of March 31, 2022, the Fund is in compliance with these covenants.

On March 24, 2021, ABPCIC Funding III entered into a warehouse financing transaction (the “Natixis Credit Facility,” and together with the HSBC Credit Facility, the 2021 HSBC Credit Facility and the Synovus Credit Facility, the “Revolving Credit Facilities”) with Natixis, New York Branch, as administrative agent (in such capacity, the “Natixis Administrative Agent”) and U.S. Bank, as collateral agent (in such capacity, the “Natixis Collateral Agent”), collateral administrator (in such capacity, the “Natixis Collateral Administrator”) and custodian (in such capacity, the “Natixis Custodian”). In connection with the Natixis Credit Facility, ABPCIC Funding III entered into, among other agreements, (i) the credit agreement (the “Natixis Credit Agreement”) among ABPCIC Funding III, the lenders referred to therein, the Natixis Administrative Agent, the Natixis Collateral Agent, the Natixis Collateral Administrator and the Natixis Custodian, (ii) the account control agreement (the “Natixis Account Control Agreement”) among ABPCIC Funding III, as debtor, the Natixis Collateral Agent, as secured party, and U.S. Bank National Association, as securities intermediary (in such capacity, the “Natixis Securities Intermediary”), (iii) the collateral management agreement (the “Natixis Collateral Management Agreement”), between ABPCIC Funding III and the Adviser, as collateral manager (in such capacity, the “Natixis Collateral Manager”), (iv) the collateral administration agreement (the “Natixis Collateral Administration Agreement”), among ABPCIC Funding III, the Natixis Collateral Manager and the Natixis Collateral Administrator and (v) the master loan sale and contribution agreement (the “Natixis Transfer Agreement”) between ABPCIC Funding III and the Fund.

On July 1, 2021, ABPCIC Funding III entered into an amendment to the Natixis Credit Agreement providing for, among other things, an upsize of the aggregate principal amount of the commitments under the Natixis Credit Agreement from $100,000,000 to $150,000,000. On November 5, 2021, pursuant to an amendment to Natixis Credit Agreement, the Fund increased the commitment of the existing lender by $75,000,000 from $150,000,000 to $225,000,000. On March 4, 2022, pursuant to Amendment No 4 to the Natixis Credit Agreement, ABPCIC Funding III increased the commitment by $25,000,000 from $225,000,000 to $250,000,000.

The Natixis Credit Facility provides for borrowings in an aggregate amount up to $250,000,000. Borrowings under the Natixis Credit Agreement will bear interest based on an annual adjusted SOFR for the relevant interest period plus an applicable spread. Interest is payable quarterly in arrears. Any amounts borrowed under the Natixis Credit Agreement will mature, and all accrued and unpaid interest thereunder will be due and payable, on the earlier of (i) March 24, 2031 (or such later date mutually agreed to by ABPCIC Funding III and the Natixis Administrative Agent) or (ii) upon certain other events which result in accelerated maturity under the Natixis Credit Facility. Borrowing under the Natixis Credit Facility is subject to certain restrictions contained in the 1940 Act.

Borrowings under the Natixis Credit Agreement are secured by all of the assets held by ABPCIC Funding III. Pursuant to the Natixis Collateral Management Agreement, the Natixis Collateral Manager will perform certain duties with respect to the purchase and management of the assets securing the Natixis Credit Facility. The Natixis Collateral Manager will not receive a fee for these services so long as the Adviser or an affiliate thereof continues providing such services. ABPCIC Funding III will reimburse the expenses incurred by the Natixis Collateral Manager in the performance of its obligations under the Natixis Collateral Management Agreement other than any ordinary overhead expenses, which shall not be reimbursed. ABPCIC Funding III has made customary representations and warranties under the Natixis Collateral Management Agreement and is required to comply with various covenants, reporting requirements and other customary requirements for similar credit facilities.

All of the collateral pledged to the lenders by ABPCIC Funding III under the Natixis Credit Agreement is held in the custody of the Natixis Custodian under the Natixis Account Control Agreement. The Natixis Collateral Administrator will maintain and perform certain collateral administration services with respect to the collateral pursuant to the Natixis Collateral Administration Agreement. As compensation for the services rendered by the Natixis Collateral Administrator, ABPCIC Funding III will pay the Natixis Collateral Administrator, on a quarterly basis, customary fee amounts and reimburse the Natixis Collateral Administrator for its reasonable out-of-pocket expenses. The Natixis Collateral Administration Agreement and the obligations of the Natixis Collateral Administrator will continue until the earlier of (i) the liquidation of the collateral and the final distribution of the proceeds of such liquidation, (ii) the date on which all obligations have been paid in full or (iii) the termination of the Natixis Collateral Management Agreement.    

 

36


Table of Contents

The Fund’s outstanding borrowings through the Revolving Credit Facilities as of March 31, 2022 were as follows:

 

     Aggregate Borrowing
Amount Committed
     Outstanding
Borrowing
     Amount
Available
     Carrying
Value
 

HSBC

   $ 50,000,000      $ 25,000,000      $ 25,000,000      $ 25,000,000  

Synovus

     200,000,000        163,300,000        36,700,000        163,300,000  

Natixis

     250,000,000        220,300,000        29,700,000        220,300,000  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ 500,000,000      $ 408,600,000      $ 91,400,000      $ 408,600,000  
  

 

 

    

 

 

    

 

 

    

 

 

 

The Fund’s outstanding borrowings through the Revolving Credit Facilities as of December 31, 2021 were as follows:

 

     Aggregate Borrowing
Amount Committed
     Outstanding
Borrowing
     Amount
Available
     Carrying
Value
 

HSBC

   $ 50,000,000      $ 40,000,000      $ 10,000,000      $ 40,000,000  

Synovus

     200,000,000        147,300,000        52,700,000        147,300,000  

Natixis

     225,000,000        193,300,000        31,700,000        193,300,000  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ 475,000,000      $ 380,600,000      $ 94,400,000      $ 380,600,000  
  

 

 

    

 

 

    

 

 

    

 

 

 

As of March 31, 2022 and December 31, 2021, deferred financing costs were $2,852,031 and $3,438,175, respectively, which remain to be amortized, and are reflected on the consolidated statements of assets and liabilities.

Collateralized Loan Obligations

On August 9, 2019, CLO VI (the “Issuer”) and ABPCI Direct Lending Fund CLO VI LLC, a limited liability company organized under the laws of the State of Delaware (the “Co-Issuer,” and together with the Issuer, the “Co-Issuers”), each a newly formed special purpose vehicle, completed a $300,500,000 term debt securitization (the “CLO Transaction”). The stated reinvestment date is August 9, 2022.

The CLO Transaction was executed through a private placement and the notes offered (the “Notes”) that remain outstanding as of March 31, 2022 and December 31, 2021 were as follows:

 

March 31, 2022  
     Principal
Amount
     Interest
Rate
    Carrying
Value(1)
 

Class A-1 Senior Secured Floating Rate Note (“Class A-1”)

   $ 178,200,000        L + 1.73   $ 177,866,208  

Class A-2A Senior Secured Floating Rate Note (“Class A-2A”)

   $ 25,000,000        L + 2.45   $ 24,953,165  

Class A-2B Senior Secured Fixed Rate Note (“Class A-2B”)

   $ 9,950,000        4.23   $ 9,910,693  

Class B Secured Deferrable Floating Rate Note (“Class B”)

   $ 16,400,000        L + 3.40   $ —  

Class C Secured Deferrable Floating Rate Note (“Class C”)

   $ 17,350,000        L + 4.40   $ —  

Subordinated Notes

   $ 53,600,000        N/A     $ —  

 

*

Class B, Class C and Subordinated Notes have been eliminated in consolidation.

(1)

Carrying value is net of unamortized discount and debt issuance costs. Unamortized discount and debt issuance costs associated with the Notes totaled $20,661 and $399,273, respectively, as of March 31, 2022 and are reflected on the consolidated statements of assets and liabilities.

 

37


Table of Contents
December 31, 2021  
     Principal
Amount
     Interest
Rate
    Carrying
Value(1)
 

Class A-1 Senior Secured Floating Rate Note (“Class A-1”)

   $ 178,200,000        L + 1.73   $ 177,636,864  

Class A-2A Senior Secured Floating Rate Note (“Class A-2A”)

   $ 25,000,000        L + 2.45   $ 24,920,997  

Class A-2B Senior Secured Fixed Rate Note (“Class A-2B”)

   $ 9,950,000        4.23   $ 9,896,743  

Class B Secured Deferrable Floating Rate Note (“Class B”)

   $ 16,400,000        L + 3.40   $ —  

Class C Secured Deferrable Floating Rate Note (“Class C”)

   $ 17,350,000        L + 4.40   $ —  

Subordinated Notes

   $ 53,600,000        N/A     $ —  

 

*

Class B, Class C and Subordinated Notes have been eliminated in consolidation.

(1)

Carrying value is net of unamortized discount and debt issuance costs. Unamortized discount and debt issuance costs associated with the Notes totaled $21,813 and $673,583, respectively, as of December 31, 2021 and are reflected on the consolidated statements of assets and liabilities.

The Notes are scheduled to mature on August 9, 2030.

The CLO VI indenture provides that the holders of the CLO VI Class A-1, Class A-2A, Class A-2B, Class B and Class C Notes are to receive quarterly interest payments, in arrears, on the 20th day in January, April, July and October of each year, commencing in August 2019.

The Notes are the secured obligations of the Co-Issuers, and the indenture governing the Notes includes customary covenants and events of default. The Notes have not been, and will not be, registered under the Securities Act or any state securities or “blue sky” laws and may not be offered or sold in the United States absent registration with the Securities and Exchange Commission or an applicable exemption from registration.

The Adviser serves as collateral manager to the Issuer pursuant to a collateral management agreement between the Adviser and the Issuer (the “CLO Collateral Management Agreement”). For so long as the Adviser serves as collateral manager to the Issuer, the Adviser will elect to irrevocably waive any base management fee or subordinated interest to which it may be entitled under the CLO Collateral Management Agreement. For the three months ended March 31, 2022, the Fund incurred collateral management fees of $456,498, which was voluntarily waived by the Adviser. For the three months ended March 31, 2021, the Fund incurred collateral management fees of $454,343, which were voluntarily waived by the Adviser.

Secured Borrowings

From time to time, the Fund may engage in sale/buy-back agreements, with Macquarie US Trading LLC (the “Macquarie Sale/Buy Back”), which are a type of secured borrowing. The amount, interest rate and terms of these agreements will be individually negotiated on a transaction-by-transaction basis. Each borrowing is secured by an interest in an underlying asset which is participated or assigned to the sale/buy-back counterparty for the duration of the agreement.

As of March 31, 2022, Secured Borrowings pursuant to the Macquarie Sale/Buy-Back were $5,360,494. As of December 31, 2021, Secured Borrowings pursuant to the Macquarie Sale/Buy-Back were $10,228,115, with a maturity of less than thirty days.

Secured Borrowings outstanding as of March 31, 2022, were as follows:

 

Loan Name

   Trade Date     

Maturity Date

   bps Daily Rate      Amount  

PAW Midco, Inc.

     2/25/2022      35 days or less from trade date      1.03      $ 5,360,494  
           

 

 

 
            $ 5,360,494  
           

 

 

 

Secured Borrowings outstanding as of December 31, 2021, were as follows:

 

Loan Name

   Trade Date     

Maturity Date

   bps Daily Rate      Amount  

PAW Midco, Inc.

     12/28/2021      60 days or less from trade date      1.03      $ 5,328,115  

Veracross LLC

     12/28/2021      60 days or less from trade date      1.03        4,900,000  
           

 

 

 
            $ 10,228,115  
           

 

 

 

 

38


Table of Contents

As of March 31, 2022 and December 31, 2021 total outstanding borrowings under the Revolving Credit Facilities, Notes, and Secured Borrowings were $626,690,560 and $603,282,719, respectively.

For the three months ended March 31, 2022 and March 31, 2021, the components of interest and other debt expenses related to the borrowings were as follows:

 

     For the three months ended
March 31,
 
     2022     2021  

Interest and borrowing expenses

   $ 3,844,607     $ 2,069,551  

Commitment fees

     131,416       42,717  

Amortization of discount, debt issuance and deferred financing costs

     1,164,762       492,785  
  

 

 

   

 

 

 

Total

   $ 5,140,785     $ 2,605,053  
  

 

 

   

 

 

 

Weighted average interest rate(1)

     2.65     2.52

Average outstanding balance

   $ 587,636,262     $ 333,224,679  

 

(1)

Calculated as the amount of the stated interest and borrowing expenses divided by average borrowings during the period.

5. Fair Value Measurement

In accordance with ASC 820, fair value is defined as the price that the Fund would receive to sell an asset or pay to transfer a liability in an orderly transaction between market participants at the measurement date. ASC 820 also establishes a framework for measuring fair value and a three-level hierarchy for fair value measurements based upon the transparency of inputs to the valuation of an asset or liability. Inputs may be observable or unobservable and refer broadly to the assumptions that market participants would use in pricing the asset or liability as of the reporting date.

Observable inputs reflect the assumptions market participants would use in pricing the asset or liability based on market data obtained from sources independent of the Fund. Unobservable inputs reflect the Fund’s own assumptions about the assumptions that market participants would use in pricing the asset or liability developed based on the best information available in the circumstances. Each investment is assigned a level based upon the observability of the inputs which are significant to the overall valuation.

The three-tier hierarchy of inputs is summarized below:

 

   

Level 1 – Quoted prices in active markets for identical investments.

 

   

Level 2 – Other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, credit risk, etc.).

 

   

Level 3 – Significant unobservable inputs (including the Fund’s own assumptions in determining the fair value of investments at the reporting date).

The level in the fair value hierarchy within which the fair value measurement is categorized in its entirety is determined on the basis of the lowest level input that is significant to the fair value measurement in its entirety. For this purpose, the significance of an input is assessed against the fair value measurement in its entirety. If a fair value measurement uses observable inputs that require significant adjustment based on unobservable inputs, that measurement is a Level 3 measurement. If a fair value measurement uses price data vendors or observable market price quotations, that measurement is a Level 2 measurement. Assessing the significance of a particular input to the fair value measurement in its entirety requires judgment, considering factors specific to the asset or liability.

The determination of what constitutes “observable” requires significant judgment by the Fund. The Fund considers observable data to be that market data that is readily available, regularly distributed or updated, reliable and verifiable, not proprietary, and provided by independent sources that are actively involved in the relevant market.

For certain investments, the Fund uses the net asset value of these investments as a practical expedient to determine their fair value. Due to the uncertainty inherent in valuing such positions, their estimated values could differ significantly from the values that could have been used had a ready market for such positions existed.

Valuation of Investments

Investments are valued at fair value as determined in good faith by our Board, based on input of management, the audit committee and independent valuation firms that have been engaged to assist in the valuation of each portfolio investment without a readily available market quotation under a valuation policy. This valuation process is conducted at the end of each fiscal quarter.

 

39


Table of Contents

The fair values of loan investments based upon pricing data vendors or observable market price quotations are generally categorized as Level 2; however, those priced using models with significant unobservable inputs are categorized as Level 3.

In determining the fair value of the Fund’s Level 3 debt and equity positions, the Adviser and the independent valuation firms use the following factors where relevant: loan to value (“LTV”) based on an enterprise value determined using the original purchase price, public equity comparable, recent M&A transaction, and a discounted cash flow (“DCF”) analysis, and yields from comparable loans, comparable high yield bonds, high yield indexes and loan indexes (“comparable yields”).

Due to the inherent uncertainty of valuations, however, estimated fair values may differ from the values that would have been used had a readily available market for the securities existed and the differences could be material.

The following tables summarize the valuation of the Fund’s investments as of March 31, 2022:

 

Assets*

   Level 1          Level 2          Level 3      Total  

Cash Equivalents

           

Investment Companies

   $ 27,552,318      $ —        $ —        $ 27,552,318  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total assets

   $ 27,552,318      $ —        $ —        $ 27,552,318  
  

 

 

    

 

 

    

 

 

    

 

 

 

Assets*

   Level 1          Level 2          Level 3      Total  

1st Lien/Senior Secured Debt

   $ —        $ —        $ 912,966,725      $ 912,966,725  

2nd Lien/Junior Secured Debt

     —          —          10,867,145        10,867,145  

Preferred Stock

     —          —          14,807,019        14,807,019  

Common Stock

     915,103        —          6,530,433        7,445,536  

Warrants

     8,065        —          1,112,346        1,120,411  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ 923,168      $ —        $ 946,283,668      $ 947,206,836  
  

 

 

    

 

 

    

 

 

    

 

 

 

Investments valued at NAV as a practical expedient#

              2,979,068  
           

 

 

 

Total assets#

            $ 950,185,904  
           

 

 

 

 

*

See consolidated schedule of investments for industry classifications.

#

Certain investments that are measured at fair value using NAV have not been categorized in the fair value hierarchy. The fair value amounts presented in the table are intended to permit reconciliation of the fair value hierarchy to the amount presented in the consolidated statements of assets and liabilities.

The following table summarizes the valuation of the Fund’s investments as of December 31, 2021:

 

Assets*

   Level 1          Level 2          Level 3      Total  

Cash Equivalents

           

Investment Companies

   $ 17,156,786      $ —        $ —        $ 17,156,786  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total assets

   $ 17,156,786      $ —        $ —        $ 17,156,786  
  

 

 

    

 

 

    

 

 

    

 

 

 

Assets*

   Level 1          Level 2          Level 3      Total  

1st Lien/Senior Secured Debt

   $ —        $ —        $ 859,412,243      $ 859,412,243  

2nd Lien/Junior Secured Debt

     —          —          10,677,299        10,677,299  

Preferred Stock

     —          —          12,563,914        12,563,914  

Common Stock

     1,220,199        —          4,695,735        5,915,934  

Warrants

     12,335        —          1,111,543        1,123,878  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ 1,232,534      $ —        $ 888,460,734      $ 889,693,268  
  

 

 

    

 

 

    

 

 

    

 

 

 

Investments valued at NAV as a practical expedient#

              2,887,725  
           

 

 

 

Total assets#

            $ 892,580,993  
           

 

 

 

 

*

See consolidated schedule of investments for industry classifications.

#

Certain investments that are measured at fair value using NAV have not been categorized in the fair value hierarchy. The fair value amounts presented in the table are intended to permit reconciliation of the fair value hierarchy to the amount presented in the consolidated statements of assets and liabilities.

 

40


Table of Contents

The following is a reconciliation of Level 3 assets for the three months ended March 31, 2022:

 

     1st Lien/Senior
Secured Debt
    2nd Lien/
Junior
Secured Debt
    Common
Stock
    Preferred
Stock
     Warrants     Total  

Balance as of December 31, 2021

   $ 859,412,243     $ 10,677,299     $ 4,695,735     $ 12,563,914      $ 1,111,543     $ 888,460,734  

Purchases (including PIK)

     85,935,069       220,045       1,854,602       811,437        —         88,821,153  

Sales and principal payments

     (29,784,473     —         (86,556     —          (170,890     (30,041,919

Realized Gain (Loss)

     649       —         —         —          170,890       171,539  

Net Amortization of Premium/Discount

     1,383,970       5,273       —         —          —         1,389,243  

Transfers In

     —         —         426,294       —          —         426,294  

Transfers Out

     —         —         (433,207     —          —         (433,207

Net Change in Unrealized Appreciation (Depreciation)

     (3,980,733     (35,472     73,565       1,431,668        803       (2,510,169
  

 

 

   

 

 

   

 

 

   

 

 

    

 

 

   

 

 

 

Balance as of March 31, 2022

   $ 912,966,725     $ 10,867,145     $ 6,530,433     $ 14,807,019      $ 1,112,346     $ 946,283,668  
  

 

 

   

 

 

   

 

 

   

 

 

    

 

 

   

 

 

 

Change in Unrealized Appreciation (Depreciation) for Investments Still Held

   $ (1,488,016   $ (35,472   $ 73,565     $ 1,431,668      $ 228,422     $ 210,167  

For the three months ended March 31, 2022, amounts of $426,294 of Common Stock were transferred into Level 3 from Investments valued at NAV as a practical expedient due to the decreased transparency of the price inputs used in the valuation of these positions. Further amounts of $433,207 of Common Stock were transferred out of Level 3 but into no other level; these positions are now valued using their net asset values as a practical expedient and therefore are excluded from levels 1, 2 or 3.

The following is a reconciliation of Level 3 assets for the year ended December 31, 2021:

 

     1st Lien/Senior
Secured Debt
    2nd Lien/
Junior
Secured Debt
    Common
Stock
    Preferred
Stock
    Warrants     Total  

Balance as of January 1, 2021

   $ 511,197,686     $ 11,396,369     $ 2,375,265     $ 7,495,949     $ 281,986     $ 532,747,255  

Purchases (including PIK)

     522,278,127       —         3,629,491       2,928,966       225,644       529,062,228  

Sales and principal payments

     (176,063,522     (837,931     (439,932     (837,355     —         (178,178,740

Realized Gain (Loss)

     (502,569     —         157,444       192,020       (615,168     (768,273

Net Amortization of Premium/Discount

     4,329,462       56,863       —         —         —         4,386,325  

Transfers In

     —         —         —         —         —         —    

Transfers Out

     (8,354,187     —         (735,350     —         (23,721     (9,113,258

Net Change in Unrealized Appreciation (Depreciation)

     6,527,246       61,998       (291,183     2,784,334       1,242,802       10,325,197  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Balance as of March 31, 2022

   $ 859,412,243     $ 10,677,299     $ 4,695,735     $ 12,563,914     $ 1,111,543     $ 888,460,734  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Change in Unrealized Appreciation (Depreciation) for Investments Still Held

   $ 5,536,736     $ 65,651     $ (324,409   $ 2,784,334     $ 639,140     $ 8,701,452  

For the year ended December 31, 2021, amounts of $8,354,187 of 1st Lien/Senior Secured Debt were transferred out of Level 3 to Level 2 due to the improved transparency of the price inputs used in the valuation of these positions. Amounts of $23,721 of Warrants were transferred out of Level 3 to Level 1 as readily observable prices are now available for these positions. Further amounts of $735,350 of Common Stock were transferred out of Level 3 but into no other level; these positions are now valued using their net asset values as a practical expedient and therefore are excluded from levels 1, 2 or 3. There were no transfers into Level 3.

The following tables present the ranges of significant unobservable inputs used to value the Fund’s Level 3 investments as of March 31, 2022 and December 31, 2021, respectively. These ranges represent the significant unobservable inputs that were used in the valuation of each type of investment. These inputs are not representative of the inputs that could have been used in the valuation of any one investment. Accordingly, the ranges of inputs presented below do not represent uncertainty in, or possible ranges of, fair value measurements of the Fund’s Level 3 investments.

 

     Fair Value
as of
March 31, 2022
    

Valuation

Techniques

  

Unobservable

Input

  

Range/Input
(Weighted
Average)(1)

  

Impact to
Valuation from

an Increase in
Input

Assets:

              

1st Lien/Senior Secured Debt

   $ 838,056,558     

Market Yield Analysis

  

Market Yield

  

5.8% - 16.2%

(8.1%)

   Decrease
     4,306,051      Market Approach    EBITDA Multiple    2.7x - 6.6x (3.5x)    Increase
     1,122,676      Liquidation Value    Asset Value    N/A    Increase
     69,481,440      Recent Purchase    Purchase Price    N/A    N/A

 

41


Table of Contents
     Fair Value
as of
March 31, 2022
    

Valuation

Techniques

  

Unobservable

Input

  

Range/Input
(Weighted
Average)(1)

  

Impact to
Valuation from

an Increase in
Input

2nd Lien/Junior Secured Debt

     10,867,145      Market Yield Analysis    Market Yield   

9.3% - 10.7%

(10.4%)

   Decrease

Common Stock

     4,111,898      Market Approach    EBITDA Multiple   

9.0x - 18.5x

(13.0x)

   Increase
     155,301      Market Approach    Revenue Multiple    36.1x    Increase
     408,583      Market Approach    Network Cashflow Multiple    35.0x    Increase
     1,854,651      Recent Purchase    Purchase Price    N/A    N/A

Preferred Stock

     5,029,004      Market Approach    EBITDA Multiple    2.7x - 9.5x (4.3x)    Increase
     7,232,685      Market Approach    Revenue Multiple   

4.5x - 18.1x

(11.8x)

   Increase
     1,737,384      Market Yield Analysis    Dividend Yield    13.1%    Increase
     807,946      Recent Purchase    Purchase Price    N/A    N/A

Warrants

     1,112,346      Market Approach    Revenue Multiple   

7.3x - 18.3x

(14.5x)

   Increase
  

 

 

             

Total Assets

   $ 946,283,668              

 

(1) 

Weighted averages are calculated based on fair value of investments.

 

     Fair Value
as of
December 31, 2021
    

Valuation

Techniques

  

Unobservable

Input

  

Range/Input
(Weighted
Average)(1)

  

Impact to
Valuation from

an Increase in
Input

Assets:

              

1st Lien/Senior Secured Debt

   $ 665,565,654      Market Yield Analysis    Market Yield   

4.7% - 14.6%

(7.7%)

   Decrease
     4,888,622      Market Approach    EBITDA Multiple    3.5x - 7.7x (4.7x)    Increase
     1,124,564      Liquidation Value    Asset Value    N/A    Increase
     187,833,403      Recent Purchase    Purchase Price    N/A    N/A

2nd Lien/Junior Secured Debt

     10,677,299      Market Yield Analysis    Market Yield   

8.5% - 10.2%

(9.7%)

   Decrease

Common Stock

     1,444,140      Market Approach    EBITDA Multiple   

8.0x - 16.0x

(13.1x)

   Increase
     163,472      Market Approach    Revenue Multiple    36.1x    Increase
     439,931      Market Approach    Network Cashflow Multiple    37.5x    Increase
     2,648,192      Recent Purchase    Purchase Price    N/A    N/A

Preferred Stock

     3,854,995      Market Approach    EBITDA Multiple    3.5x - 10.0x (5.2x)    Increase
     6,990,517      Market Approach    Revenue Multiple   

4.4x - 20.0x

(12.9x)

   Increase
     1,718,402      Market Yield Analysis    Dividend Yield    11.5%    Increase

Warrants

     1,103,948      Market Approach    Revenue Multiple   

1.9x - 18.0x

(10.3x)

   Increase
     7,595      Recent Purchase    Purchase Price    N/A    N/A
  

 

 

             

Total Assets

   $ 888,460,734              

 

(1) 

Weighted averages are calculated based on fair value of investments.

 

42


Table of Contents

Financial Instruments Disclosed, But Not Carried, At Fair Value

The following table presents the carrying value and fair value of the Fund’s financial liabilities disclosed, but not carried, at fair value as of March 31, 2022 and the level of each financial liability within the fair value hierarchy.

 

     Carrying
Value (1)
     Fair
Value
     Level 1      Level 2      Level 3  

Class A-1 Senior Secured Notes

   $ 177,866,208      $ 178,200,000      $ —        $ —        $ 178,200,000  

Class A-2A Senior Secured Notes

     24,953,165        25,000,000        —          —          25,000,000  

Class A-2B Senior Secured Notes

     9,910,693        9,950,000        —          —          9,950,000  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ 212,730,066      $ 213,150,000      $ —        $ —        $ 213,150,000  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

 

(1)

Carrying value is net of unamortized discount and debt issuance costs. Unamortized discount and debt issuance costs associated with the Notes totaled $20,661 and $399,273 as of March 31, 2022 and are reflected on the consolidated statements of assets and liabilities.

The following table presents the carrying value and fair value of the Fund’s financial liabilities disclosed, but not carried, at fair value as of December 31, 2021 and the level of each financial liability within the fair value hierarchy.

 

     Carrying
Value (1)
     Fair
Value
     Level 1      Level 2      Level 3  

Class A-1 Senior Secured Notes

   $ 177,636,864      $ 179,091,000      $ —        $ —        $ 179,091,000  

Class A-2A Senior Secured Notes

     24,920,997        25,500,000        —          —          25,500,000  

Class A-2B Senior Secured Notes

     9,896,743        10,298,250        —          —          10,298,250  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ 212,454,604      $ 214,889,250      $ —        $ —        $ 214,889,250  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

 

(1)

Carrying value is net of unamortized discount and debt issuance costs. Unamortized discount and debt issuance costs associated with the Notes totaled $21,813 and $673,583 as of December 31, 2021 and are reflected on the consolidated statements of assets and liabilities.

6. Commitments & Contingencies

Commitments

The Fund may enter into commitments to fund investments. As of March 31, 2022, the Adviser believed that the Fund had adequate financial resources to satisfy its unfunded commitments. The amounts associated with unfunded commitments to provide funds to portfolio companies are not recorded in the Fund’s consolidated statements of assets and liabilities. Since these commitments and the associated amounts may expire without being drawn upon, the total commitment amount does not necessarily represent a future cash requirement. The Fund had the following unfunded commitments by investment types as of March 31, 2022:

 

Investment

Type

  

Facility

Type

   Commitment
Expiration Date (1)
     Unfunded
Commitment (2)
     Fair
Value (3)
 

1st Lien/Senior Secured Debt

           

5 Bars, LLC

   Delayed Draw Term Loan      09/27/2022      $ 3,448,816      $ —    

5 Bars, LLC

   Revolver      09/27/2024        646,653        —    

AAH Topco, LLC

   Delayed Draw Term Loan      12/22/2023        7,191,076        (197,755

AAH Topco, LLC

   Revolver      12/22/2027        787,273        (13,777

Accelerate Resources Operating, LLC

   Revolver      02/24/2026        414,764        —    

Activ Software Holdings, LLC

   Revolver      05/04/2027        648,837        (3,244

AEG Holding Company, Inc.

   Revolver      11/20/2023        1,116,864        —    

Airwavz Solutions, Inc

   Delayed Draw Term Loan      03/31/2024        3,263,699        (32,637

Airwavz Solutions, Inc

   Revolver      03/31/2027        652,740        (11,423

American Physician Partners, LLC

   Revolver      07/21/2022        97,681        —    

AMI US Holdings, Inc.

   Revolver      04/01/2024        656,763        —    

Analogic Corporation

   Revolver      06/22/2023        61,111        (1,833

AOM Acquisition, LLC.

   Revolver      02/18/2027        1,218,605        (24,372

Arrowstream Acquisition Co., Inc.

   Delayed Draw Term Loan      08/17/2023        604,235        —    

Arrowstream Acquisition Co., Inc.

   Revolver      12/15/2025        386,309        —    

 

43


Table of Contents

Investment

Type

  

Facility

Type

   Commitment
Expiration Date (1)
     Unfunded
Commitment (2)
     Fair Value
(3)
 

Avant Communications, LLC

   Revolver      11/30/2026      $ 566,910      $ (9,921

Avetta, LLC

   Revolver      04/10/2024        494,396        (1,236

BAART Programs, Inc.

   Delayed Draw Term Loan      06/11/2023        3,190,661        (47,860

Banneker V Acquisition, Inc.

   Revolver      12/04/2025        259,300        —    

BEP Borrower Holdco, LLC

   Revolver      06/12/2024        429,435        —    

BEXP I OG, LLC

   Revolver      01/25/2027        254,434        (5,089

BEXP I OG, LLC

   Term Loan      01/03/2023        1,781,035        (35,621

Bridgepointe Technologies, LLC

   Delayed Draw Term Loan      12/31/2023        3,887,472        (38,875

Bridgepointe Technologies, LLC

   Delayed Draw Term Loan      06/30/2022        907,180        (13,608

Bridgepointe Technologies, LLC

   Revolver      12/31/2027        777,494        (15,550

Brightspot Buyer, Inc

   Revolver      11/16/2027        680,292        (11,905

BusinesSolver.com, Inc.

   Delayed Draw Term Loan      12/01/2023        1,986,913        (24,836

Captain D’s, Inc.

   Revolver      12/15/2023        195,053        —    

Choice Health At Home, LLC,

   Delayed Draw Term Loan      12/29/2026        2,308,549        (17,314

Coding Solutions Acquisition, Inc.

   Delayed Draw Term Loan      12/31/2022        2,443,965        —    

Coding Solutions Acquisition, Inc.

   Revolver      12/31/2025        46,552        —    

Community Based Care Acquisition, Inc.

   Delayed Draw Term Loan      09/16/2023        1,854,175        (4,636

Community Based Care Acquisition, Inc.

   Revolver      09/16/2027        388,716        (3,887

Community Brands Parentco, LLC

   Delayed Draw Term Loan      02/24/2024        834,415        (8,344

Community Brands Parentco, LLC

   Revolver      02/24/2028        417,208        (8,344

Coretelligent Intermediate LLC

   Delayed Draw Term Loan      10/21/2023        3,799,263        (9,498

Coretelligent Intermediate LLC

   Revolver      10/21/2027        1,266,421        (12,664

Cybergrants Holdings, LLC

   Delayed Draw Term Loan      09/08/2023        3,419,390        (25,645

Cybergrants Holdings, LLC

   Revolver      09/08/2027        345,525        (5,183

Datacor, Inc.

   Delayed Draw Term Loan      03/31/2024        2,545,283        (12,726

Datacor, Inc.

   Revolver      12/29/2025        643,849        (3,219

Degreed, Inc.

   Delayed Draw Term Loan      03/24/2023        1,391,394        (6,957

Degreed, Inc.

   Revolver      05/31/2025        417,813        (4,178

Delaware Valley Management Holdings, Inc.

   Delayed Draw Term Loan      09/18/2022        1,053,759        (126,451

Dillon Logistics, Inc.

   Revolver      12/11/2023        30,562        (23,190

Dispatch Track, LLC

   Revolver      03/25/2026        301,930        —    

EET Buyer, Inc.

   Revolver      11/08/2027        690,794        (15,543

Engage2Excel, Inc.

   Revolver      03/07/2023        70,582        (706

EnterpriseDB Corporation

   Revolver      06/22/2026        1,012,902        (7,597

EvolveIP, LLC

   Revolver      06/07/2025        510,182        (3,827

Exterro, Inc.

   Revolver      05/31/2024        247,500        —    

Faithlife, LLC

   Delayed Draw Term Loan      09/19/2022        1,328,991        —    

Faithlife, LLC

   Revolver      09/18/2025        279,053        —    

Fatbeam, LLC

   Delayed Draw Term Loan      02/22/2023        1,609,623        (64,385

Firstdigital Communications LLC

   Revolver      12/17/2026        1,586,726        (39,668

Foundation Risk Partners, Corp.

   Delayed Draw Term Loan      10/29/2023        384,278        (961

Foundation Risk Partners, Corp.

   Revolver      10/29/2027        1,038,062        (10,381

Freddy’s Frozen Custard, L.L.C

   Revolver      03/03/2027        412,270        —    

Galway Borrower, LLC

   Delayed Draw Term Loan      09/30/2023        516,484        (5,165

Galway Borrower, LLC

   Revolver      09/30/2027        270,410        (5,408

GHA Buyer, Inc.

   Revolver      06/24/2025        760,861        (5,706

Global Radar Holdings, LLC

   Revolver      12/31/2025        116,379        —    

GlobalWebIndex Inc.

   Delayed Draw Term Loan      12/30/2022        1,841,860        36,837  

Greenhouse Software, Inc.

   Revolver      03/01/2027        1,232,251        (9,242

GS AcquisitionCo, Inc.

   Delayed Draw Term Loan      11/02/2023        1,344,054        (13,441

GS AcquisitionCo, Inc.

   Revolver      05/22/2026        68,505        (1,370

Higginbotham Insurance Agency, Inc.

   Delayed Draw Term Loan      12/23/2023        2,935,369        —    

Honor HN Buyer, Inc

   Delayed Draw Term Loan      10/15/2023        1,087,739        (16,316

Honor HN Buyer, Inc

   Revolver      10/15/2027        304,093        (6,082

Iodine Software, LLC

   Revolver      05/19/2027        1,227,453        —    

Kaseya, Inc.

   Delayed Draw Term Loan      09/08/2023        286,272        —    

Kaseya, Inc.

   Revolver      05/02/2025        375,990        —    

Kindeva Drug Delivery L.P.

   Revolver      05/01/2025        150,313        (4,885

Krispy Krunchy Foods, L.L.C

   Revolver      11/17/2027        974,884        (19,498

Mathnasium LLC

   Revolver      11/15/2027        565,781        (11,315

 

44


Table of Contents

Investment

Type

  

Facility

Type

   Commitment
Expiration Date (1)
     Unfunded
Commitment (2)
     Fair
Value (3)
 

Mavenlink, Inc.

   Revolver      06/03/2027      $ 1,789,816      $ (35,796

MBS Holdings, Inc.

   Revolver      04/16/2027        974,169        —    

Medbridge Holdings, LLC

   Revolver      12/23/2026        917,485        —    

Medical Management Resource Group, LLC

   Delayed Draw Term Loan      09/30/2023        1,582,075        (19,776

Medical Management Resource Group, LLC

   Revolver      09/30/2026        316,415        (7,119

Medsuite Purchaser, LLC

   Delayed Draw Term Loan      06/22/2022        1,632,961        (16,330

Medsuite Purchaser, LLC

   Delayed Draw Term Loan      10/22/2023        7,144,203        (71,442

Medsuite Purchaser, LLC

   Revolver      10/22/2026        680,400        (6,804

Metametrics, Inc.

   Revolver      09/10/2025        651,183        (1,628

MMP Intermediate, LLC

   Revolver      02/15/2027        552,880        (11,058

Moon Buyer, Inc.

   Delayed Draw Term Loan      10/21/2022        4,538,792        —    

Moon Buyer, Inc.

   Revolver      04/21/2027        1,163,793        —    

MSM Acquisitions, Inc.

   Delayed Draw Term Loan      01/30/2023        3,163,475        —    

MSM Acquisitions, Inc.

   Revolver      12/09/2026        885,095        (4,425

MSP Global Holdings, Inc.

   Delayed Draw Term Loan      01/24/2024        1,208,470        (21,148

MSP Global Holdings, Inc.

   Revolver      01/24/2027        422,965        (7,402

Mykaarma Acquisition LLC

   Revolver      03/21/2028        593,215        (11,864

Navigate360, LLC

   Delayed Draw Term Loan      03/17/2024        1,812,705        (18,127

Navigate360, LLC

   Revolver      03/17/2027        604,235        (12,085

Netwrix Corporation And Concept Searching Inc.

   Revolver      09/30/2026        166,551        —    

NI Topco, Inc

   Revolver      12/28/2026        549,052        (10,981

OMH-HealthEdge Holdings, LLC

   Revolver      10/24/2024        458,721        (2,294

Pace Health Companies, LLC

   Revolver      08/02/2024        616,682        —    

PerimeterX, Inc.

   Delayed Draw Term Loan      07/01/2023        1,075,406        (16,131

PerimeterX, Inc.

   Delayed Draw Term Loan      05/23/2022        698,833        (10,482

PerimeterX, Inc.

   Revolver      11/22/2024        279,533        (4,193

Peter C. Foy & Associates Insurance Services, LLC

   Delayed Draw Term Loan      08/16/2023        5,089,086        (25,445

Pinnacle Dermatology Management, LLC

   Delayed Draw Term Loan      12/08/2023        1,536,273        (26,885

Pinnacle Dermatology Management, LLC

   Revolver      12/08/2026        399,431        (10,985

Pinnacle Treatment Centers, Inc.

   Revolver      12/31/2022        292,954        —    

Ranger Buyer, Inc.

   Revolver      11/18/2027        959,386        —    

Redwood Family Care Network, Inc.

   Delayed Draw Term Loan      12/18/2022        2,484,335        (31,054

Redwood Family Care Network, Inc.

   Revolver      06/18/2026        588,705        (7,359

Rep Tec Intermediate Holdings, Inc.

   Revolver      06/19/2025        789,253        (3,946

Salisbury House, LLC

   Revolver      08/30/2025        328,785        (8,220

Sauce Labs, Inc.

   Delayed Draw Term Loan      02/12/2023        1,922,732        (14,420

Sauce Labs, Inc.

   Revolver      08/16/2027        1,281,821        (22,432

SCA Buyer, LLC

   Revolver      01/20/2026        386,309        (1,932

SecureLink, Inc.

   Revolver      10/01/2025        439,523        4,395  

Single Digits, Inc.

   Revolver      12/21/2023        416,149        (11,444

Sirsi Corporation

   Revolver      03/15/2024        553,741        (2,769

SIS Purchaser, Inc.

   Revolver      10/15/2026        1,165,951        (14,574

Smartlinx Solutions, LLC

   Revolver      03/04/2026        363,639        (2,727

Smile Brands, Inc.

   Revolver      10/12/2025        245,542        (1,842

Spark DSO LLC

   Delayed Draw Term Loan      02/09/2023        1,842,933        (9,215

Spark DSO LLC

   Revolver      04/19/2026        1,105,760        (16,587

Stratus Networks, Inc.

   Delayed Draw Term Loan      12/15/2023        3,960,391        (69,307

Stratus Networks, Inc.

   Revolver      12/15/2027        620,461        (10,858

Streamsets, Inc.

   Revolver      11/25/2024        350,524        7,010  

SugarCRM, Inc.

   Revolver      07/31/2024        310,244        (3,102

Sundance Group Holdings, Inc

   Delayed Draw Term Loan      07/02/2023        3,547,253        (53,209

Sundance Group Holdings, Inc

   Revolver      07/02/2027        1,087,824        (19,037

Swiftpage, Inc.

   Revolver      06/13/2023        225,317        (5,633

Syntax Systems Ltd

   Delayed Draw Term Loan      10/29/2023        2,434,137        (24,342

Syntax Systems Ltd

   Revolver      10/29/2026        431,005        (4,310

TA/WEG Holdings, LLC

   Delayed Draw Term Loan      08/13/2022        2,405,226        (6,013

TA/WEG Holdings, LLC

   Revolver      10/04/2027        285,937        (715

TBG Food Acquisition Corp

   Delayed Draw Term Loan      12/25/2023        1,056,104        (18,482

TBG Food Acquisition Corp

   Revolver      12/25/2027        264,026        (4,620

 

45


Table of Contents

Investment

Type

  

Facility

Type

   Commitment
Expiration Date (1)
     Unfunded
Commitment (2)
     Fair
Value (3)
 

Telcor Buyer, Inc.

   Revolver      08/20/2027      $ 290,770      $ (4,362

Telesoft Holdings, LLC

   Revolver      12/16/2025        596,866        —    

The Center for Orthopedic and Research Excellence, Inc.

   Delayed Draw Term Loan      10/01/2023        1,253,068        (15,664

The Center for Orthopedic and Research Excellence, Inc.

   Delayed Draw Term Loan      03/31/2024        1,709,776        (17,098

The Center for Orthopedic and Research Excellence, Inc.

   Revolver      08/15/2025        276,213        (4,834

Thrive Buyer, Inc.

   Delayed Draw Term Loan      06/30/2023        2,102,670        (5,256

Thrive Buyer, Inc.

   Revolver      01/22/2027        1,109,722        (2,774

Towerco IV Holdings, LLC

   Delayed Draw Term Loan      10/23/2023        2,985,129        (37,314

TRGRP, Inc.

   Revolver      11/01/2023        333,333        —    

Ungerboeck Systems International, LLC

   Revolver      04/30/2027        161,196        —    

Valcourt Holdings II, LLC

   Delayed Draw Term Loan      01/07/2023        1,093,174        —    

Vardiman Black Holdings, LLC

   Delayed Draw Term Loan      03/18/2024        2,958,440        (14,792

Vectra AI, Inc.

   Delayed Draw Term Loan      03/18/2023        1,163,793        (32,004

Vectra AI, Inc.

   Revolver      03/18/2026        232,759        (6,401

Velocity Purchaser Corporation

   Revolver      12/01/2022        193,237        —    

Veracross LLC

   Delayed Draw Term Loan      12/28/2023        1,668,830        (16,688

Veracross LLC

   Revolver      12/28/2027        1,112,553        (22,251
        

 

 

    

 

 

 

Total

         $ 176,235,827      $ (1,855,019
        

 

 

    

 

 

 

The Fund had the following unfunded commitments by investment types as of December 31, 2021:

 

Investment

Type

  

Facility

Type

   Commitment
Expiration Date (1)
     Unfunded
Commitment (2)
     Fair
Value (3)
 

1st Lien/Senior Secured Debt

           

5 Bars, LLC

   Delayed Draw Term Loan      09/27/2022      $ 3,448,816      $ —    

5 Bars, LLC

   Revolver      09/27/2024        646,653        —    

AAH Topco, LLC

   Delayed Draw Term Loan      12/22/2023        8,108,576        (162,172

AAH Topco, LLC

   Revolver      12/22/2027        787,273        (7,873

Accelerate Resources Operating, LLC

   Revolver      02/24/2026        414,764        —    

Activ Software Holdings, LLC

   Revolver      05/04/2027        648,837        (3,244

AEG Holding Company, Inc.

   Revolver      11/20/2023        1,116,864        —    

Alphasense, Inc.

   Revolver      05/29/2024        872,355        (4,362

American Physician Partners, LLC

   Revolver      02/22/2022        97,681        —    

AMI US Holdings, Inc.

   Revolver      04/01/2024        656,763        —    

Analogic Corporation

   Revolver      06/22/2023        91,667        (2,979

Arrowstream Acquisition Co., Inc.

   Revolver      12/15/2025        386,309        (2,897

Avant Communications, LLC

   Revolver      11/30/2026        566,910        (11,338

Avetta, LLC

   Revolver      04/10/2024        494,396        (1,236

Banneker V Acquisition, Inc.

   Revolver      12/04/2025        259,300        —    

BEP Borrower Holdco, LLC

   Revolver      06/12/2024        429,435        —    

Bridgepointe Technologies, LLC

   Delayed Draw Term Loan      12/31/2023        3,887,472        (77,749

Bridgepointe Technologies, LLC

   Delayed Draw Term Loan      06/30/2022        2,779,542        (55,591

Bridgepointe Technologies, LLC

   Revolver      12/31/2027        777,494        (15,550

Brightspot Buyer, Inc

   Revolver      11/16/2027        680,292        (13,606

BusinesSolver.com, Inc.

   Delayed Draw Term Loan      12/01/2023        1,986,913        (19,869

Captain D’s, Inc.

   Revolver      12/15/2023        195,053        —    

Caregiver 2, Inc.

   Delayed Draw Term Loan      03/10/2023        270,904        (4,741

Choice Health At Home, LLC,

   Delayed Draw Term Loan      12/29/2026        2,308,549        (34,628

Coding Solutions Acquisition, Inc.

   Delayed Draw Term Loan      12/31/2022        2,443,965        (18,330

Coding Solutions Acquisition, Inc.

   Revolver      12/31/2025        46,552        (349

Community Based Care Acquisition, Inc.

   Delayed Draw Term Loan      09/16/2023        1,854,175        —    

Community Based Care Acquisition, Inc.

   Revolver      09/16/2027        388,716        (2,915

Coretelligent Intermediate LLC

   Delayed Draw Term Loan      10/21/2023        3,799,263        —    

Coretelligent Intermediate LLC

   Revolver      10/21/2027        1,266,421        (18,996

 

46


Table of Contents

Investment

Type

  

Facility

Type

   Commitment
Expiration Date (1)
     Unfunded
Commitment (2)
     Fair
Value (3)
 

Cybergrants Holdings, LLC

   Delayed Draw Term Loan      09/08/2023      $ 1,151,751      $ (11,518

Cybergrants Holdings, LLC

   Revolver      09/08/2027        1,151,751        (11,518

Datacor, Inc.

   Delayed Draw Term Loan      10/26/2023        2,545,283        —    

Datacor, Inc.

   Revolver      12/20/2025        643,849        (3,219

Degreed, Inc.

   Delayed Draw Term Loan      03/24/2023        1,391,394        (3,478

Degreed, Inc.

   Revolver      05/31/2025        417,813        (3,134

Delaware Valley Management Holdings, Inc.

   Delayed Draw Term Loan      09/18/2022        1,053,759        (121,182

Dillon Logistics, Inc.

   Revolver      12/11/2023        30,562        (23,089

Dispatch Track, LLC

   Revolver      12/17/2026        301,930        (755

EET Buyer, Inc.

   Revolver      11/08/2027        690,794        (13,816

Engage2Excel, Inc.

   Revolver      03/07/2023        9,423        (94

EnterpriseDB Corporation

   Revolver      06/22/2026        1,012,902        (2,532

EvolveIP, LLC

   Revolver      06/07/2025        510,182        (2,551

Exterro, Inc.

   Revolver      05/31/2024        247,500        —    

Faithlife, LLC

   Delayed Draw Term Loan      09/19/2022        1,328,991        —    

Faithlife, LLC

   Revolver      09/18/2025        279,053        —    

Fatbeam, LLC

   Delayed Draw Term Loan      02/22/2022        1,609,623        (64,385

Fatbeam, LLC

   Delayed Draw Term Loan      02/22/2023        1,609,623        (64,385

Fatbeam, LLC

   Revolver      02/22/2026        386,309        (15,452

Firstdigital Communications LLC

   Revolver      12/17/2026        1,586,726        (31,735

Foundation Risk Partners, Corp.

   Delayed Draw Term Loan      10/29/2023        915,937        (6,870

Foundation Risk Partners, Corp.

   Revolver      10/29/2027        1,038,062        (12,976

Freddy’s Frozen Custard, L.L.C

   Revolver      03/03/2027        412,270        —    

Fuze, Inc.

   Revolver      09/20/2024        1,111,471        29,436  

Galway Borrower, LLC

   Delayed Draw Term Loan      09/30/2023        567,862        (5,679

Galway Borrower, LLC

   Revolver      09/30/2027        270,410        (5,408

GHA Buyer, Inc.

   Revolver      06/24/2025        634,051        —    

Global Radar Holdings, LLC

   Revolver      12/31/2025        116,379        —    

GlobalWebIndex Inc.

   Delayed Draw Term Loan      12/30/2024        1,841,860        (64,465

Greenhouse Software, Inc.

   Revolver      03/01/2027        1,232,251        (6,161

GS AcquisitionCo, Inc.

   Delayed Draw Term Loan      11/02/2022        1,344,054        —    

GS AcquisitionCo, Inc.

   Revolver      05/22/2026        239,766        (1,199

Higginbotham Insurance Agency, Inc.

   Delayed Draw Term Loan      12/23/2023        2,935,369        (16,438

Honor HN Buyer, Inc

   Delayed Draw Term Loan      10/15/2023        1,659,616        (16,596

Honor HN Buyer, Inc

   Revolver      10/15/2027        304,093        (6,082

Iodine Software, LLC

   Revolver      05/19/2027        1,227,453        —    

Kaseya, Inc.

   Delayed Draw Term Loan      09/08/2023        345,912        —    

Kaseya, Inc.

   Revolver      05/02/2025        375,990        —    

Kindeva Drug Delivery L.P.

   Revolver      05/01/2025        757,349        (24,614

Krispy Krunchy Foods, L.L.C

   Revolver      11/17/2027        974,884        (19,498

Mathnasium LLC

   Revolver      11/15/2027        565,781        (11,315

Mavenlink, Inc

   Revolver      06/03/2027        1,789,816        (35,796

MBS Holdings, Inc.

   Revolver      04/16/2027        974,169        (4,871

Medbridge Holdings, LLC

   Revolver      12/23/2026        917,485        —    

Medical Management Resource Group, LLC

   Delayed Draw Term Loan      09/30/2023        1,582,075        (11,866

Medical Management Resource Group, LLC

   Revolver      09/30/2026        316,415        (5,537

MedMark Services, Inc.

   Delayed Draw Term Loan      06/11/2023        4,853,121        (48,531

Metametrics, Inc.

   Revolver      09/10/2025        390,710        —    

Millin Purchaser LLC

   Delayed Draw Term Loan      02/22/2022        1,632,961        (12,247

Millin Purchaser LLC

   Delayed Draw Term Loan      10/22/2023        7,144,203        (53,582

Millin Purchaser LLC

   Revolver      10/22/2026        680,400        (10,206

Moon Buyer, Inc.

   Delayed Draw Term Loan      10/21/2022        4,538,792        —    

Moon Buyer, Inc.

   Revolver      04/21/2027        1,163,793        —    

MSM Acquisitions, Inc.

   Delayed Draw Term Loan      01/30/2023        3,199,307        —    

MSM Acquisitions, Inc.

   Revolver      12/09/2026        1,111,729        (5,559

 

47


Table of Contents

Investment

Type

  

Facility

Type

   Commitment
Expiration Date (1)
     Unfunded
Commitment (2)
     Fair
Value (3)
 

Netwrix Corporation And Concept Searching Inc.

   Delayed Draw Term Loan      03/23/2022      $ 1,103,804      $ —    

Netwrix Corporation And Concept Searching Inc.

   Revolver      09/30/2026        166,551        —    

NI Topco, Inc

   Revolver      12/28/2026        549,052        (12,354

OMH-HealthEdge Holdings, LLC

   Revolver      10/24/2024        458,721        (2,294

Pace Health Companies, LLC

   Revolver      08/02/2024        616,682        —    

PerimeterX, Inc.

   Delayed Draw Term Loan      07/01/2023        1,075,406        (10,754

PerimeterX, Inc.

   Delayed Draw Term Loan      05/23/2022        698,833        (6,988

PerimeterX, Inc.

   Revolver      11/22/2024        279,533        (2,795

Pinnacle Dermatology Management, LLC

   Delayed Draw Term Loan      12/08/2023        1,536,273        (38,407

Pinnacle Dermatology Management, LLC

   Revolver      12/08/2026        537,696        (6,721

Pinnacle Treatment Centers, Inc.

   Delayed Draw Term Loan      01/17/2022        234,363        —    

Pinnacle Treatment Centers, Inc.

   Revolver      12/31/2022        292,954        —    

Ranger Buyer Inc

   Revolver      11/18/2027        959,386        (19,188

Redwood Family Care Network, Inc.

   Delayed Draw Term Loan      12/18/2022        2,484,335        (6,211

Redwood Family Care Network, Inc.

   Revolver      06/18/2026        588,705        (1,472

Rep Tec Intermediate Holdings, Inc.

   Revolver      12/01/2027        789,253        —    

Salisbury House, LLC

   Revolver      08/30/2025        448,343        (6,725

Saturn Borrower Inc

   Delayed Draw Term Loan      12/15/2023        3,960,391        (79,208

Saturn Borrower Inc

   Revolver      12/15/2027        745,874        (14,918

Sauce Labs, Inc.

   Delayed Draw Term Loan      02/12/2023        1,922,732        (24,034

Sauce Labs, Inc.

   Revolver      08/16/2027        1,281,821        (19,227

SCA Buyer, LLC

   Revolver      01/20/2026        386,309        (966

SecureLink, Inc.

   Revolver      10/01/2025        439,523        —    

Single Digits, Inc.

   Revolver      12/21/2023        416,149        (4,161

Sirsi Corporation

   Revolver      03/15/2024        553,741        (1,384

SIS Purchaser, Inc.

   Revolver      10/15/2026        1,165,951        —    

Smartlinx Solutions, LLC

   Revolver      03/04/2026        519,484        (2,597

Smile Brands, Inc.

   Revolver      10/12/2025        240,909        (2,409

Streamsets, Inc.

   Revolver      11/25/2024        350,524        (12,268

SugarCRM, Inc.

   Revolver      07/31/2024        310,244        —    

Sundance Group Holdings, Inc

   Delayed Draw Term Loan      07/02/2023        3,547,253        (26,604

Sundance Group Holdings, Inc

   Revolver      07/02/2027        993,231        (14,898

Swiftpage, Inc.

   Revolver      06/13/2023        225,317        (1,690

Syntax Systems Ltd

   Revolver      10/29/2026        547,843        (5,479

Syntax Systems Ltd

   Delayed Draw Term Loan      10/29/2023        2,434,137        (24,341

TA/WEG Holdings, LLC

   Delayed Draw Term Loan      08/13/2022        2,962,646        —    

TA/WEG Holdings, LLC

   Revolver      10/04/2027        233,655        —    

TBG Food Acquisition Corp

   Delayed Draw Term Loan      12/25/2023        1,056,104        (10,561

TBG Food Acquisition Corp

   Revolver      12/25/2027        264,026        (2,640

Telcor Buyer, Inc.

   Revolver      08/20/2027        290,770        (2,181

Telesoft Holdings, LLC

   Revolver      12/16/2025        596,866        (2,984

The Center for Orthopedic and Research Excellence, Inc.

   Delayed Draw Term Loan      10/01/2023        1,441,028        (3,603

The Center for Orthopedic and Research Excellence, Inc.

   Revolver      08/15/2025        379,793        (1,899

Thrive Buyer, Inc

   Revolver      01/22/2027        1,109,722        (2,774

Thrive Buyer, Inc.

   Delayed Draw Term Loan      12/30/2023        3,625,292        (9,063

Towerco IV Holdings, LLC

   Delayed Draw Term Loan      10/23/2023        3,383,145        (33,831

TRGRP, Inc.

   Revolver      11/01/2023        333,333        —    

Ungerboeck Systems International, LLC

   Revolver      04/30/2027        161,196        —    

Valcourt Holdings II, LLC

   Delayed Draw Term Loan      01/07/2023        1,093,174        —    

Vectra AI, Inc.

   Delayed Draw Term Loan      03/18/2023        2,327,586        (58,190

Vectra AI, Inc.

   Revolver      03/18/2026        232,759        (5,819

Velocity Purchaser Corporation

   Revolver      12/01/2022        193,237        —    

Veracross LLC,

   Delayed Draw Term Loan      12/28/2023        1,668,830        (16,688

 

48


Table of Contents

Investment

Type

  

Facility

Type

   Commitment
Expiration Date (1)
     Unfunded
Commitment (2)
     Fair
Value (3)
 

Veracross LLC,

   Revolver      12/28/2027      $ 1,112,554      $ (22,251
        

 

 

    

 

 

 

Total

         $ 164,163,963      $ (1,707,905
        

 

 

    

 

 

 

 

(1)

Commitments are generally subject to borrowers meeting certain criteria such as compliance with covenants and certain operational metrics. These amounts may remain outstanding until the commitment period of an applicable loan expires, which may be shorter than its maturity.

(2)

Net of capitalized fees, expenses and original issue discount (“OID”).

(3)

A negative fair value was reflected as investments, at fair value in the consolidated statements of assets and liabilities. The negative fair value is the result of the capitalized discount on the loan.

Contingencies

In the normal course of business, the Fund enters into contracts that provide a variety of general indemnifications. Any exposure to the Fund under these arrangements could involve future claims that may be made against the Fund. Currently, no such claims exist or are expected to arise and, accordingly, the Fund has not accrued any liability in connection with such indemnifications.

7. Net Assets

Equity Issuance

In connection with its formation, the Fund has the authority to issue 200,000,000 Shares.

On September 29, 2017, the Fund completed its Initial Closing after entering into Subscription Agreements with several investors, including the Adviser, providing for the private placement of Shares. Under the terms of the Subscription Agreements, investors are required to fund drawdowns to purchase Shares up to the amount of their respective Capital Commitments on an as-needed basis upon the issuance of a capital draw-down notice. At March 31, 2022 the Fund had total Capital Commitments of $515,060,614, of which 25% is unfunded. At December 31, 2021, the Fund had total Capital Commitments of $471,572,464, of which 25% was unfunded. The minimum Capital Commitment of an investor is $50,000. The Adviser, however, may waive the minimum Capital Commitment at its discretion.

Capital Commitments may be drawn down by the Fund on a pro rata basis, as needed (including for follow-on investments), for paying the Fund’s expenses, including fees under the Amended and Restated Advisory Agreement, and/or maintaining a reserve account for the payment of future expenses or liabilities.

The following table summarizes the total Shares issued and amount received related to capital drawdowns delivered pursuant to the Subscription Agreements during the three months ended March 31, 2022 and March 31, 2021:

 

     For the three months ended
March 31, 2022
     For the three months ended
March 31, 2021
 

Quarter Ended

   Shares      Amount      Shares      Amount  

March 31

     3,095,246      $ 30,684,000        4,001,981      $ 37,708,999  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total capital drawdowns

     3,095,246      $ 30,684,000        4,001,981      $ 37,708,999  
  

 

 

    

 

 

    

 

 

    

 

 

 

Distributions

The following tables reflect the distributions declared on Shares during the three months ended March 31, 2022 and March 31, 2021:

 

Date Declared

 

Record Date

 

Payment Date

 

Amount Per Share

 

Dollar Amount

3/29/2022

  3/29/2022   4/28/2022   $0.25   $9,709,845
       

 

        $9,709,845
       

 

 

Date Declared

 

Record Date

 

Payment Date

 

Amount Per Share

 

Dollar Amount

3/29/2021

  3/29/2021   4/28/2021   $0.16   $4,358,022
       

 

        $4,358,022
       

 

 

49


Table of Contents

Dividend Reinvestment Plan

On September 26, 2017, the Fund adopted a dividend reinvestment plan, which was amended and restated on November 11, 2021 (the “DRIP”). Pursuant to the DRIP (both before and after it was amended), stockholders receive dividends or other distributions in cash unless a stockholder elects to reinvest his or her dividends and other distributions. As a result of adopting the DRIP, if the Board authorizes, and the Fund declares, a cash dividend or distribution, stockholders who have opted into the DRIP will have their cash dividends or distributions automatically reinvested in additional Shares, rather than receiving cash.

The following tables summarize Shares distributed pursuant to the DRIP during the three months ended March 31, 2022 and March 31, 2021 to stockholders who opted into the DRIP:

 

Date Declared

 

Record Date

 

Reinvestment Date

 

Shares

 

Dollar Amount

3/29/2022

  3/29/2022   3/31/2022   526,163   $5,101,704
     

 

 

 

      526,163   $5,101,704
     

 

 

 

 

Date Declared

 

Record Date

 

Reinvestment Date

 

Shares

 

Dollar Amount

3/29/2021

  3/29/2021   3/31/2021   229,904   $2,167,568
     

 

 

 

      229,904   $2,167,568
     

 

 

 

General Tender Program

Beginning with the quarter ended March 31, 2021, the Fund began to conduct quarterly general tender offers (each, a “General Tender,” and collectively, the “General Tender Program”), at the Board’s discretion, in accordance with the requirements of Rule 13e-4 under the Exchange Act and the 1940 Act, to allow each of its stockholders to tender Shares at a specific per Share price (the “Purchase Price”) based on the Fund’s net asset value as of the last date of the quarter in which the General Tender is conducted. The Fund intends to conduct each General Tender to repurchase up to a certain percentage of the weighted average of the number of Shares outstanding during the three-month period prior to the quarter in which the General Tender is conducted. The General Tender Program includes numerous restrictions that limit stockholders’ ability to sell their Shares.

On February 25, 2022, the Fund commenced a General Tender (the “Q1 2022 Tender Offer”) for up to 795,163.70 Shares (the “Q1 2022 Tender Offer Cap”) tendered prior to March 31, 2022. Stockholders who tendered Shares in the Q1 2022 Tender Offer received, at the expiration of the Q1 2022 Tender Offer, a non-interest bearing, non-transferable promissory note entitling such stockholders to an amount in cash equal to the number of Shares accepted for purchase multiplied by the Purchase Price. The Purchase Price for the Q1 2022 Tender Offer was $9.70 per Share and the Q1 2022 Tender Offer expired on March 31, 2022.

On February 26, 2021, the Fund commenced a General Tender (the “Q1 2021 Tender Offer”) for up to 502,190.45 Shares (the “Q1 2021 Tender Offer Cap”) tendered prior to March 31, 2021 (the “Initial Expiration Date”). As a result of the number of Shares tendered to the Fund prior to the Initial Expiration Date, the Fund extended the Q1 2021 Tender Offer and increased the Q1 2021 Tender Offer Cap to 2,083,220 Shares. Stockholders who tendered Shares in the Q1 2021 Tender Offer received, at the expiration of the Q1 2021 Tender Offer, a non-interest bearing, non-transferable promissory note entitling such stockholders to an amount in cash equal to the number of Shares accepted for purchase multiplied by the Purchase Price. The Purchase Price for the Q1 2021 Tender Offer was $9.43 per Share and the Q1 2021 Tender Offer expired on April 16, 2021.

The following table summarizes Shares purchased during the three months ended March 31, 2022:

 

Quarter Ended

   Payment Date      Shares      Dollar
Amount
 

March 31

     May 10, 2022        420,864      $ 4,081,370  

The following table summarizes Shares purchased during the three months ended March 31, 2021:

 

Quarter Ended

   Payment Date      Shares      Dollar
Amount
 

March 31

     May 6, 2021        1,173,288      $ 11,061,881  

 

50


Table of Contents

8. Earnings Per Share

The following information sets forth the computation of basic and diluted earnings per Share for the three months ended March 31, 2022 and March 31, 2021:

 

     For the three months ended
March 31,
 
     2022      2021  

Net increase (decrease) in net assets from operations

   $ 5,511,700      $ 6,171,513  

Weighted average common shares outstanding

     36,411,259        26,432,156  

Earnings per common share-basic and diluted

   $ 0.15      $ 0.23  

9. Financial Highlights

Below is the schedule of financial highlights of the Fund for the three months ended March 31, 2022 and March 31, 2021:

 

     For the three months
ended
March 31, 2022
    For the three months
ended
March 31, 2021
 

Per Share Data:(1)(2)

 

Net asset value, beginning of period

   $ 9.80     $ 9.35  

Net investment income (loss)

     0.23       0.16  

Net realized and unrealized gains (losses) on investments

     (0.08     0.08  
  

 

 

   

 

 

 

Net increase (decrease) in net assets resulting from operations

     0.15       0.24  
  

 

 

   

 

 

 

Distributions to stockholders(3)

     (0.25     (0.16
  

 

 

   

 

 

 

Net asset value, end of period

   $ 9.70     $ 9.43  

Shares outstanding, end of period

     38,544,494       26,833,819  

Total return at net asset value before incentive
fees(4)(5)

     1.95     2.73

Total return at net asset value after incentive fees(4)(5)

     1.57     2.49

Ratio/Supplemental Data:(2)

 

Net assets, end of period

   $ 373,766,108     $ 252,987,809  

Ratio of total expenses to weighted average net assets(6)

     11.81     10.11

Ratio of net expenses to weighted average net
assets(6)(7)

     11.17     9.30

Ratio of net investment income (loss) before waivers to weighted average net assets(6)

     10.37     8.42

Ratio of net investment income (loss) after waivers to weighted average net assets(6)(7)

     11.01     9.23

Ratio of interest and credit facility expenses to weighted average net assets(6)

     5.79     4.45

Ratio of incentive fees to weighted average net assets(5)

     0.38     0.27

Portfolio turnover rate(5)

     3.26     4.23

Asset coverage ratio(8)

     160     170

 

(1)

The per share data was derived by using the weighted average shares outstanding during the applicable period.

(2)

Ratios calculated with Net Assets excluding the Non-Controlling Interest.

(3)

The per share data for distributions is the actual amount of distributions paid or payable per share of common stock outstanding during the entire period.

(4)

Total return based on NAV is calculated as the change in NAV per share during the respective periods, assuming dividends and distributions, if any, are reinvested in accordance with the Fund’s dividend reinvestment plan.

(5)

Not annualized.

(6)

Annualized, except for professional fees, directors’ fees and incentive fees.

(7)

For the three months ended March 31, 2022 and March 31, 2021, the Adviser voluntarily waived collateral management fees. Additionally, the Adviser received reimbursement payments from the Fund as per the Expense Support and Conditional Reimbursement Agreement. The ratios include the effects of the voluntary waived expenses of 0.51% and 1.09% for the three months ended March 31, 2022 and March 31, 2021, respectively.

(8)

Asset coverage ratio is equal to (i) the sum of (A) net assets at end of period and (B) debt outstanding at end of period, divided by (ii) total debt outstanding at the end of the period.

 

51


Table of Contents

10. Subsequent Events

Subsequent events after the consolidated statements of assets and liabilities date have been evaluated through the date the consolidated financial statements were issued. The Fund has concluded that there are no events requiring adjustment or disclosure in the consolidated financial statements other than below.

The CLO VI indenture was refinanced under terms of the first supplemental indenture dated April 28, 2022 among the Issuer and U.S. Bank National Association, as trustee. As a result of the refinancing, the outstanding notes under the indenture dated August 9, 2019 in the amount of $300,500,000 were paid off. The Issuer issued new notes as listed below, and collectively, the “CLO VI Notes”.

 

Note

  

Type

   Principal
Amount
     Interest
Rate

Class A-1-R

   Senior Secured Floating Rate    $  98,250,000      S + 1.83%

Class A-1-L

   Senior Secured Floating Rate    $  75,000,000      S + 1.83%

Class A-1-F

   Senior Secured Fixed Rate    $  30,000,000      4.305%

Class A-2-R

   Senior Secured Deferrable Floating Rate    $  43,500,000      S + 2.25%

Class B-R

   Senior Secured Deferrable Floating Rate    $  19,250,000      S + 3.10%

Class C-R

   Senior Secured Deferrable Floating Rate    $  20,125,000      S + 4.15%

Subordinated Notes

      $  61,320,000      N/A
     

 

 

    
      $ 347,445,000     

The CLO VI indenture provides that the holders of the CLO VI Notes are to receive quarterly interest payments, in arrears, on the 27th day in January, April, July and October of each year, commencing in July 2022. The CLO VI Notes will mature on April 27, 2034.

On April 21, 2022, the Fund called capital of $39,550,987 from its investors due May 2, 2022.

 

52


Table of Contents
Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

Forward-Looking Statements

This Quarterly Report on Form 10-Q (this “Quarterly Report”) contains forward-looking statements that involve substantial risks and uncertainties. Such statements involve known and unknown risks, uncertainties and other factors, and undue reliance should not be placed thereon. These forward-looking statements are not historical facts, but rather are based on current expectations, estimates and projections about the Fund, its current and prospective portfolio investments, its industry, its beliefs and opinions, and its assumptions. Words such as “anticipates,” “expects,” “intends,” “plans,” “will,” “may,” “continue,” “believes,” “seeks,” “estimates,” “would,” “could,” “should,” “targets,” “projects,” “outlook,” “potential,” “predicts” and variations of these words and similar expressions are intended to identify forward-looking statements. These statements are not guarantees of future performance and are subject to risks, uncertainties and other factors, some of which are beyond the Fund’s control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements, including without limitation:

 

   

an economic downturn could impair the Fund’s portfolio companies’ ability to continue to operate, which could lead to the loss of some or all of the Fund’s investments in such portfolio companies;

 

   

such an economic downturn could disproportionately impact the companies that the Fund intends to target for investment, potentially causing the Fund to experience a decrease in investment opportunities and diminished demand for capital from these companies;

 

   

pandemics or other serious public health events, such as the global outbreak of a novel strain of the coronavirus, commonly known as “COVID-19”;

 

   

a contraction of available credit and/or an inability to access the equity markets could impair the Fund’s lending and investment activities;

 

   

interest rate volatility could adversely affect the Fund’s results, particularly if the Fund elects to use leverage as part of its investment strategy;

 

   

the Fund’s future operating results;

 

   

the Fund’s business prospects and the prospects of the Fund’s portfolio companies;

 

   

the Fund’s contractual arrangements and relationships with third parties;

 

   

the ability of the Fund’s portfolio companies to achieve their objectives;

 

   

competition with other entities and the Fund’s affiliates for investment opportunities;

 

   

the speculative and illiquid nature of the Fund’s investments;

 

   

the use of borrowed money to finance a portion of the Fund’s investments;

 

   

the adequacy of the Fund’s financing sources and working capital;

 

   

the loss of key personnel;

 

   

the timing of cash flows, if any, from the operations of the Fund’s portfolio companies;

 

   

the ability of the Adviser to locate suitable investments for the Fund and to monitor and administer the Fund’s investments;

 

   

the ability of the Adviser to attract and retain highly talented professionals;

 

   

the Fund’s ability to qualify and maintain its qualification as a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”), and as a business development company (“BDC”);

 

   

the effect of legal, tax and regulatory changes; and

 

   

the other risks, uncertainties and other factors the Fund identifies under “Risk Factors” of its Annual Report on Form 10-K for the fiscal year ended December 31, 2021.

Although the Fund believes that the assumptions on which these forward-looking statements are based are reasonable, any of those assumptions could prove to be inaccurate, and as a result, the forward-looking statements based on those assumptions also could be inaccurate. In light of these and other uncertainties, the inclusion of a projection or forward-looking statement in this report should not be regarded as a representation by the Fund that the Fund’s plans and objectives will be achieved. These risks and uncertainties include those described or identified in the section entitled “Item 1A. Risk Factors” of the Annual Report on Form 10-K for the fiscal year ended December 31, 2021, and elsewhere in this report. These forward-looking statements apply only as of the date of this report. Moreover, the Fund assumes no duty and does not undertake to update the forward-looking statements. The forward-looking

 

53


Table of Contents

statements and projections contained in this Quarterly Report are excluded from the safe harbor protection provided by Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) because the Fund is an investment company.

The following analysis of the Fund’s financial condition and results of operations should be read in conjunction with the Fund’s financial statements and the related notes thereto contained elsewhere in this Quarterly Report.

Overview

The Fund was formed on February 6, 2015 as a corporation under the laws of the State of Maryland. The Fund is structured as an externally managed, non-diversified, closed-end management investment company. The Fund was formed to invest primarily in primary-issue middle-market credit opportunities that are directly sourced and privately negotiated. The Fund commenced investment operations on November 15, 2017 (“Commencement”). The Fund is advised by AB Private Credit Investors LLC (the “Adviser”), which is registered with the Securities and Exchange Commission (“SEC”) under the Investment Advisers Act of 1940, as amended (the “Advisers Act”). The Adviser is responsible for sourcing potential investments, conducting due diligence on prospective investments, analyzing investment opportunities, structuring investments and monitoring the Fund’s portfolio on an ongoing basis. State Street Bank and Trust Company (the “Administrator”) provides the administrative services necessary for the Fund to operate.

The Fund has elected to be treated as a BDC under the 1940 Act. The Fund has also elected to be treated and intends to qualify annually as a RIC under Subchapter M of the Code for U.S. federal income tax purposes. As a BDC and a RIC, respectively, the Fund is and will be required to comply with various regulatory requirements, such as the requirement to invest at least 70% of its assets in “qualifying assets,” source of income limitations, asset diversification requirements, and the requirement to distribute annually at least 90% of its taxable income and tax exempt interest.

The Fund is an “emerging growth company,” as defined in the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”). The Fund will remain an emerging growth company for up to five years following its initial public offering, if any, although if the market value of its common stock that is held by non-affiliates exceeds $700 million as of any June 30 before that time, the Fund would cease to be an emerging growth company as of the following December 31. For so long as the Fund remains an emerging growth company under the JOBS Act, it will be subject to reduced public company reporting requirements.

Effects of COVID-19 on the Fund’s Results of Operations

The rapid spread of COVID-19, a novel strain of coronavirus causing respiratory illness (“COVID-19”) resulted in temporary closures of many corporate offices, retail stores, and manufacturing facilities and factories around the world beginning in late 2019. The COVID-19 pandemic since has had a significant impact on the global economy as the follow-on effects of positive case counts and subsequent, mandated quarantine periods interrupted or slowed supply chains worldwide among other consequences. Businesses largely have reopened aided by the continued administration of vaccines, ‘herd immunity’ and individuals’ increasing comfort with living with the risk of the illness. The ultimate extent of the impact of the COVID-19 outbreak on the global economy and the financial performance of the Fund’s current and future investments will continue to depend on future developments, including the duration and spread of the virus, any related advisories and restrictions, and secondary impacts of the business disruptions, all of which are highly uncertain and cannot be predicted. Adverse impacts on the Fund’s investments may have a material adverse impact on the Fund’s future net investment income, the fair value of the Fund’s portfolio investments, the Fund’s financial condition and results of operations and the financial condition of the Fund’s portfolio companies.

As of March 31, 2022, the Fund was in compliance with its asset coverage requirements under the 1940 Act. In addition, the Fund was not in default of any of the covenants under the Revolving Credit Facilities as of March 31, 2022. However, any increase in unrealized depreciation of the Fund’s investment portfolio or further significant reductions in the Fund’s net asset value as a result of the effects of the COVID-19 pandemic or otherwise may increase the risk of breaching the relevant covenants and requirements.

The Fund will continue to monitor the rapidly evolving situation surrounding the COVID-19 pandemic and guidance from U.S. and international authorities, including federal, state and local public health authorities, and may take additional actions based on their recommendations. Given the dynamic nature of this situation, the Fund cannot reasonably estimate the impact of COVID-19 on its financial condition, results of operations or cash flows in the future.

The Private Offering

The Fund enters into separate subscription agreements with investors providing for the private placement of its common stock (the “Shares”) in reliance on exemptions from the registration requirements of the Securities. Each investor makes a Capital Commitment to purchase Shares pursuant to a subscription agreement. Investors are required to make capital contributions to purchase Shares each time the Fund delivers a capital call notice, which is issued based on the Fund’s anticipated investment activities and capital needs, delivered at least 10 business days prior to the required funding date, provided that investors may fund such

 

54


Table of Contents

requirements sooner than the deadline as agreed between the Fund and the investor. Generally, purchases of the Fund’s Shares are made pro rata in accordance with each investor’s Capital Commitment, in an amount not to exceed each investor’s remaining capital commitment (“Remaining Commitment”), at a per-Share price equal to the net asset value per share of the Fund’s common stock subject to any adjustments. Pursuant to the Private Offering, the Fund’s initial closing occurred on September 29, 2017.

The Fund may accept additional Capital Commitments quarterly (“Subsequent Closings”) from new investors as well as existing investors that wish to increase their commitment and shareholding in the Fund. These Subsequent Closings are expected to occur on a calendar-quarter end based on investor interest as well as the state of the market and the Fund’s capacity to invest the additional capital in a reasonable period. Each Capital Commitment is for the life of the Fund or for a shorter period based on the investor’s liquidation election, subject to the Fund’s receipt of exemptive relief that would permit stockholders to liquidate their investments pursuant to transactions that are currently prohibited by the 1940 Act and would require an SEC order in order to be established.

Revenues

The Fund’s investment objective is to generate current income and prioritize capital preservation through a portfolio that primarily invests in directly-sourced, privately-negotiated, secured, middle market loans. The Fund intends to primarily invest in middle market businesses based in the United States. The Fund expects that the primary use of proceeds by the companies in which the Fund invests will be for leveraged buyouts, recapitalizations, mergers and acquisitions and growth capital.

The Fund will seek to build its portfolio in a defensive manner that minimizes cyclical and correlated risks across individual names and sector verticals by targeting companies with strong underlying business models and durable intrinsic value.

The Fund will primarily hold secured loans, which encompass traditional first lien, unitranche and second lien loans, but may also invest in mezzanine, structured preferred stock and non-control equity co-investment opportunities. The Fund will seek to deliver attractive risk adjusted returns with lower volatility and low correlation relative to the public credit markets. The Adviser believes the Fund’s flexibility to invest across the capital structure and liquidity spectrum will allow the Fund to optimize investor risk-adjusted returns.

Expenses

Under the Amended and Restated Advisory Agreement, the Fund’s primary operating expenses will include the payment of fees to the Adviser, the Fund’s allocable portion of overhead expenses under the Expense Reimbursement Agreement and other operating costs described below. The Fund bears all other out-of-pocket costs and expenses of the Fund’s operations and transactions, including those relating to:

 

   

reasonable and documented organization and offering expenses to the extent reimbursement of such expenses is included in any future agreement with the Adviser;

 

   

calculating the Fund’s net asset value (including the cost and expenses of any independent valuation firm);

 

   

fees and expenses payable to third parties, including agents, consultants or other advisers, in connection with monitoring financial (including advising with respect to the Fund’s financing strategy) and legal affairs for the Fund and in providing administrative services, monitoring the Fund’s investments and performing due diligence on the Fund’s prospective portfolio companies or otherwise relating to, or associated with, evaluating and making investments;

 

   

interest payable on debt, if any, incurred to finance the Fund’s investments;

 

   

sales and purchases of the Fund’s common stock and other securities;

 

   

base management fees and incentive fees payable to the Adviser;

 

   

transfer agent and custodial fees;

 

   

federal and state registration fees;

 

   

all costs of registration and listing the Fund’s securities on any securities exchange;

 

   

U.S. federal, state and local taxes;

 

   

independent directors’ fees and expenses;

 

   

costs of preparing and filing reports or other documents required by the SEC, the Financial Industry Regulatory Authority or other regulators;

 

   

costs of any reports, proxy statements or other notices to stockholders, including printing costs;

 

55


Table of Contents
   

the Fund’s allocable portion of any fidelity bond, directors’ and officers’ errors and omissions liability insurance, and any other insurance premiums;

 

   

direct costs and expenses of administration, including printing, mailing, long distance telephone, copying, secretarial and other staff, independent auditors and outside legal costs; and

 

   

all other expenses incurred by the Fund, the Administrator or the Adviser in connection with administering the Fund’s business, including payments under the Administration Agreement and payments under the Expense Reimbursement Agreement based on the Fund’s allocable portion of the Adviser’s overhead in performing its obligations under the Expense Reimbursement Agreement, including the allocable portion of the cost of the Fund’s Chief Compliance Officer and Chief Financial Officer and their respective staffs.

Effects of Geopolitical Events and Economic Policy on the Fund’s Results of Operation

Various social and geopolitical factors in the United States and around the world, such as ongoing trade tensions between the U.S. and China or the Russia-Ukraine conflict, may give rise to increased macroeconomic volatility and uncertainty. The Adviser does not believe the current macroeconomic factors have a direct material impact on the Fund’s investments, although the Fund’s investments may be at-risk of indirect impacts such as supply chain disruptions, inflationary pressures, or other related factors.

The U.S. Federal Reserve and other central banks recently have raised certain interest rates and have guided to further increases. As a result, base rates (e.g., LIBOR, SOFR) on which the Fund’s loans are anchored have risen. An increase in base rates to levels that exceed the base rate floors, which are prevalent in most loans, will increase the interest cost to existing borrowers and consequently, the Fund’s gross investment income. However, in the event of continued rate increases above the base rate floor, borrowers may be challenged to service the regular interest burden on the loans.

Inflation may adversely affect the Fund’s investments in a number of ways. Certain of the Fund’s portfolio companies are in Inflation may adversely affect the Fund’s investments in a number of ways. Certain of the Fund’s portfolio companies are in industries that may be impacted by inflationary pressures on the cost of goods or services. If such portfolio companies are unable to pass along cost increases to their customers or effect offsetting cost savings, the incremental costs related to inflation could adversely affect their earnings and ultimately their ability to pay interest and principal on the Fund’s loans. This dynamic may be further exacerbated with an increase in interest rates rise in response to the inflation. Any fundamental impact to the Fund’s portfolio companies due to inflation or rising rates could adversely impact the fair value of those investments, thereby potentially resulting in future realized or unrealized losses.

Portfolio and Investment Activity

The following table presents certain information regarding the Fund’s portfolio and investment activity:

 

     For the Three
Months Ended
March 31, 2022
    For the Three
Months Ended
March 31, 2021
 

Investments in Portfolio Companies

   $ (74,262,180 )(1)    $ (64,356,307 )(2) 

Draw Downs against Revolvers and Delayed Draw Term Loans

     (13,964,576     (5,881,161

Principal Repayments

     27,485,721 (3)      15,637,321 (4) 

Sales

     2,387,617       7,921,954  
  

 

 

   

 

 

 

Net Repayments (Investments)

   $ (58,353,418   $ (46,678,193
  

 

 

   

 

 

 

 

(1) 

Includes investments in 22 portfolio companies.

(2) 

Includes investments in 12 portfolio companies.

(3) 

Includes $1,699,247 in revolver and delayed draw term paydowns.

(4) 

Includes $1,348,999 in revolver and delayed draw term paydowns.

 

56


Table of Contents

The following table shows the composition of the investment portfolio and associated yield data as of March 31, 2022:

 

     As of March 31, 2022  
     Amortized Cost      Percentage of
Total 
    Fair Value      Percentage of
Total
    Weighted
Average
Yield(1)
 

First Lien Senior Secured Debt

   $ 916,105,004        90.91   $ 912,966,725        90.26     6.91

Second Lien Junior Secured Debt

     10,759,919        1.07       10,867,145        1.07       9.19

Preferred Stock

     10,909,691        1.08       15,642,451        1.55       —    

Common Stock

     8,269,076        0.82       9,589,172        0.95       —    

Warrants

     347,740        0.03       1,120,411        0.11       —    

Cash and cash equivalents

     61,344,800        6.09       61,344,800        6.06       —    
  

 

 

    

 

 

   

 

 

    

 

 

   

Total

   $ 1,007,736,230        100   $ 1,011,530,704        100  
  

 

 

    

 

 

   

 

 

    

 

 

   

 

(1) 

Based upon the par value of the Fund’s debt investments.

The following table shows the composition of the investment portfolio and associated yield data as of December 31, 2021:

 

     As of December 31, 2021  
     Amortized Cost      Percentage of
Total 
    Fair Value      Percentage of
Total 
    Weighted
Average
Yield(1)
 

First Lien Senior Secured Debt

   $ 858,569,789        91.30   $ 859,412,243        90.75     6.87

Second Lien Junior Secured Debt

     10,534,601        1.12       10,677,299        1.13       9.04

Preferred Stock

     10,098,254        1.07       13,399,346        1.41       —    

Common Stock

     6,330,140        0.67       7,968,227        0.84       —    

Warrants

     347,740        0.04       1,123,878        0.12       —    

Cash and cash equivalents

     54,489,043        5.80       54,489,043        5.75       —    
  

 

 

    

 

 

   

 

 

    

 

 

   

Total

   $ 940,369,567        100   $ 947,070,036        100  
  

 

 

    

 

 

   

 

 

    

 

 

   

 

(1) 

Based upon the par value of the Fund’s debt investments.

The following table presents certain selected financial information regarding the debt investments in the Fund’s portfolio as of March 31, 2022 and December 31, 2021:

 

     As of
March 31, 2022
    As of
December 31, 2021
 

Number of portfolio companies

     165       151  

Percentage of debt bearing a floating rate(1)

     100.00     100.00

Percentage of debt bearing a fixed rate(1)

     0.00     0.00

 

(1) 

Measured on a fair value basis and excluding equity securities.

The following table shows the amortized cost and fair value of the Fund’s performing and non-accrual debt investments as of March 31, 2022:

 

     As of March 31, 2022  
     Amortized Cost      Percentage at
Amortized Cost
    Fair Value      Percentage at
Fair Value
 

Performing

   $ 919,170,386        99.17   $ 921,846,399        99.78

Non-accrual

     7,694,537        0.83     1,987,471        0.22
  

 

 

    

 

 

   

 

 

    

 

 

 

Total

   $ 926,864,923        100   $ 923,833,870        100
  

 

 

    

 

 

   

 

 

    

 

 

 

 

57


Table of Contents

The following table shows the amortized cost and fair value of the Fund’s performing and non-accrual debt investments as of December 31, 2021:

 

     As of December 31, 2021  
     Amortized Cost      Percentage at
Amortized Cost
    Fair Value      Percentage at
Fair Value
 

Performing

   $ 864,817,447        99.52   $ 868,964,978        99.87

Non-accrual

     4,286,943        0.48     1,124,564        0.13
  

 

 

    

 

 

   

 

 

    

 

 

 

Total

   $ 869,104,390        100   $ 870,089,542        100
  

 

 

    

 

 

   

 

 

    

 

 

 

Generally, when interest and/or principal payments on a loan become past due, or if the Fund otherwise does not expect the borrower to be able to service its debt and other obligations, the Fund will place the loan on non-accrual status and will cease recognizing interest income on that loan for financial reporting purposes until all principal and interest have been brought current through payment or due to restructuring such that the interest income is deemed to be collectible. The Fund generally restores non-accrual loans to accrual status when past due principal and interest is paid and, in the management’s judgment, is likely to remain current. As of March 31, 2022 the Fund had four investments, across two issuers, that were on non-accrual status. As of December 31, 2021, the Fund had three investments, with one issuer, that were on non-accrual status.

The following table shows the composition of the investment portfolio (excluding cash and cash equivalents) by industry, at amortized cost and fair value as of March 31, 2022 and December 31, 2021 (with corresponding percentage of total portfolio investments):

 

     As of March 31, 2022  
   Amortized Cost      Percentage of
Total 
    Fair Value      Percentage of
Total 
 

Business Services

   $ 63,838,923        6.75   $ 64,381,613        6.78

Consumer Discretionary

     8,705,700        0.92       8,684,320        0.91  

Consumer Non-Cyclical

     57,485,928        6.07       56,831,245        5.98  

Digital Infrastructure & Services

     150,830,925        15.94       150,989,660        15.89  

Energy

     12,734,162        1.35       14,649,000        1.54  

Financials

     30,433,869        3.22       30,568,123        3.22  

Healthcare & HCIT

     226,307,861        23.91       222,977,055        23.47  

Software & Tech Services

     391,574,116        41.37       399,549,731        42.05  

Transport & Logistics

     4,479,946        0.47       1,555,157        0.16  
  

 

 

    

 

 

   

 

 

    

 

 

 
   $ 946,391,430        100   $ 950,185,904        100
  

 

 

    

 

 

   

 

 

    

 

 

 

 

     As of December 31, 2021  
     Amortized Cost      Percentage of
Total
    Fair Value      Percentage of
Total
 

Business Services

   $ 62,680,825        7.08   $ 63,308,037        7.09

Consumer Discretionary

     8,853,961        1.00       8,896,144        1.00  

Consumer Non-Cyclical

     49,444,346        5.58       49,124,299        5.50  

Digital Infrastructure & Services

     144,135,884        16.27       147,187,636        16.49  

Energy

     9,634,235        1.09       10,335,624        1.16  

Financial Services

     28,629,622        3.23       28,663,648        3.21  

Healthcare & HCIT

     204,484,590        23.08       202,451,176        22.68  

Software & Tech Services

     373,536,348        42.17       381,063,571        42.69  

Transport & Logistics

     4,480,713        0.50       1,550,858        0.18  
  

 

 

    

 

 

   

 

 

    

 

 

 
   $ 885,880,524        100   $ 892,580,993        100
  

 

 

    

 

 

   

 

 

    

 

 

 

The Adviser monitors the Fund’s portfolio companies on an ongoing basis. It monitors the financial trends of each portfolio company to determine if they are meeting their respective business plans and to assess the appropriate course of action for each company. The Adviser has several methods of evaluating and monitoring the performance and fair value of the Fund’s investments, which may include the following:

 

   

assessment of success in adhering to the portfolio company’s business plan and compliance with covenants;

 

   

periodic or regular contact with portfolio company management and, if appropriate, the financial or strategic sponsor to discuss financial position, requirements and accomplishments;

 

58


Table of Contents
   

comparisons to the Fund’s other portfolio companies in the industry, if any;

 

   

attendance at and participation in board meetings or presentations by portfolio companies; and

 

   

review of monthly and quarterly consolidated financial statements and financial projections of portfolio companies.

Results of Operations

The following is a summary of the Fund’s operating results for the three months ended March 31, 2022 and March 31, 2021:

 

     For the
Three Months
Ended
March 31,
2022
     For the
Three Months
Ended
March 31,
2021
 

Total investment income

   $ 19,687,437      $ 10,859,760  

Total expenses

     11,614,038        6,858,084  
  

 

 

    

 

 

 

Reimbursement payments to Adviser

     259,263        280,779  

Waived collateral management fees

     (456,498      (454,343

Waived management fees

     (283,566      (183,001
  

 

 

    

 

 

 

Net investment income before taxes

     8,554,200        4,358,241  

Income tax expense, including excise tax

     308,827        —    
  

 

 

    

 

 

 

Net investment income after tax

     8,245,373        4,358,241  

Net realized and change in unrealized appreciation (depreciation) on investments

     (2,733,663      1,813,079  
  

 

 

    

 

 

 

Net increase in net assets resulting from operations

   $ 5,511,710      $ 6,171,320  

Less: Net increase (decrease) in net assets resulting from operations related to Non-Controlling Interest in ABPCIC Equity Holdings, LLC

   $ 10      $ (193
  

 

 

    

 

 

 

Net increase (decrease) in net assets resulting from operations related to AB Private Credit Investors Corporation

   $ 5,511,700      $ 6,171,513  
  

 

 

    

 

 

 

Investment Income

During the three months ended March 31, 2022, the Fund’s investment income was comprised of $19,084,451 of interest income, which includes $1,390,757 from the net amortization of premium and accretion of discounts, $594,399 of payment-in-kind interest, and $8,587 of dividend income. The increase in net investment income during the three months ended March 31, 2022, compared to the three months ended March 31, 2021, can primarily be attributed to an increase in gross assets.

During the three months ended March 31, 2021, the Fund’s investment income was comprised of $10,484,277 of interest income, which includes $788,271 from the net amortization of premium and accretion of discounts, and $375,483 of payment-in-kind interest.

Operating Expenses

The following is a summary of the Fund’s operating expenses for the three months ended March 31, 2022 and March 31, 2021:

 

     For the Three
Months
Ended
March 31,
2022
     For the Three
Months
Ended
March 31,
2021
 

Interest and borrowing expenses

   $ 5,140,785      $ 2,605,053  

Management fees

     3,402,792        2,069,181  

Income-based incentive fee

     1,931,939        641,062  

Professional fees

     476,980        549,052  

Collateral management fees

     456,498        454,343  

Administration and custodian fees

     223,237        163,051  

Insurance expenses

     153,239        146,334  

Directors’ fees

     50,000        50,000  

 

59


Table of Contents
     For the Three
Months
Ended
March 31,
2022
     For the Three
Months
Ended
March 31,
2021
 

Transfer agent fees

     25,676        16,386  

Capital gains incentive fee

     (546,733      —    

Other expenses

     299,625        163,622  
  

 

 

    

 

 

 

Total expenses

     11,614,038        6,858,084  

Reimbursement payments to Adviser

     259,263      280,779  

Waived collateral management fees

     (456,498      (454,343

Waived management fees

     (283,566      (183,001

Income tax expense, including excise tax

     308,827        —    
  

 

 

    

 

 

 

Net expenses

   $ 11,442,064      $ 6,501,519  
  

 

 

    

 

 

 

Interest and Borrowing Expenses

Interest and borrowing expenses includes interest, amortization of debt issuance and deferred financing costs, upfront commitment fees and unused fees on the unused portion of the Revolving Credit Facilities, Secured Borrowings and the Notes issued in the CLO Transaction. As of March 31, 2022, there were outstanding balances of $25,000,000, $163,300,000 and $220,300,000 on the 2021 HSBC Credit Facility, Synovus Credit Facility and the Natixis Credit Facility, respectively, and an outstanding balance of $5,360,494 in Secured Borrowings.

As of December 31, 2021, there were outstanding balances of $40,000,000, $147,300,000, and $193,300,000 on the 2021 HSBC Credit Facility, Synovus Credit Facility, and the Natixis Credit Facility, respectively, and an outstanding balance of $10,228,115 in Secured Borrowings.

The outstanding amount on the Notes is $212,730,066, net of unamortized discount and debt issuance costs as of March 31, 2022. The outstanding amount on the Notes was $212,454,604, net of unamortized discount and debt issuance costs as of December 31, 2021.

Interest and borrowing expenses for the three months ended March 31, 2022 and March 31, 2021 were $5,140,785 and $2,605,053, respectively. The weighted average interest rate (excluding deferred upfront financing costs and unused fees) on the Fund’s debt outstanding was 2.65% and 2.52% for the three months ended March 31, 2022 and March 31, 2021, respectively. The increase in interest and borrowing expenses during the three months ended March 31, 2022 compared to the three months ended March 31, 2021 can primarily be attributed to an increase in debt outstanding and interest rates.

Management Fee

The gross management fee expenses for the three months ended March 31, 2022 and March 31, 2021 were $3,402,792 and $2,069,181, respectively. The increase in the management fee for the three months ended March 31, 2022 was a result of the increase in average gross assets during this period, which are the basis used to calculate management fees. For the three months ended March 31, 2022 and March 31, 2021, the Adviser waived management fees of $283,566 and $183,001, respectively.

Fund Expenses

For the three months ended March 31, 2022, the Fund incurred $11,614,038 of expenses in relation to interest and borrowing expenses, management fees, incentive fees, professional fees, administration and custodian fees, insurance expenses, directors’ fees, collateral management fees, transfer agent fees, and other expenses. Additionally, $259,263 was reimbursed by the Fund to the Adviser and its affiliates. Further, $283,566 of management fees and $456,498 of collateral management fees were waived by the Adviser. The Fund incurred $308,827 of tax expense.

For the three months ended March 31, 2021, the Fund incurred $6,858,084 of expenses in relation to professional fees, directors’ fees, collateral management fees, management fees, incentive fees, insurance expenses, interest and borrowing expenses, transfer agent fees, other fees, and administration and custodian fees. Additionally, $280,779 was reimbursed by the Fund to the Adviser and its affiliates. Further, $183,001 of management fees and $454,343 of collateral management fees were waived by the Adviser.

Net Realized Gain (Loss) on Investments

During the three months ended March 31, 2022, the Fund had principal repayments and sales which resulted in $172,332 of net realized gain.

 

60


Table of Contents

During the three months ended March 31, 2021, the Fund had principal repayments and sales which resulted in $59,470 of net realized gain.

Net Change in Unrealized Appreciation (Depreciation) on Investments

During the three months ended March 31, 2022, the Fund had $2,905,995 in net change in unrealized depreciation on $946,391,430 of investments in 165 portfolio companies. Net change in unrealized depreciation for the three months ended March 31, 2022, resulted from a broad portfolio decline due to a decline in loan market secondary prices and widening primary issue credit spreads as well as a reclass of prior unrealized gain to investment income from a large prepayment fee on one investment. This depreciation was partially offset by gains on debt and equity positions marked up due to company performance or expectation of near-term repayment at par.

During the three months ended March 31, 2021, the Fund had $1,753,609 in net change in unrealized appreciation on $587,129,877 of investments in 121 portfolio companies. Unrealized appreciation for the three months ended March 31, 2021, resulted from an increase in fair value, primarily due to positive valuation adjustments on level 3 securities.

Net Increase (Decrease) in Net Assets Resulting from Operations

For the three months ended March 31, 2022 and 2021, the net increase in net assets resulting from operations was $5,511,700 and $6,171,513, respectively. Based on the weighted average shares of common stock outstanding for the three months ended March 31, 2022 and 2021, the Fund’s per share net increase in net assets resulting from operations was $0.15 and $0.23, respectively.

Cash Flows

For the three months ended March 31, 2022, cash increased by $6,855,757. During the same period, the Fund used $59,973,005 in operating activities, primarily as a result of net purchases of investments. During the three months ended March 31, 2022, the Fund generated $66,828,762 from financing activities, primarily from issuance of common stock, and net borrowings on the Revolving Credit Facilities.

For the three months ended March 31, 2021, cash increased by $28,479,861. During the same period, the Fund used $39,889,032 in operating activities, primarily as a result of net purchases of investments. During the three months ended March 31, 2021, the Fund generated $68,368,893 from financing activities, primarily from issuance of common stock and net borrowings on the Revolving Credit Facility.

Hedging

The Fund may enter into currency hedging contracts, interest rate hedging agreements such as futures, options, swaps and forward contracts, and credit hedging contracts, such as credit default swaps. However, no assurance can be given that such hedging transactions will be entered into or, if they are, that they will be effective. For the three months ended March 31, 2022 and March 31, 2021, the Fund did not enter into any hedging contracts.

Financial Condition, Liquidity and Capital Resources

At March 31, 2022, and December 31, 2021, the Fund had $61,344,800 and $54,489,043 in cash and cash equivalents, respectively. The Fund expects to generate cash primarily from (i) the net proceeds of the Private Offering, (ii) cash flows from the Fund’s operations, (iii) any financing arrangements now existing or that the Fund may enter into in the future and (iv) any future offerings of the Fund’s equity or debt securities. The Fund may fund a portion of its investments through borrowings from banks, or other large global institutions such as insurance companies, and issuances of senior securities.

The Fund’s primary use of funds from a credit facility will be investments in portfolio companies, cash distributions to holders of its common stock and the payment of operating expenses.

In the future, the Fund may also securitize or finance a portion of its investments with a special purpose vehicle. If the Fund undertakes a securitization transaction, the Fund will consolidate its allocable portion of the debt of any securitization subsidiary on its financial statements, and include such debt in the Fund’s calculation of the asset coverage test, if and to the extent required pursuant to the guidance of the staff of the SEC.

Cash and cash equivalents as of March 31, 2022, taken together with the Fund’s uncalled Capital Commitments of $129,623,483 and $25,000,000 undrawn amount on the 2021 HSBC Credit Facility, $36,700,000 undrawn amount on the Synovus Credit Facility and $29,700,000 undrawn amount on the Natixis Credit Facility, is expected to be sufficient for the Fund’s investing activities and to conduct the Fund’s operations for at least the next twelve months.

 

61


Table of Contents

As of March 31, 2022, the Fund has unfunded commitments to fund future investments in the amount of $176,235,827, and contractual obligations in the form of Revolving Credit Facilities of $408,600,000 and Notes of $212,730,066.

This “Financial Condition, Liquidity and Capital Resources” section should be read in conjunction with “Effects of COVID-19 on the Fund’s Results of Operations” above.

Equity Activity

The Fund has the authority to issue 200,000,000 Shares.

The Fund has entered into Subscription Agreements with investors providing for the private placement of Shares. Under the terms of the Subscription Agreements, investors are required to fund drawdowns to purchase Shares up to the amount of their respective Capital Commitments on an as-needed basis upon the issuance of a capital draw down notice. As of March 31, 2022, the Fund received Capital Commitments of $515,060,614. Inception to March 31, 2022, the Fund received Capital Contributions to the Fund of $385,437,131. Proceeds from the issuances of Shares in respect of drawdown notices described below were used for investing activities and for other general corporate purposes.

Consistent with the Fund’s offering documents, beginning with the quarter ending March 31, 2021, the Fund was required to begin conducting quarterly General Tenders. Pursuant to the General Tender Program, at the Board’s discretion and in accordance with the requirements of Rule 13e-4 under the Exchange Act and the 1940 Act, each stockholder is given the opportunity to tender Shares at a specific Purchase Price based on the Fund’s net asset value as of the last date of the quarter in which the General Tender is conducted. The Fund intends to conduct each General Tender to repurchase up to a certain percentage of the weighted average of the number of Shares outstanding during the three-month period prior to the quarter in which the General Tender is conducted, as determined by the Board. The General Tender Program includes numerous restrictions that limit stockholders’ ability to sell their Shares.

On February 25, 2022, the Fund commenced the Q1 2022 Tender Offer for up to 795,163.70 Shares. The Purchase Price for the Q1 2022 Tender Offer was $9.70 per Share and the Q1 2022 Tender Offer expired on March 31, 2022.

On February 26, 2021, the Fund commenced the Q1 2021 Tender Offer for up to 502,190.45 Shares (the “Q1 2021 Tender Offer Cap”) tendered prior to March 31, 2021 (the “Initial Expiration Date”). As a result of the number of Shares tendered to the Fund prior to the Initial Expiration Date, the Fund extended the Q1 2021 Tender Offer and increased the Q1 2021 Tender Offer Cap to 2,083,220 Shares. The Purchase Price for the Q1 2021 Tender Offer was $9.43 per Share and the Q1 2021 Tender Offer expired on April 16, 2021.

Stockholders who tendered Shares in the Q1 2022 Tender Offer and Q1 2021 Tender Offer received a non-interest bearing, non-transferable promissory note entitling such stockholders to an amount in cash equal to the number of Shares accepted for purchase multiplied by the applicable Purchase Price.

The following is a summary of the Fund’s equity activity for the three months ended March 31, 2022 and March 31, 2021.

 

     For the Three
Months
Ended
March 31,
2022
     For the Three
Months
Ended
March 31,
2021
 

Capital Commitments

   $ 50,603,350      $ 18,824,108  

Capital Commitments rescinded due to participation in General Tender Program

   $ 7,115,200      $ 9,797,000  

Dividend reinvestments

   $ 5,101,704      $ 2,167,568  

Shares issued to investors under DRIP

     526,163        229,904  

Value of capital drawdown notices

   $ 30,684,000      $ 37,708,999  

Shares issued to investors under capital drawdown notices

     3,095,246        4,001,981  

Value of Shares purchased in General Tender Program

   $ 4,081,370      $ 11,061,881  

Shares purchased in General Tender Offer

     420,864        1,173,288  

Distributions

Distributions to stockholders are recorded on the record date. To the extent that the Fund has income available, the Fund intends to distribute quarterly distributions to its stockholders. The Fund’s quarterly distributions, if any, will be determined by the Board. Any distributions to the Fund’s stockholders will be declared out of assets legally available for distribution.

 

62


Table of Contents

The following table summarizes distributions declared during the three months ended March 31, 2022:

 

Date Declared

   Record Date      Payment Date      Amount Per Share      Total Distributions  

March 29, 2022

     March 29, 2022        April 28, 2022      $ 0.25      $ 9,709,845  
        

 

 

    

 

 

 

Total distributions declared

         $ 0.25      $ 9,709,845  
        

 

 

    

 

 

 

The following table summarizes distributions declared during the three months ended March 31, 2021:

 

Date Declared

   Record Date      Payment Date      Amount Per Share      Total Distributions  

March 29, 2021

     March 29, 2021        April 28, 2021      $ 0.16      $ 4,358,022  
        

 

 

    

 

 

 

Total distributions declared

         $ 0.16      $ 4,358,022  
        

 

 

    

 

 

 

The federal income tax characterization of distributions declared and paid for the fiscal year will be determined at fiscal year-end based upon the Fund’s investment company taxable income for the full fiscal year and distributions paid during the full year. For the three months ended March 31, 2022, all of the Fund’s distributions to stockholders were attributable to ordinary income. The character of distributions for federal income tax purposes are determined in accordance with income tax regulations which may differ from GAAP. Stockholders should read any written disclosure accompanying a distribution payment carefully and should not assume that the source of any distribution is only ordinary income or gains.

To the extent the Fund’s taxable earnings fall below the total amount of its distributions paid for that fiscal year, a portion of those distributions may be deemed a return of capital to the Fund’s stockholders for U.S. federal income tax purposes. Thus, the source of a distribution to stockholders may be the original capital invested by the stockholder rather than the Fund’s income or gains.

For the three months ended March 31, 2022, all of the Fund’s distributions to stockholders were attributable to ordinary income. The character of distributions for federal income tax purposes are determined in accordance with income tax regulations which may differ from GAAP. Stockholders should read any written disclosure accompanying a distribution payment carefully and should not assume that the source of any distribution is only ordinary income or gains.

Co-investment Exemptive Order

On August 6, 2018, the SEC granted the Fund relief sought in a new exemptive application that expands the co-investment exemptive relief previously granted to the Fund in October 2016 to allow the Fund to co-invest in portfolio companies with Affiliated Funds in a manner consistent with its investment objective, positions, policies, strategies and restrictions as well as regulatory requirements and other pertinent factors, subject to compliance with the Order. Pursuant to the Order, the Fund is permitted to co-invest with Affiliated Funds, which the new exemptive relief defines to include affiliated managed accounts, if, among other things, a “required majority” (as defined in Section 57(o) of the 1940 Act) of the Fund’s independent directors make certain conclusions in connection with a co-investment transaction, including that (1) the terms of the transactions, including the consideration to be paid, are reasonable and fair to the Fund and the Fund’s stockholders and do not involve overreaching in respect of the Fund or the Fund’s stockholders on the part of any person concerned, and (2) the transaction is consistent with the interests of the Fund’s stockholders and is consistent with the Fund’s investment objective and strategies. The Fund intends to co-invest with Affiliated Funds, subject to the conditions included in the Order.

Revolving Credit Facilities

2021 HSBC Credit Facility

On November 15, 2017, the Fund entered into the HSBC Credit Agreement to establish the HSBC Credit Facility with the HSBC Administrative Agent and any other lender that becomes a party to the HSBC Credit Agreement in accordance with the terms of the HSBC Credit Agreement, as lenders. The Fund amended and restated the HSBC Credit Agreement on January 31, 2019, and on July 8, 2021, the Fund terminated the HSBC Credit Agreement and all outstanding loans thereunder were repaid and all obligations thereunder were released and terminated. Concurrent with the termination of the HSBC Credit Agreement, the Fund entered into the HSBC Joinder, pursuant to which the Fund became a party to the 2021 HSBC Credit Facility evidenced by the 2021 HSBC Credit Agreement. As of March 31, 2022, the Fund had $25,000,000 outstanding on the 2021 HSBC Credit Facility and the Fund was in compliance with the terms of the 2021 HSBC Credit Facility. As of December 31, 2021, the Fund had $40,000,000 outstanding on the 2021 HSBC Credit Facility and the Fund was in compliance with the terms of the 2021 HSBC Credit Facility.

For further details, see “Note 4. Borrowings,” to the Fund’s consolidated financial statements.

 

63


Table of Contents

Synovus Credit Facility

On October 15, 2020, ABPCIC Funding II entered into the Synovus Credit Facility. In connection with the Synovus Credit Facility, ABPCIC Funding II entered into, among other agreements, (i) the Synovus Loan Agreement, (ii) the securities account control agreement (the “Synovus Control Agreement”), by and among ABPCIC Funding II, the Synovus Collateral Agent and the Synovus Securities Intermediary and (iii) the amended and restated sale and contribution agreement (the “Synovus Transfer Agreement”) by and between the Fund, as seller, and ABPCIC Funding II, as purchaser.

Borrowings of ABPCIC Funding II are considered borrowings by the Fund for purposes of complying with the asset coverage requirements under the 1940 Act applicable to business development companies. As of March 31, 2022, the Fund had $163,300,000 outstanding on the Synovus Credit Facility and the Fund was in compliance with the terms of the Synovus Credit Facility. As of December 31, 2021, the Fud had $147,300,000 outstanding on the Synovus Credit Facility and the Fund was in compliance with the terms of the Synovus Credit Facility.

For further details, see “Note 4. Borrowings,” to the Fund’s consolidated financial statements.

Natixis Credit Facility

On March 24, 2021, ABPCIC Funding III entered into the Natixis Credit Facility. In connection with the Natixis Credit Facility, ABPCIC Funding III entered into, among other agreements, (i) the Natixis Credit Agreement, (ii) the Natixis Account Control Agreement, (iii) the Natixis Collateral Management Agreement, (iv) the Natixis Collateral Administration Agreement and (v) the Natixis Transfer Agreement. On March 4, 2022, pursuant to Amendment No 4 to the Natixis Credit Agreement, ABPCIC Funding III increased the commitment by $25,000,000 from $225,000,000 to $250,000,000. As of March 31, 2022, the Fund had $220,300,000 outstanding on the Natixis Credit Facility and the Fund was in compliance with the terms of the Natixis Credit Facility. As of December 31, 2021, the Fund had $193,300,000 outstanding on the Natixis Credit Facility and the Fund was in compliance with the terms of the Natixis Credit Facility.

For further details, see “Note 4. Borrowings,” to the Fund’s consolidated financial statements.

Secured Borrowings

From time to time, the Fund may engage in sale/buy-back agreements, which are a type of secured borrowing. The amount, interest rate and terms of these agreements will be individually negotiated on a transaction-by-transaction basis. Each borrowing is secured by an interest in an underlying asset which is participated or assigned to the sale/buy-back counterparty for the duration of the agreement.

Outstanding Secured Borrowings pursuant to the Macquarie Sale/Buy-Back was $5,360,494 and $10,228,115 as of March 31, 2022 and December 31, 2021, respectively.

For further details, see “Note 4. Borrowings,” to the Fund’s consolidated financial statements.    

Debt Securitization

On August 9, 2019, the Issuer and the Co-Issuer, each a newly formed special purpose vehicle, completed the CLO Transaction. The Notes offered by the Co-Issuers in the CLO Transaction are secured by a diversified portfolio of the Co-Issuers consisting primarily of middle market loans and participation interests in middle market loans and may also include some broadly syndicated loans. The CLO Transaction was executed through a private placement of: (i) $178,200,000 of Class A-1 Senior Secured Floating Rate Notes, which bear interest at three-months LIBOR plus 1.73% per annum; (ii) $25,000,000 of Class A-2A Senior Secured Floating Rate Notes, which bear interest at LIBOR plus 2.45% per annum; (iii) $9,950,000 of Class A-2B Senior Secured Fixed Rate Notes, which bear interest at 4.23% per annum; (iv) $16,400,000 of Class B Secured Deferrable Floating Rate Notes, which bear interest at LIBOR plus 3.40% per annum; and (v) $17,350,000 of Class C Secured Deferrable Floating Rate Notes, which bear interest at LIBOR plus 4.40% per annum. The Notes are scheduled to mature on August 9, 2030.

The Notes are the secured obligations of the Co-Issuers, and the indenture governing the Notes includes customary covenants and events of default. The Notes have not been, and will not be, registered under the Securities Act, as amended, or any state securities or “blue sky” laws and may not be offered or sold in the United States absent registration with the SEC or an applicable exemption from registration.

The Adviser serves as collateral manager to the Issuer pursuant to the CLO Collateral Management Agreement. For so long as the Adviser serves as collateral manager to the Issuer, the Adviser will elect to irrevocably waive any base management fee or subordinated interest to which it may be entitled under the CLO Collateral Management Agreement.

For further details, see “Note 4. Borrowings,” to the Fund’s consolidated financial statements.

 

64


Table of Contents

Asset Coverage

In accordance with the 1940 Act, the Fund has historically only been allowed to borrow amounts such that its “asset coverage,” as defined in the 1940 Act, is at least 200% after such borrowing, permitting the Fund to borrow up to one dollar for investment purposes for every one dollar of investor equity. “Asset coverage” generally refers to a company’s total assets, less all liabilities and indebtedness not represented by “senior securities,” as defined in the 1940 Act, divided by total senior securities representing indebtedness and, if applicable, preferred stock. “Senior securities” for this purpose includes borrowings from banks or other lenders, debt securities and preferred stock.

On March 23, 2018, the SBCAA was signed into law. The SBCAA, among other things, modifies the applicable provisions of the 1940 Act to reduce the required asset coverage ratio applicable to BDCs from 200% to 150% subject to certain approval, time and disclosure requirements (including either stockholder approval or approval of a majority of the directors who are not interested persons of the BDC and who have no financial interest in the proposal). On July 5, 2018, the Board voted to approve the adoption of the reduced asset coverage ratio and separately recommended that Investors approve the reduced asset coverage requirements at the 2018 annual meeting of stockholders. On September 26, 2018, at the Fund’s 2018 annual meeting of stockholders, the Fund’s stockholders approved the reduction of the required minimum asset coverage ratio applicable to the Fund from 200% to 150%, which took effect on September 27, 2018. This reduction in the required minimum asset coverage ratio increases the amount of debt that the Fund is permitted to incur, permitting the Fund to borrow up to two dollars for investment purposes for every one dollar of investor equity.

As of March 31, 2022, and December 31, 2021, the Fund had total senior securities of $627,110,494 and $603,978,115, respectively, consisting of borrowings under the Revolving Credit Facilities, secured borrowings and the Notes, and had asset coverage ratios of 160% and 157%, respectively.

Critical Accounting Policies

Valuation of Investments

The Fund measures the value of its investments at fair value accordance with Accounting Standards Codification Topic 820, Fair Value Measurements and Disclosure, or “ASC Topic 820,” issued by the Financial Accounting Standards Board, or “FASB.” Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.

The audit committee of the Board (the “Audit Committee”) is also responsible for assisting the Board in valuing investments that are not publicly traded or for which current market values are not readily available. Investments for which market quotations are readily available are valued using market quotations, which are generally obtained from independent pricing services, broker-dealers or market makers. With respect to portfolio investments for which market quotations are not readily available, the Board, with the assistance of the Adviser and its senior investment team and independent valuation firms, is responsible for determining in good faith the fair value in accordance with the valuation policy approved by the Board. If more than one valuation method is used to measure fair value, the results are evaluated and weighted, as appropriate, considering the reasonableness of the range indicated by those results. The Fund considers a range of fair values based upon the valuation techniques utilized and selects the value within that range that was most representative of fair value based on current market conditions as well as other factors the Adviser’s senior investment team considers relevant.

ASC Topic 820 specifies a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. ASC Topic 820 also provides guidance regarding a fair value hierarchy, which prioritizes information used to measure fair value and the effect of fair value measurements on earnings and provides for enhanced disclosures determined by the level within the hierarchy of information used in the valuation. In accordance with ASC Topic 820, these inputs are summarized in the three levels listed below:

 

   

Level 1 – Quoted prices in active markets for identical investments.

 

   

Level 2 – Other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, credit risk, etc.).

 

   

Level 3 – Significant unobservable inputs (including the Fund’s own assumptions in determining the fair value of investments at the reporting date).

The level in the fair value hierarchy within which the fair value measurement is categorized in its entirety is determined on the basis of the lowest level input that is significant to the fair value measurement in its entirety. For this purpose, the significance of an input is assessed against the fair value measurement in its entirety. If a fair value measurement uses observable inputs that require significant adjustment based on unobservable inputs, that measurement is a Level 3 measurement. If a fair value measurement uses

 

65


Table of Contents

price data vendors or observable market price quotations, that measurement is a Level 2 measurement. Assessing the significance of a particular input to the fair value measurement in its entirety requires judgment, considering factors specific to the asset or liability.

The determination of what constitutes “observable” requires significant judgment by the Fund. The Fund considers observable data to be that market data that is readily available, regularly distributed or updated, reliable and verifiable, not proprietary, and provided by independent sources that are actively involved in the relevant market.

Because of the inherent uncertainty of valuation for all fair value investments and interests, the Board’s determination of fair value may differ from the values that would have been used had a ready market existed, or that could have been (or will be) realized in an actual sale, and such differences could be material.

The value of any investment on any valuation date is intended to represent the fair value of such investment on such date based upon the amount at which the investment could be exchanged between willing parties, other than in a forced liquidation sale, and reflects the Board’s determination of fair value using the methodology described herein. Any valuation of an investment may not reflect the actual amount received by the Fund upon the liquidation of such investment.

The Fund’s investments will be primarily loans made to middle-market companies. These investments are mostly considered Level 3 assets under ASC Topic 820 because there is not usually a known or accessible market or market indices for these types of debt instruments and, thus, the Adviser’s senior investment team must estimate the fair value of these investment securities based on models utilizing unobservable inputs.

Management and Incentive Fees

The Fund will accrue for the base management fee and incentive fee. The accrual for the incentive fee includes the recognition of the incentive fee on unrealized capital gains, even though such incentive fee is neither earned nor payable to the Adviser until the gains are both realized and in excess of unrealized depreciation on investments. The amount of capital gains incentive fee expense related to the hypothetical liquidation of the portfolio (and assuming no other changes in realized or unrealized gains and losses) would only become payable to the Adviser in the event of a complete liquidation of the Fund’s portfolio as of period end and the termination of the Amended and Restated Advisory Agreement on such date. Also, it should be noted that the capital gains incentive fee expense fluctuates with the Fund’s overall investment results.

Federal Income Taxes

The Fund has elected to be treated, and to qualify annually, as a RIC under Subchapter M of the Code. Generally, a RIC is not subject to federal income taxes on distributed income and gains if it distributes at least 90% of its net ordinary income and net short-term capital gains in excess of its net long-term capital losses, if any, to its stockholders. The Fund intends to distribute sufficient dividends to maintain its RIC status each year and the Fund does not anticipate paying any material federal income taxes in the future.

 

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

The Fund is subject to financial market risks, including changes in interest rates. To the extent that the Fund borrows money to make investments, the Fund’s net investment income is dependent upon the difference between the rate at which the Fund borrows funds and the rate at which the Fund invests these funds. In periods of rising interest rates, the Fund’s cost of funds would increase, which may reduce the Fund’s net investment income. Because the Fund expects that most of its investments will bear interest at floating rates, the Fund anticipates that an increase in interest rates would have a corresponding increase in the Fund’s interest income that would likely offset any increase in the Fund’s cost of funds and, thus, net investment income would not be reduced. However, there can be no assurance that a significant change in market interest rates will not have an adverse effect on the Fund’s net investment income. In addition, U.S. and global capital markets and credit markets have experienced a higher level of stress due to the global COVID-19 pandemic, which has resulted in an increase in the level of volatility across such markets and a general decline in the value of the securities held by the Fund.

The Fund will generally invest in illiquid loans and securities including debt and equity securities of middle-market companies. Because the Fund expects that there will not be a readily available market for many of the investments in the Fund’s portfolio, the Fund expects to value many of its portfolio investments at fair value as determined in good faith by the Board using a documented valuation policy and a consistently applied valuation process. Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market value, the fair value of the Fund’s investments may differ significantly from the values that would have been used had a readily available market value existed for such investments, and the differences could be material.

 

66


Table of Contents

In connection with the COVID-19 pandemic, the U.S. Federal Reserve and other central banks have reduced certain interest rates and LIBOR has decreased. A prolonged reduction in interest rates will reduce the Fund’s gross investment income and could result in a decrease in the Fund’s net investment income if such decreases in LIBOR are not offset by a corresponding increase in the spread over LIBOR that the Fund earns on any portfolio investments, a decrease in the Fund’s operating expenses, including with respect to the Fund’s income incentive fee, or a decrease in the interest rate of the Fund’s floating interest rate liabilities tied to LIBOR.

Assuming that the consolidated statement of assets and liabilities as of March 31, 2022, were to remain constant and that the Fund took no actions to alter its existing interest rate sensitivity, the following table shows the annualized impact of hypothetical base rate changes in interest rates.

 

Change in Interest Rates

   Increase (Decrease) in
Interest Income
     Increase (Decrease) in
Interest Expense
     Net Increase (Decrease) in
Net Investment Income
 

Down 25 basis points

   $ (687,052    $ (2,177,896    $ 1,490,844  

Up 100 basis points

     8,655,872        5,139,405        3,516,467  

Up 200 basis points

     18,079,727        11,007,405        7,072,321  

Up 300 basis points

     27,503,581        16,875,405        10,628,176  

In addition, although the Fund does not currently intend to make investments that are denominated in a foreign currency, to the extent it does, the Fund will be subject to risks associated with changes in currency exchange rates. These risks include the possibility of significant fluctuations in the foreign currency markets, the imposition or modification of foreign exchange controls and potential illiquidity in the secondary market. These risks will vary depending upon the currency or currencies involved.

The Fund may hedge against interest rate and currency exchange rate fluctuations by using standard hedging instruments such as futures, options and forward contracts subject to the requirements of the 1940 Act. While hedging activities may insulate the Fund against adverse changes in interest rates, they may also limit the Fund’s ability to participate in benefits of lower interest rates with respect to the Fund’s portfolio of investments with fixed interest rates.

 

Item 4.

Controls and Procedures

As of the end of the period covered by this report, the Fund carried out an evaluation, under the supervision and with the participation of the Fund’s management, including the Fund’s Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of the Fund’s disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) under the Exchange Act). Based on that evaluation, the Fund’s Chief Executive Officer and Chief Financial Officer have concluded that the Fund’s current disclosure controls and procedures are effective in timely alerting them to material information relating to the Fund that is required to be disclosed by the Fund in the reports it files or submits under the Exchange Act.

There have been no changes in the Fund’s internal control over financial reporting that occurred during the Fund’s most recently completed fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Fund’s internal control over financial reporting.

PART II. OTHER INFORMATION

 

Item 1.

Legal Proceedings

The Fund is not currently subject to any material legal proceedings, nor, to the Fund’s knowledge, is any material legal proceeding threatened against the Fund. From time to time, the Fund may be a party to certain legal proceedings in the ordinary course of business, including proceedings relating to the enforcement of the Fund’s rights under contracts with its portfolio companies. The Fund’s business is also subject to extensive regulation, which may result in regulatory proceedings against the Fund. While the outcome of these legal proceedings cannot be predicted with certainty, the Fund does not expect that these proceedings will have a material effect upon its financial condition or results of operations.

 

Item 1A.

Risk Factors

In addition to the other information set forth in this report, you should carefully consider the factors discussed in Part I, “Item 1A. Risk Factors” in the Fund’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021, which could materially affect the Fund’s business, financial condition and/or operating results. The risks described in the Fund’s Annual Report on Form 10-K are not the only risks the Fund faces. Additional risks and uncertainties that are not currently known to the Fund or that the Fund currently deems to be immaterial also may materially adversely affect the Fund’s business, financial condition and/or operating results. During the three months ended March 31, 2022, there have been no material changes from the risk factors set forth in the Fund’s Annual Report on Form 10-K for the year ended December 31, 2021, except for the following.

 

67


Table of Contents

The Small Business Credit Availability Act allows the Fund to incur additional leverage, which may increase the risk of investing with the Fund.

On March 23, 2018, the SBCAA was signed into law. The SBCAA, among other things, modifies the applicable provisions of the 1940 Act to reduce the required asset coverage ratio applicable to BDCs from 200% to 150% subject to certain approval, time and disclosure requirements (including either stockholder approval or approval of a majority of the directors who are not interested persons of the BDC and who have no financial interest in the proposal). On July 5, 2018, the Board voted to approve the adoption of the reduced asset coverage ratio and separately recommended that Investors approve the reduced asset coverage requirements at the 2018 annual meeting of stockholders. On September 26, 2018, the Fund’s stockholders voted to approve the adoption of the reduced asset coverage ratio, effective September 27, 2018.

Increased leverage could increase the risks associated with investing in the Fund. For example, if the value of the Fund’s assets decreases, although the asset base and expected revenues would be larger because increased leverage would permit the Fund to acquire additional assets, leverage will cause the Fund’s net asset value to decline more sharply than it otherwise would have without leverage or with lower leverage. Similarly, any decrease in the Fund’s revenue would cause its net income to decline more sharply, on a relative basis, than it would have if the Fund had not borrowed or had borrowed less (although, as noted above, the Fund’s asset base and expected revenues would likely be larger). However, since the Fund already uses leverage in optimizing its investment portfolio, there are no material new risks associated with increased leverage other than the amount of the leverage.

If the Fund’s asset coverage ratio falls below the required limit, the Fund will not be able to incur additional debt until it is able to comply with the asset coverage ratio. This could have a material adverse effect on the Fund’s operations, and the Fund may not be able to make distributions to stockholders. The actual amount of leverage that the Fund employs will depend on the Board’s and the Adviser’s assessment of market and other factors at the time of any proposed borrowing. The Fund currently anticipates being able to obtain sufficient credit on acceptable terms, although the Fund can make no assurance that this will be the case or that it will remain such in the future.

The following table illustrates the effect of leverage on returns from an investment in the Shares assuming that the Fund employs leverage such that the Fund’s asset coverage equals (1) the Fund’s actual asset coverage as of March 31, 2022 and (2) 150%, each at various annual returns, net of expenses and as of March 31, 2022.

The calculations in the tables below are hypothetical, and are provided for illustrative purposes only. Actual returns may be higher or lower than those appearing below.

 

Assumed Return on the Fund’s Portfolio (net of expenses)

     (10.00 )%      (5.00 )%      0.00     5.00     10.00
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Corresponding net return to holders of common stock assuming actual asset coverage as of March 31, 2022(1)

     (33.4 )%      (19.7 )%      (6.1 )%      7.6     21.3

Corresponding net return to holders of common stock assuming 150% asset coverage(2)

     (37.0 )%      (22.0 )%      (7.0 )%      8.0     23.0
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(1) 

Assumes $1,020.9 million in total portfolio assets, $647.1 million in debt outstanding, $373.8 million in net assets, and an average cost of funds of 3.5%. Actual interest payments may be different.

(2) 

Assumes $1,020.9 million in total portfolio assets, $680.6 million in debt outstanding, $340.3 million in net assets, and an average cost of funds of 3.5%. Actual interest payments may be different.

 

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

Except as previously reported by the Fund on its current reports on Form 8-K, the Fund did not sell any securities during the period covered by this Quarterly Report that were not registered under the Securities Act.

 

Item 3.

Defaults Upon Senior Securities

None.

 

Item 4.

Mine Safety Disclosure

Not applicable.

 

Item 5.

Other Information

None.

 

68


Table of Contents
Item 6.

Exhibits

The following exhibits are filed as part of this report or hereby incorporated by reference to exhibits previously filed with the SEC:

 

10.1    Fourth Amendment to Credit Agreement, dated as of March 7, 2022, among ABPCIC Funding III LLC, as borrower, the lenders referred to therein, Natixis, New York Branch, as administrative agent, U.S. Bank Trust Company, National Association (as successor in interest to U.S. Bank National Association), as collateral agent and collateral administrator, and U.S. Bank National Association, as custodian (incorporated by reference to Exhibit 10.1 to the Fund’s Current Report on Form 8-K (File No. 814-01196) filed on March 11, 2022).
10.2    Second Amended and Restated Investment Advisory Agreement, dated as of March 24, 2022, by and between AB Private Credit Investors Corporation and AB Private Credit Investors LLC (incorporated by reference to Exhibit 10.1 to the Fund’s Current Report on Form 8-K (File No. 814-01196) filed on March 25, 2022).
10.3    Fee Waiver Letter Delivered to AB Private Credit Investors Corporation by AB Private Credit Investors LLC, dated March 24, 2022 (incorporated by reference to Exhibit 10.2 to the Fund’s Current Report on Form 8-K (File No. 814-01196) filed on March 25, 2022).
31.1    Certification of Chief Executive Officer pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, as amended.*
31.2    Certification of Chief Financial Officer pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, as amended.*
32.1    Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, as amended.*

 

*

Filed herewith

 

69


Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

      AB PRIVATE CREDIT INVESTORS CORPORATION
Date: May 16, 2022     By:  

/s/ J. Brent Humphries

      J. Brent Humphries
      President and Chief Executive Officer
      (Principal Executive Officer)
Date: May 16, 2022     By:  

/s/ Wesley Raper

      Wesley Raper
      Chief Financial Officer and Treasurer
      (Principal Financial and Accounting Officer)